cats20160401

0001437749-16-031856.txt : 20160513 0001437749-16-031856.hdr.sgml : 20160513 20160513163808 ACCESSION NUMBER: 0001437749-16-031856 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 40 CONFORMED PERIOD OF REPORT: 20160331 FILED AS OF DATE: 20160513 DATE AS OF CHANGE: 20160513 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CATASYS, INC. CENTRAL INDEX KEY: 0001136174 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 880464853 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-31932 FILM NUMBER: 161648961 BUSINESS ADDRESS: STREET 1: 11601 WILSHIRE BLVD. STREET 2: SUITE 1100 CITY: LOS ANGELES STATE: CA ZIP: 90025 BUSINESS PHONE: 310 444 4300 MAIL ADDRESS: STREET 1: 11601 WILSHIRE BLVD. STREET 2: SUITE 1100 CITY: LOS ANGELES STATE: CA ZIP: 90025 FORMER COMPANY: FORMER CONFORMED NAME: HYTHIAM, INC. DATE OF NAME CHANGE: 20101029 FORMER COMPANY: FORMER CONFORMED NAME: HYTHIAM INC DATE OF NAME CHANGE: 20031003 FORMER COMPANY: FORMER CONFORMED NAME: ALASKA FREIGHTWAYS INC DATE OF NAME CHANGE: 20010305 10-Q 1 cats20160401_10q.htm FORM 10-Q cats20160401_10q.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2016

Commission File Number 001-31932

CATASYS, INC.

(Exact name of registrant as specified in its charter)

Delaware	88-0464853
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

11601 Wilshire Boulevard, Suite 1100, Los Angeles, California 90025

(Address of principal executive offices, including zip code)

(310) 444-4300

(Registrant's telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ☑ No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes ☑ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer or a smaller reporting company. See definitions of “accelerated filer,” “large accelerated filer,’’ and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer ☐

Accelerated filer ☐

Non-accelerated filer ☐

Smaller reporting company ☑

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes ☐ No ☑

As of May 12, 2016, there were 55,007,761 shares of registrant's common stock, $0.0001 par value, outstanding.

TABLE OF CONTENTS

PART I - FINANCIAL INFORMATION			3

	ITEM 1. Financial Statements		3

		Condensed Consolidated Balance Sheets as of March 31, 2016 (unaudited) and December 31, 2015	3

		Condensed Consolidated Statements of Operations for the Three Months Ended March 31, 2016 and 2015 (unaudited)	4

		Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2016 and 2015 (unaudited)	5

		Notes to Condensed Consolidated Financial Statements	6

	ITEM 2. Management's Discussion and Analysis of Financial Condition and Results of Operations		13

	ITEM 3. Quantitative and Qualitative Disclosures About Market Risk		19

	ITEM 4. Controls and Procedures		19

PART II – OTHER INFORMATION			20

	ITEM 1. Legal Proceedings		20

	ITEM 1A. Risk Factors		20

	ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds		20

	ITEM 3. Defaults Upon Senior Securities		20

	ITEM 4. Mine Safety Disclosures		20

	ITEM 5. Other Information		20

	ITEM 6. Exhibits		20

In this report, except as otherwise stated or the context otherwise requires, the terms “we,” “us” or “our” refer to Catasys, Inc. and our wholly-owned subsidiaries. Our common stock, par value $0.0001 per share, is referred to as “common stock.”

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements

CATASYS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

	(unaudited)
(In thousands, except for number of shares)	March 31,			December 31,
	2016			2015
ASSETS
Current assets
Cash and cash equivalents	$	262		$	916
Receivables, net of allowance for doubtful accounts of $0 and $0, respectively		610			590
Prepaids and other current assets		434			575
Total current assets		1,306			2,081
Long-term assets
Property and equipment, net of accumulated depreciation of $1,515 and $1,491, respectively		390			412
Deposits and other assets		371			387
Total Assets	$	2,067		$	2,880

LIABILITIES AND STOCKHOLDERS' DEFICIT
Current liabilities
Accounts payable	$	772		$	753
Accrued compensation and benefits		1,703			1,703
Deferred revenue		2,276			1,683
Other accrued liabilities		627			682
Short term debt, related party, net of discount $0 and $0, respectively		4,676			-
Short term derivative liability		3,685			-
Total current liabilities		13,739			4,821
Long-term liabilities
Deferred rent and other long-term liabilities		178			198
Capitol leases		38			66
Long term debt, related party, net of discount $0 and $0, respectively		-			3,662
Long term derivative liability		-			2,348
Warrant liabilities		953			509
Total Liabilities		14,908			11,604

Stockholders' deficit
Preferred stock, $0.0001 par value; 50,000,000 shares authorized; no shares issued and outstanding		-			-
Common stock, $0.0001 par value; 500,000,000 shares authorized; 55,007,761 and 55,007,761 shares issued and outstanding at March 31, 2016 and December 31, 2015, respectively		6			6
Additional paid-in-capital		253,228			253,053
Accumulated deficit		(266,075	)		(261,783	)
Total Stockholders' Deficit		(12,841	)		(8,724	)
Total Liabilities and Stockholders' Deficit	$	2,067		$	2,880

See accompanying notes to the condensed consolidated financial statements.

CATASYS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(unaudited)

	Three Months Ended
(In thousands, except per share amounts)	March 31,
	2016			2015
Revenues
Healthcare services revenues	$	728		$	433

Operating expenses
Cost of healthcare services		966			406
General and administrative		2,187			2,734
Depreciation and amortization		32			34
Total operating expenses		3,185			3,174

Loss from operations		(2,457	)		(2,741	)

Other income		65			11
Interest expense		(333	)		(2	)
Change in fair value of warrant liability		(228	)		2,474
Change in fair value of derivative liability		(1,337	)		-
Loss from operations before provision for income taxes		(4,290	)		(258	)
Provision for income taxes		2			2
Net Loss	$	(4,292	)	$	(260	)

Basic net loss from operations per share:	$	(0.08	)	$	(0.01	)

Basic and diluted weighted number of shares outstanding		55,008			25,286

See accompanying notes to the condensed consolidated financial statements.

CATASYS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

(unaudited)

	Three Months Ended
(In thousands)	March 31,
	2016			2015
Operating activities:
Net loss	$	(4,292	)	$	(260	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization		32			33
Issuance costs included in interest expense		216			-
Provision for doubtful accounts		7			66
Deferred rent		(23	)		(17	)
Share-based compensation expense		174			828
Common stock issued for consulting services		-			172
Fair value adjustment on derivative liability		1,337			-
Fair value adjustment on warrant liability		228			(2,474	)
Changes in current assets and liabilities:
Receivables		(27	)		380
Prepaids and other current assets		141			(18	)
Deferred revenue		593			160
Accounts payable and other accrued liabilities		96			319
Net cash used in operating activities	$	(1,518	)	$	(811	)

Investing activities:
Purchases of property and equipment	$	(10	)	$	(8	)
Deposits and other assets		16			-
Net cash provided by/(used in) investing activities	$	6		$	(8	)

Financing activities:
Proceeds from bridge loan	$	900		$	200
Capital lease obligations		(42	)		(5	)
Net cash provided by financing activities	$	858		$	195

Net decrease in cash and cash equivalents	$	(654	)	$	(624	)
Cash and cash equivalents at beginning of period		916			708
Cash and cash equivalents at end of period	$	262		$	84

Supplemental disclosure of cash paid
Income taxes	$	26		$	2
Supplemental disclosure of non-cash activity
Common stock issued for investor relations services	$	-		$	172

See accompanying notes to the condensed consolidated financial statements.

Catasys, Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

(unaudited)

Note 1. Basis of Consolidation, Presentation and Going Concern

The accompanying unaudited condensed consolidated financial statements for Catasys, Inc. and its subsidiaries have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) and instructions to Form 10-Q and, therefore, do not include all disclosures necessary for a complete presentation of financial position, results of operations, and cash flows in conformity with U.S. GAAP. In our opinion, all adjustments, consisting of normal recurring adjustments, considered necessary for a fair presentation have been included. Interim results are not necessarily indicative of the results that may be expected for the entire fiscal year. The accompanying financial information should be read in conjunction with the financial statements and the notes thereto included in our most recent Annual Report on Form 10-K for the year-ended December 31, 2015, from which the balance sheets, as of December 31, 2015, have been derived.

Our financial statements have been prepared on the basis that we will continue as a going concern. At March 31, 2016, cash and cash equivalents was $262,000 and we had a working capital deficit of approximately $12.4 million. In April 2016, we amended the March 2016 promissory note with Acuitas Group Holdings, LLC (“Acuitas”), a limited liability company 100% owned by our Chief Executive Officer and Chairman, to increase the amount of the promissory note by $400,000, for a total of $1.3 million in principal amount. We have incurred significant operating losses and negative cash flows from operations since our inception. During the three months ended March 31, 2016, our cash used in operating activities was $1.5 million. We anticipate that we could continue to incur negative cash flows and net losses for the next twelve months. The financial statements do not include any adjustments relating to the recoverability of the carrying amount of the recorded assets or the amount of liabilities that might result from the outcome of this uncertainty. As of March 31, 2016, these conditions raised substantial doubt as to our ability to continue as a going concern. We expect our current cash resources to cover expenses through the end of May 2016; however delays in cash collections, revenue, or unforeseen expenditures could negatively impact our estimate. We are in need of additional capital, however, there is no assurance that additional capital can be timely raised in an amount which is sufficient for us or on terms favorable to us and our stockholders, if at all. If we do not obtain additional capital, there is a significant doubt as to whether we can continue to operate as a going concern and we will need to curtail or cease operations or seek bankruptcy relief. If we discontinue operations, we may not have sufficient funds to pay any amounts to stockholders.

Note 2. Summary of Significant Accounting Policies

Revenue Recognition

Our Catasys contracts are generally designed to provide cash fees to us on a monthly basis based on enrolled members. To the extent our contracts may include a minimum performance guarantee; we reserve a portion of the monthly fees that may be at risk until the performance measurement period is completed. To the extent we receive case rates or other fees in advance that are not subject to the performance guarantees, we recognize the case rate ratably over the twelve months of the program.

Cost of Services

Cost of healthcare services consists primarily of salaries related to our care coaches, healthcare provider claims payments, and fees charged by our third party administrators for processing these claims. Healthcare services cost of services is recognized in the period in which an eligible member receives services. We contract with doctors and licensed behavioral healthcare professionals, on a fee-for-services basis. We determine that a member has received services when we receive a claim or in the absence of a claim, by utilizing member data recorded in the OnTrak^TM database within the contracted timeframe, with all required billing elements correctly completed by the service provider.

Cash Equivalents and Concentration of Credit Risk

We consider all highly liquid investments with an original maturity of three months or less to be cash equivalents. Financial instruments that potentially subject us to a concentration of credit risk consist of cash and cash equivalents. Cash is deposited with what we believe are highly credited, quality financial institutions. The deposited cash may exceed Federal Deposit Insurance Corporation (“FDIC”) insured limits. At March 31, 2016, cash and cash equivalents exceeding federally insured limits totaled $110,900.

For the three months ended March 31, 2016, four customers accounted for approximately 94% of revenues and three customers accounted for approximately 93% of accounts receivable.

Basic and Diluted Income (Loss) per Share

Basic income (loss) per share is computed by dividing the net income (loss) to common stockholders for the period by the weighted average number of common shares outstanding during the period. Diluted income (loss) per share is computed by dividing the net income (loss) for the period by the weighted average number of common and dilutive common equivalent shares outstanding during the period.

Common equivalent shares, consisting of 3,720,716 and 23,409,694 common shares for the three months ended March 31, 2016 and 2015, respectively, issuable upon the exercise of stock options and warrants have been excluded from the diluted earnings per share calculation as their effect is anti-dilutive.

Share-Based Compensation

Our 2010 Stock Incentive Plan, as amended (the “Plan”), provides for the issuance of up to 1,825,000 shares of our common stock. Incentive stock options (ISOs) under Section 422A of the Internal Revenue Code and non-qualified options (NSOs) are authorized under the Plan. We have granted stock options to executive officers, employees, members of our board of directors, and certain outside consultants. The terms and conditions upon which options become exercisable vary among grants, but option rights expire no later than ten years from the date of grant and employee and board of director awards generally vest over three to five years. At March 31, 2016, we had 1,464,154 vested and unvested shares outstanding and 303,609 shares available for future awards under the Plan.

Total share-based compensation expense on a consolidated basis was $174,000 and $828,000 for the three months ended March 31, 2016 and 2015, respectively.

Stock Options – Employees and Directors

We measure and recognize compensation expense for all share-based payment awards made to employees and directors based on estimated fair values on the date of grant. We estimate the fair value of share-based payment awards using the Black-Scholes option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods in the condensed consolidated statements of operations.

Share-based compensation expense recognized for employees and directors for the three months ended March 31, 2016 and 2015 was $174,000 and $826,000, respectively.

For share-based awards issued to employees and directors, share-based compensation is attributed to expense using the straight-line single option method. Share-based compensation expense recognized in our condensed consolidated statements of operations for the three months ended March 31, 2016 and 2015, is based on awards ultimately expected to vest, reduced for estimated forfeitures. Accounting rules for stock options require forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.

There were no options granted to employees and directors during the three months ended March 31, 2016 and 1,300,000 options were granted to employees and directors during the same period in 2015 under the Plan. Employee and director stock option activity for the three months ended March 31, 2016 are as follows:

				Weighted Avg.
	Shares			Exercise Price
Balance December 31, 2015		1,471,000		$	6.49

Granted		-		$	-
Cancelled		(7,000	)	$	10.38

Balance March 31, 2016		1,464,000		$	6.49

The expected volatility assumptions have been based on the historical and expected volatility of our stock, measured over a period generally commensurate with the expected term. The weighted average expected option term for the three months ended March 31, 2016 and 2015, reflects the application of the simplified method prescribed in SEC Staff Accounting Bulletin (“SAB”) No. 107 (as amended by SAB 110), which defines the life as the average of the contractual term of the options and the weighted average vesting period for all option tranches.

As of March 31, 2016, there was $841,000 of total unrecognized compensation cost related to non-vested share-based compensation arrangements granted under the Plan. That cost is expected to be recognized over a weighted-average period of approximately 1.51 years.

Stock Options and Warrants – Non-employees

We account for the issuance of options and warrants for services from non-employees by estimating the fair value of warrants issued using the Black-Scholes pricing model. This model’s calculations include the option or warrant exercise price, the market price of shares on grant date, the weighted average risk-free interest rate, the expected life of the option or warrant, and the expected volatility of our stock and the expected dividends.

For options and warrants issued as compensation to non-employees for services that are fully vested and non-forfeitable at the time of issuance, the estimated value is recorded in equity and expensed when the services are performed and benefit is received. For unvested shares, the change in fair value during the period is recognized in expense using the graded vesting method.

There were no options issued to non-employees for the three months ended March 31, 2016 and 2015, respectively. Share-based compensation expense relating to stock options and warrants recognized for non-employees was $0 and $2,000 for the three months ended March 31, 2016 and 2015, respectively.

There was no stock option activity for the three months ended March 31, 2016.

Common Stock

There were 0 and 76,000 shares of common stock issued in exchange for investor relations services during the three months ended March 31, 2016 and 2015, respectively. Generally, the costs associated with shares issued for services are being amortized to the related expense on a straight-line basis over the related service periods.

Income Taxes

We have recorded a full valuation allowance against our otherwise recognizable deferred tax assets as of March 31, 2016. As such, we have not recorded a provision for income tax for the period ended March 31, 2016. We utilize the liability method of accounting for income taxes as set forth in ASC 740, Income Taxes. Under the liability method, deferred taxes are determined based on the temporary differences between the financial statement and tax basis of assets and liabilities using tax rates expected to be in effect during the years in which the basis differences reverse. A valuation allowance is recorded when it is more likely than not that some of the deferred tax assets will not be realized. In determining the need for valuation allowances, we consider projected future taxable income and the availability of tax planning strategies. After evaluating all positive and negative historical and perspective evidences, management has determined it is more likely than not that our deferred tax assets will not be realized.

We assess our income tax positions and record tax benefits for all years subject to examination based upon our evaluation of the facts, circumstances and information available at the reporting date. For those tax positions where there is greater than 50% likelihood that a tax benefit will be sustained, we have recorded the largest amount of tax benefit that may potentially be realized upon ultimate settlement with a taxing authority that has full knowledge of all relevant information. For those income tax positions where there is less than 50% likelihood that a tax benefit will be sustained, no tax benefit has been recognized in the financial statements. Based on management's assessment of the facts, circumstances and information available, management has determined that all of the tax benefits for the period ended March 31, 2016 should be realized.

Fair Value Measurements

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Assets and liabilities recorded at fair value in the condensed consolidated balance sheets are categorized based upon the level of judgment associated with the inputs used to measure fair value. The fair value hierarchy distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level I) and the lowest priority to unobservable inputs (Level III). The three levels of the fair value hierarchy are described below:

Level Input:		Input Definition:
Level I		Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.
Level II		Inputs, other than quoted prices included in Level I, that are observable for the asset or liability through corroboration with market data at the measurement date.
Level III		Unobservable inputs that reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date.

The following table summarizes fair value measurements by level at March 31, 2016 for assets and liabilities measured at fair value:

	Balance at March 31, 2016


*(Amounts in thousands)*	Level I		Level II		Level III		Total
Certificates of deposit		106		-		-		106
Total assets		106		-		-		106

Warrant liabilities		-		-		953		953
Derivative Liability						3,685		3,685
Total liabilities		-		-		4,638		4,638

Financial instruments classified as Level III in the fair value hierarchy as of March 31, 2016, represent our liabilities measured at market value on a recurring basis which include warrant liabilities and derivative liabilities resulting from recent debt and equity financings. In accordance with current accounting rules, the warrant liabilities and derivative liabilities are being marked-to-market each quarter-end until they are completely settled. The warrants are valued using the Black-Scholes option-pricing model, using both observable and unobservable inputs and assumptions consistent with those used in our estimate of fair value of employee stock options. See Warrant Liabilities below.

The following table summarizes our fair value measurements using significant Level III inputs, and changes therein, for the three months ended March 31, 2016:

	Level III				Level III
	Warrant				Warrant
*(Dollars in thousands)*	Liabilities		*(Dollars in thousands)*		Liabilities
Balance as of December 31, 2015	$	509	Balance as of December 31, 2015		$	2,348
Issuance of warrants		216		Issuance of warrants		-
Change in fair value		228		Change in fair value		1,337
Balance as of March 31, 2016	$	953	Balance as of March 31, 2016		$	3,685

Intangible Assets

Property and Equipment

Property and equipment are stated at cost, less accumulated depreciation. Additions and improvements to property and equipment are capitalized at cost. Expenditures for maintenance and repairs are charged to expense as incurred. Depreciation is computed using the straight-line method over the estimated useful lives of the related assets, which range from two to seven years for furniture and equipment. Leasehold improvements are amortized over the lesser of the estimated useful lives of the assets or the related lease term, which is typically five to seven years.

Warrant Liabilities

In March 2016, we entered into a promissory note with Acuitas, pursuant to which we received aggregate gross proceeds of $900,000 for the sale of $900,000 in principal amount (the "March 2016 Promissory Note"). The March 2016 Promissory Note is due within 30 business days of demand by Acuitas (the "Maturity Date"), and carries an interest rate on any unpaid principal amount of 8% per annum until the Maturity Date, after which the interest will increase to 12% per annum. In addition, Acuitas was granted five-year warrants to purchase an aggregate 450,000 shares of our common stock, at an exercise price of $0.47 per share, which warrants include, subject to certain exceptions, a full-ratchet anti-dilution protection (the “March 2016 Warrants”).

The warrant liability associated with the March 2016 Warrants were calculated using the Black-Scholes model based upon the following assumptions:

	March 31, 2016
Expected volatility		133.19	%
Risk-free interest rate		1.21	%
Weighted average expected lives in years		5
Expected dividend		0	%

We have issued warrants to purchase common stock in December 2011, February 2012, April 2015, July 2015, and March 2016. The warrants are being accounted for as liabilities in accordance with FASB accounting rules, due to anti-dilution provisions in some warrants that protect the holders from declines in our stock price and a requirement to deliver registered shares upon exercise of the warrants, which is considered outside our control. The warrants are marked-to-market each reporting period, using the Black-Scholes pricing model, until they are completely settled or expire.

For the three months ended March 31, 2016 and 2015, we recognized a loss of $228,000 and a gain of $2.5 million, respectively, related to the revaluation of our warrant liabilities.

Derivative Liability

In July 2015, we entered into the July 2015 Convertible Debenture. The derivative liability associated with the July 2015 Convertible Debenture was calculated using the Black-Scholes model based upon the following assumptions:

	March 31, 2016
Expected volatility		133.19	%
Risk-free interest rate		0.59	%
Weighted average expected lives in years		0.80
Expected dividend		0	%

The expected volatility assumption for the three months ended March 31, 2016 was based on the historical volatility of our stock, measured over a period generally commensurate with the expected term. The weighted average expected lives in years for 2015 reflect the application of the simplified method set out in Security and Exchange Commission (SEC) Staff Accounting Bulletin (SAB) 107 (and as amended by SAB 110), which defines the life as the average of the contractual term of the options and the weighted average vesting period for all option tranches. We use historical data to estimate the rate of forfeitures assumption for awards granted to employees.

For the three months ended March 31, 2016 and 2015, we recognized a loss of $1.3 million and $0 related to the revaluation of our derivative liability, respectively.

Recently Issued or Newly Adopted Accounting Standards

In April 2016, the FASB issued Accounting Standards Update (“ASU”) 2016-10, Revenue from Contracts with Customers (Topic 606), which amends certain aspects of the Board’s new revenue standard, ASU 2014-09, Revenue from Contracts with Customers. The standard should be adopted concurrently with adoption of ASU 2014-09 which is effective for annual and interim periods beginning after December 15, 2017. Early adoption is permitted. The Company has not yet selected a transition method nor has it determined the effect of the standard on its ongoing financial reporting.

In March 2016, the FASB issued ASU 2016-09, Compensation — Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting, which outlines new provisions intended to simplify various aspects related to accounting for share-based payments and their presentation in the financial statements. The standard is effective for the Company beginning December 15, 2016, and interim periods within those annual periods. Early adoption is permitted. The Company is evaluating the impact of the adoption of this guidance on its financial statements.

In February 2015, the FASB issued ASU 2015-02, Consolidation (Topic 810): Amendments to the Consolidation Analysis (“ASU 2015-02”). ASU 2015-02 modifies existing consolidation guidance for reporting organizations that are required to evaluate whether they should consolidate certain legal entities. ASU 2015-02 is effective for fiscal years and interim periods within those years beginning after December 15, 2015, and requires either a retrospective or a modified retrospective approach to adoptions. Early adoption is permitted. We are currently evaluating the potential impact of this standard on our consolidated financial statements, as well as the available transition methods.

In August 2014, the FASB issued FASB ASU 2014-15, Presentation of Financial Statements—Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern, (“ASU 2014-15”). ASU 2014-15 changes to the disclosure of uncertainties about an entity’s ability to continue as a going concern. Under U.S. GAAP, continuation of a reporting entity as a going concern is presumed as the basis for preparing financial statements unless and until the entity’s liquidation becomes imminent. Even if an entity’s liquidation is not imminent, there may be conditions or events that raise substantial doubt about the entity’s ability to continue as a going concern. Because there is no guidance in U.S. GAAP about management’s responsibility to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern or to provide related note disclosures, there is diversity in practice whether, when, and how an entity discloses the relevant conditions and events in its financial statements. As a result, these changes require an entity’s management to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the entity’s ability to continue as a going concern within one year after the date that financial statements are issued. Substantial doubt is defined as an indication that it is probable that an entity will be unable to meet its obligations as they become due within one year after the date that financial statements are issued. If management has concluded that substantial doubt exists, then the following disclosures should be made in the financial statements: (i) principal conditions or events that raised the substantial doubt, (ii) management’s evaluation of the significance of those conditions or events in relation to the entity’s ability to meet its obligations, (iii) management’s plans that alleviated the initial substantial doubt or, if substantial doubt was not alleviated, management’s plans that are intended to at least mitigate the conditions or events that raise substantial doubt, and (iv) if the latter in (iii) is disclosed, an explicit statement that there is substantial doubt about the entity’s ability to continue as a going concern. ASU 2014-15 is effective for periods beginning after December 15, 2016. The adoption of ASU 2013-15 will not have a material effect on our consolidated financial position or results of operations.

Note 3. Related Party Disclosure

In March 2016 we entered into the March 2016 Promissory Note and March 2016 Warrants with Acuitas. In addition, we have accounts payable outstanding with Mr. Peizer for travel and expenses of $129,000 as of March 31, 2016.

Note 4. Short-term Debt

In March 2016, we entered into the March 2016 Promissory Note with Acuitas. The March 2016 Promissory Note is due within 30 business days of the Maturity Date, and carries an interest rate on any unpaid principal amount of 8% annum until the Maturity Date, after which the interest will increase to 12% annum. In addition, Acuitas was granted the March 2016 Warrants.

Note 5. Subsequent Event

In April 2016, we amended the March 2016 Promissory Note with Acuitas to increase the amount of the March 2016 Promissory Note by $400,000, for a total of $1.3 million in principle amount. In connection with the amendment, Acuitas was granted five-year warrants to purchase an additional 200,000 shares of our common stock, at an exercise price of $0.47 which warrants include, subject to certain exceptions, a full-ratchet anti-dilution protection.

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

The following discussion of our financial condition and results of operations should be read in conjunction with our financial statements including the related notes, and the other financial information included elsewhere in this report.

CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING INFORMATION

This report contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 with respect to the financial condition, results of operations, business strategies, operating efficiencies or synergies, competitive positions, growth opportunities for existing products, plans and objectives of management, markets for our stock and other matters. Statements in this report that are not historical facts are hereby identified as “forward-looking statements” for the purpose of the safe harbor provided by Section 21E of the Exchange Act of 1934 and Section 27A of the Securities Act of 1933. Such forward-looking statements, including, without limitation, those relating to the future business prospects, our revenue and income, wherever they occur, are necessarily estimates reflecting the best judgment of our senior management as of the date on which they were made, or if no date is stated, as of the date of this report. These forward-looking statements are subject to risks, uncertainties and assumptions, including those described in the “Risk Factors” in Item 1A of Part I of our most recent Annual Report on Form 10-K (“Form 10-K”) for the fiscal year ended December 31, 2015 and other reports we filed with the Securities and Exchange Commission (“SEC”), that may affect the operations, performance, development and results of our business. Because the factors discussed in this report could cause actual results or outcomes to differ materially from those expressed in any forward-looking statements made by us or on our behalf, you should not place undue reliance on any such forward-looking statements. New factors emerge from time to time, and it is not possible for us to predict which factors will arise. In addition, we cannot assess the impact of each factor on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. We assume no obligation and do not intend to update these forward looking statements, except as required by law.

OVERVIEW

General

We provide data analytics based specialized behavioral health management and treatment services to health plans through our OnTrak program. Our OnTrak program is designed to improve member health and at the same time lower costs to the insurer for underserved populations where behavioral health conditions are causing or exacerbating co-existing medical conditions. The program utilizes proprietary analytics, member engagement and patient centric treatment that integrates evidence-based medical and psychosocial interventions along with care coaching in a 52-week outpatient program. Our initial focus was members with substance use disorders. In the second quarter of 2015, we expanded our program into anxiety disorders, and we have plans to expand into other behavioral health conditions for depression. We currently operate our OnTrak programs in Florida, Illinois, Kansas, Kentucky, Louisiana, Massachusetts, Missouri, New Jersey, Oklahoma, Pennsylvania, Texas, West Virginia and Wisconsin, and our OnTrak for anxiety program in Kansas. We provide services to commercial (employer funded), managed Medicare Advantage and managed Medicaid populations.

Recent Developments

In March 2016, we entered into a promissory note with Acuitas Group Holdings, LLC (“Acuitas”), a limited liability company 100% owned by our Chief Executive Officer and Chairman, pursuant to which we received aggregate gross proceeds of $900,000 for the sale of $900,000 in principal amount (the "March 2016 Promissory Note"). The March 2016 Promissory Note is due within 30 business days of demand by Acuitas (the "Maturity Date"), and carries an interest rate on any unpaid principal amount of 8% per annum until the Maturity Date, after which the interest will increase to 12% per annum. In addition, Acuitas was granted five-year warrants to purchase an aggregate 450,000 shares of our common stock, at an exercise price of $0.47 per share which warrants include, subject to certain exceptions, a full-ratchet anti-dilution protection ( the “March 2016 Warrants”).

In April 2016, we amended the March 2016 Promissory Note with Acuitas, to increase the amount of the March 2016 Promissory Note by $400,000, for a total of $1.3 million in principle amount. In connection with the amendment, Acuitas was granted five-year warrants to purchase an additional 200,000 shares of our common stock, at an exercise price of $0.47 which warrants include, subject to certain exceptions, a full-ratchet anti-dilution protection.

Operations

We currently operate our OnTrak programs in Florida, Illinois, Kansas, Kentucky, Louisiana, Massachusetts, Missouri, New Jersey, Oklahoma, Pennsylvania, Texas, West Virginia, and Wisconsin. We provide services to commercial (employer funded), managed Medicare Advantage and managed Medicaid populations. We have generated fees from our launched programs and expect to increase enrollment and fees throughout 2016. However, there can be no assurance that we will generate such fees or that new programs will launch as we expect.

RESULTS OF OPERATIONS

Table of Summary Consolidated Financial Information

The table below and the discussion that follows summarize our results of consolidated operations for the three months ended March 31, 2016 compared to the three months ended March 31, 2015:

	Three Months Ended
(In thousands, except per share amounts)	March 31,
	2016			2015
Revenues
Healthcare services revenues	$	728		$	433

Operating expenses
Cost of healthcare services		966			406
General and administrative		2,187			2,734
Depreciation and amortization		32			34
Total operating expenses		3,185			3,174

Loss from operations		(2,457	)		(2,741	)

Other income		65			11
Interest expense		(333	)		(2	)
Change in fair value of warrant liability		(228	)		2,474
Change in fair value of derivative liability		(1,337	)		-
Loss from operations before provision for income taxes		(4,290	)		(258	)
Provision for income taxes		2			2
Net Loss	$	(4,292	)	$	(260	)

Basic net loss from operations per share:	$	(0.08	)	$	(0.01	)

Basic and diluted weighted number of shares outstanding		55,008			25,286

Summary of Consolidated Operating Results

Loss from operations before provision for income taxes for the three months ended March 31, 2016 was $4.3 million, compared with a net loss of $258,000 for the same period in 2015. The difference primarily relates to the decrease in the change in fair value of warrant liability and the decrease in the change in fair value of the derivative liability for the three months ended March 31, 2016, compared to the same period in 2015.

Revenues

During the three months ended March 31, 2016, we have expanded our customer base and health plan populations covered under our programs, which has resulted in a significant increase in the number of patients enrolled in our programs compared with the same period in 2015. For the three months ended March 31, 2016, enrollment increased by more than 175% over the same period in 2015. Recognized revenue increased by $295,000, or 68% for the three months ended March 31, 2016, compared with the same periods in 2015, respectively. We reserve a portion, and in some cases all, of the revenue related to these contracts as the revenue is subject to performance guarantees, or in the instance of case rates received upon enrollment and other fees in advance, recognized ratably over the period of enrollment. Deferred revenue increased by $593,000 since December 31, 2015.

Cost of Healthcare Services

Cost of healthcare services consists primarily of salaries related to our care coaches, community care coordinators, healthcare provider claims payments to our network of physicians and psychologists, and fees charged by our third party administrators for processing these claims. The increase of $560,000 for the months ended March 31, 2016, compared with the same period in 2015, relates primarily to the increase in the number of members being treated, the addition of care coaches and clinical care coordinators to our staff to manage the increasing number of enrolled members, and the expansion of our program in Kansas to cover high cost members with anxiety disorders.

General and Administrative Expenses

Total general and administrative expense decreased by $547,000 for the three months ended March 31, 2016, compared with the same period in 2015. The decrease was due primarily to a decrease in share-based compensation expense related to stock options issued to our board of directors during the first quarter of 2015.

Depreciation and Amortization

Depreciation and amortization was immaterial for the three months ended March 31, 2016 and 2015, respectively.

Interest Expense

Interest expense increased by $331,000 for the three months ended March 31, 2016 compared with the same period in 2015. The increase related to the issuance of warrants as part of our March 2016 financings and no such warrants were issued during the three months ended March 31, 2015.

Change in fair value of warrant liability

The decrease in the change in fair value for the warrants was $2.7 million for the three months ended March 31, 2016 compared with the same period in 2015.

We will continue to mark-to-market the warrants to market value each quarter-end until they are completely settled.

Change in fair value of warrant liability

The change in fair value of derivative liabilities was $2.7 million for the three months ended March 31, 2016 compared with the same period in 2015. The derivative liability was the result of the issuance of the July 2015 Convertible Debenture.

We will continue to mark-to-market the derivative liability to market value each quarter-end until they are completely settled.

LIQUIDITY AND CAPITAL RESOURCES

Liquidity and Going Concern

As of May 12, 2016, we had a balance of approximately $78,000 cash on hand. We had a working capital deficit of approximately $12.4 million at March 31, 2016. We have incurred significant operating losses and negative operating cash flows since our inception. We could continue to incur negative cash flows and operating losses for the next twelve months. Our current cash burn rate is approximately $450,000 per month, excluding non-current accrued liability payments. We expect our current cash resources to cover expenses through the end of May 2016; however delays in cash collections, revenue, or unforeseen expenditures could impact this estimate. We are in need of additional capital, however, there is no assurance that additional capital can be timely raised in an amount which is sufficient for us or on terms favorable to us and our stockholders, if at all. If we do not obtain additional capital, there is a significant doubt as to whether we can continue to operate as a going concern and we will need to curtail or cease operations or seek bankruptcy relief. If we discontinue operations, we may not have sufficient funds to pay any amounts to stockholders.

Our ability to fund our ongoing operations and continue as a going concern is dependent on increasing the number of members that are eligible for our programs by signing new contracts and generating fees from existing and new contracts for our managed care programs and the success of management’s plans to increase revenue and continue to control expenses. We currently operate our OnTrak programs in Florida, Illinois, Kansas, Kentucky, Louisiana, Massachusetts, Missouri, New Jersey, Oklahoma, Pennsylvania, Texas, West Virginia, and Wisconsin. We provide services to commercial (employer funded), managed Medicare Advantage and managed Medicaid populations. We have generated fees from our launched programs and expect to increase enrollment and fees throughout 2016. However, there can be no assurance that we will generate such fees or that new programs will launch as we expect. We are in need of additional capital, however, there is no assurance that additional capital can be timely raised in an amount which is sufficient for us or on terms favorable to us and our stockholders, if at all. If we do not obtain additional capital, there is a significant doubt as to whether we can continue to operate as a going concern and we will need to curtail or cease operations or seek bankruptcy relief. If we discontinue operations, we may not have sufficient funds to pay any amounts to our stockholders.

Cash Flows

We used $1.5 million of cash from operating activities during the three months ended March 31, 2016 compared with $811,000 in the same period in 2015. The increase in cash used in operating activities reflects the increase in the number of members being treated, the addition of care coaches and clinical care coordinators to our staff to manage the increasing number of enrolled members, and the expansion of our program in Kansas to cover high cost members with anxiety disorders. Significant non-cash adjustments to operating activities for the three months ended March 31, 2016 included a fair value adjustment on derivative liability of $1.3 million, a fair value adjustment on warrant liability of $228,000, and issuance costs of $216,000 related to the March 2016 Promissory Note.

Capital expenditures for the three months ended March 31, 2016 were not material. We anticipate that capital expenditures will increase in the future as we replace our computer systems that are reaching their useful lives, upgrade equipment to support our increased number of enrolled members, and enhance the reliability and security of our systems. These future capital expenditure requirements will depend upon many factors, including obsolescence or failure of our systems, progress with expanding the adoption of our programs, and our marketing efforts, the necessity of, and time and costs involved in obtaining, regulatory approvals, competing technological and market developments, and our ability to establish collaborative arrangements, effective commercialization, marketing activities and other arrangements.

Our net cash provided by financing activities was $858,000 for the three months ended March 31, 2016, compared with net cash provided by financing activities of $195,000 for the three months ended March 31, 2015. Cash provided by financing activities for the three months ended March 31, 2016 consisted of the net proceeds from the loan provided by Acuitas in March 2016, leaving a balance of $262,000 in cash and cash equivalents at March 31, 2016.

As discussed above, we currently expend cash at a rate of approximately $450,000 per month. We also anticipate cash inflow to increase during 2016 as we continue to service our executed contracts and sign new contracts. We expect our current cash resources to cover our operations through the end of May 2016; however delays in cash collections, revenue, or unforeseen expenditures could impact this estimate. We are in need of additional capital, however, there is no assurance that additional capital can be timely raised in an amount which is sufficient for us or on terms favorable to us and our stockholders, if at all. If we do not obtain additional capital, there is a significant doubt as to whether we can continue to operate as a going concern and we will need to curtail or cease operations or seek bankruptcy relief. If we discontinue operations, we may not have sufficient funds to pay any amounts to our stockholders.

OFF BALANCE SHEET ARRANGEMENTS

As of March 31, 2016, we had no off-balance sheet arrangements.

CRITICAL ACCOUNTING ESTIMATES

The discussion and analysis of our financial condition and results of operations is based upon our financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). U.S. GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and the disclosure of contingent assets and liabilities. We base our estimates on experience and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that may not be readily apparent from other sources. On an on-going basis, we evaluate the appropriateness of our estimates and we maintain a thorough process to review the application of our accounting policies. Our actual results may differ from these estimates.

We consider our critical accounting estimates to be those that (1) involve significant judgments and uncertainties, (2) require estimates that are more difficult for management to determine, and (3) may produce materially different results when using different assumptions. We have discussed these critical accounting estimates, the basis for their underlying assumptions and estimates and the nature of our related disclosures herein with the audit committee of our Board of Directors. We believe our accounting policies related to the fair value of warrants, the estimation of the fair value of our derivative liability, and share-based compensation expense, involve our most significant judgments and estimates that are material to our consolidated financial statements. They are discussed further below.

Warrant Liabilities

For the three months ended March 31, 2016 and 2015, we recognized a loss of $228,000 and a gain of $2.5 million, respectively, related to the revaluation of our warrant liabilities.

We will continue to mark the warrants to market value each reporting period, using the Black-Scholes pricing model until they are completely settled or expire.

Derivative Liabilities

	March 31, 2016
Expected volatility		133.19	%
Risk-free interest rate		0.59	%
Weighted average expected lives in years		0.80
Expected dividend		0	%

For the three months ended March 31, 2016 and 2015, we recognized a loss of $1.3 million and $0 related to the revaluation of our derivative liability, respectively.

Share-based compensation expense

We account for the issuance of stock, stock options, and warrants for services from non-employees based on an estimate of the fair value of options and warrants issued using the Black-Scholes pricing model. This model’s calculations include the exercise price, the market price of shares on grant date, weighted average assumptions for risk-free interest rates, expected life of the option or warrant, expected volatility of our stock and expected dividend yield.

The amounts recorded in the financial statements for share-based compensation expense could vary significantly if we were to use different assumptions. For example, the assumptions we have made for the expected volatility of our stock price have been based on the historical volatility of our stock, measured over a period generally commensurate with the expected term. If we were to use a different volatility than the actual volatility of our stock price, there may be a significant variance in the amounts of share-based compensation expense from the amounts reported. The weighted average expected option term for the three months ended March 31, 2016 and 2015, reflects the application of the simplified method set out in SEC Staff Accounting Bulletin No. 107, which defines the life as the average of the contractual term of the options and the weighted average vesting period for all option tranches.

From time to time, we retain terminated employees as part-time consultants upon their resignation from the Company. Because the employees continue to provide services to us, their options continue to vest in accordance with the original terms. Due to the change in classification of the option awards, the options are considered modified at the date of termination. The modifications are treated as exchanges of the original awards in return for the issuance of new awards. At the date of termination, the unvested options are no longer accounted for as employee awards and are accounted for as new non-employee awards. The accounting for the portion of the total grants that have already vested and have been previously expensed as equity awards is not changed. There were no employees moved to consulting status for the three months ended March 31, 2016 and 2015, respectively.

RECENT ACCOUNTING PRONOUNCEMENTS

In February 2015, the FASB issued ASU, Consolidation (Topic 810): Amendments to the Consolidation Analysis (“ASU 2015-02”). ASU 2015-02 modifies existing consolidation guidance for reporting organizations that are required to evaluate whether they should consolidate certain legal entities. ASU 2015-02 is effective for fiscal years and interim periods within those years beginning after December 15, 2015, and requires either a retrospective or a modified restrospective approach to adoptions. Early adoption is permitted. We are currently evaluating the potential impact of this standard on our consolidated financial statements, as well as the available transition methods.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Not applicable.

Item 4. Controls and Procedures

Disclosure Controls

We have evaluated, with the participation of our principal executive officer and our principal financial officer, the effectiveness of our disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of March 31, 2016. Based on this evaluation, our principal executive officer and our principal financial officer have concluded that as of March 31, 2016,our disclosure controls and procedures were effective to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms, and is accumulated and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

There were no changes in our internal controls over financial reporting during the three months ended March 31, 2016, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II – OTHER INFORMATION

Item 1. Legal Proceedings

None.

Item 1A. Risk Factors

There have been no material changes in our risk factors from those disclosed in our most recent Annual Report on Form 10-K.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

In connection with the March 2016 Promissory Note, Acuitas was granted five-year warrants to purchase an aggregate 450,000 shares of our common stock, at an exercise price of $0.47 per share.

In connection with the amendment to the March 2016 Promissory Note with Acuitas to increase the amount of the March 2016 Promissory Note by $400,000, for a total of $1.3 million in principle amount. Acuitas was granted five-year warrants to purchase an additional 200,000 shares of our common stock, at an exercise price of $0.47.

The warrants were issued without registration pursuant to exemption afforded by Section 4(a)(2) of the Securities Act of 1933, as amended.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures.

Not applicable.

Item 5. Other Information

Item 6. Exhibits

Exhibit 4.1*	Form of First Amended and Restated Promissory Note 8% Promissory Note, dated April 27, 2016
Exhibit 4.2*	Form of Common Stock Purchase Warrant, dated April 27, 2016.
Exhibit 4.3	Form of 8% Promissory Note, dated March 30, 2016, incorporated by reference to Exhibit 4.9 of Catasys, Inc.’s Form 10-K filed with Securities and Exchange Commission on March 30, 2016.
Exhibit 4.4*	Form of Common Stock Purchase Warrant, dated March 30, 2016.
Exhibit 31.1*	Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
Exhibit 31.2*	Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
Exhibit 32.1*	Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
Exhibit 32.2*	Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS*	XBRL Instance
101.SCH*	XBRL Taxonomy Extension Schema
101.CAL*	XBRL Taxonomy Extension Calculation
101.DEF*	XBRL Taxonomy Extension Definition
101.LAB*	XBRL Taxonomy Extension Labels
101.PRE*	XBRL Taxonomy Extension Presentation

* filed herewith.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	CATASYS, INC.
Date: May 13, 2016	By:	/s/ TERREN S. PEIZER
		Terren S. Peizer
		Chief Executive Officer (Principal Executive Officer)


Date: May 13, 2016	By:	/s/ SUSAN ETZEL
		Susan Etzel
		Chief Financial Officer (Principal Financial and Accounting Officer)

EX-4.1 2 ex4-1.htm EXHIBIT 4.1 cats20160401_10q.htm

Exhibit 4.1

this note HAs NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR UNDER THE SECURITIES LAW OF ANY STATE OR OTHER JURISDICTION. this note MAY NOT BE OFFERED, SOLD, PLEDGED, OR TRANSFERRED in the absence of such registration or AN EXEMPTION THEREFROM IS AVAILABLE AND THAT SUCH OFFER, SALE, PLEDGE, OR TRANSFER IS IN COMPLIANCE WITH the act aND THE APPLICABLE SECURITIES LAWS OF ANY STATE OR OTHER JURISDICTION.

FIRST AMENDED AND RESTATED PROMISSORY NOTE

$1,300,000	Original Issue Date: March 30, 2016
	First Amendment and Restatement Date: April 27, 2016

	Los Angeles, CA

FOR VALUE RECEIVED, and subject to the terms and conditions set forth in this Promissory Note ("Note"), Catasys, Inc. (the "Payor"), hereby unconditionally promises to pay to the order of Acuitas Group Holdings, LLC or its assigns (the "Payee"), in lawful money of the United States of America in immediately available funds, at such location as the Payee shall designate in writing, $1,300,000, within thirty (30) business day of demand by Payee (the "Maturity Date"), and to pay interest on the unpaid principal amount hereof at the rates specified below on the Maturity Date. This note amends, restates and replaces that certain secured convertible promissory note, originally issued on March 30, 2016, in the original principal amount of $900,000.

The Payor further agrees to pay interest to the Payee on the unpaid principal amount hereof from the date hereof at a rate per annum equal to 8% until the Maturity Date, and thereafter, until payment in full of the principal amount hereof (whether before or after judgment) at a rate per annum equal to 12%. Interest shall be payable on the Maturity Date, on the date of any prepayment and, after the Maturity Date, on demand.

The Payor may prepay the principal amount of this Note in whole or in part at any time or from time to time without premium or penalty; provided that each prepayment shall be accompanied by payment of accrued interest to the date of prepayment.

Upon the commencement by or against the Payor of any bankruptcy, reorganization, arrangement, adjustment of debt, relief of debtors, dissolution, insolvency or liquidation or similar proceeding of any jurisdiction relating to the Payor or its debts, the unpaid principal amount hereof shall become immediately due and payable without presentment, demand, protest or notice of any kind in connection with this Note.

The Payee is hereby authorized to record all loans and advances made by it to the Payor (all of which shall be evidenced by this Note), and all repayments or prepayments thereof, in its books and records, such books and records constituting prima facie evidence of the accuracy of the information contained therein.

The Payor hereby waives diligence, presentment, demand, protest or notice of any kind in connection with this Note. All payments under this Note shall be made without offset, counterclaim or deduction of any kind.

This Note shall be binding upon the Payor and its successors and assigns, and the terms and provisions of this Note shall inure to the benefit of the Payee and its successors and assigns, including subsequent holders hereof. The Payor's obligations under this Note may not be assigned without the prior written consent of the Payee.

THIS NOTE SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF [CALIFORNIA].

[SIGNATURE PAGE FOLLOWS]

IN WITNESS WHEREOF, the parties hereto have executed this Note as of the date first above written.

	Catasys, Inc. as Payor

	By_____________________

	Name:
	Title:

	Acuitas Group Holdings, LLC as Payee

	By_____________________

	Name:
	Title:

EX-4.2 3 ex4-2.htm EXHIBIT 4.2 cats20160401_10q.htm

Exhibit 4.2

NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.

COMMON STOCK PURCHASE WARRANT

CATASYS, INC.

Warrant Shares: 200,000

Initial Exercise Date: April 27, 2016

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Acuitas Group Holdings, LLC. or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the five year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Catasys, Inc., a Delaware corporation (the “Company”), up to 200,000 shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 1(b).

Section 1. Exercise.

a) Exercise of Warrant. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company (or such other office or agency of the Company as it may designate by notice in writing to the registered Holder at the address of the Holder appearing on the books of the Company) of a duly executed facsimile copy (or e-mail attachment) of the Notice of Exercise in the form annexed hereto and within three (3) Trading Days of the date said Notice of Exercise is delivered to the Company, the Company shall have received payment of the aggregate Exercise Price of the shares thereby purchased by wire transfer or cashier’s check drawn on a United States bank or, if available, pursuant to the cashless exercise procedure specified in Section 1(c) below. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one (1) Business Day of receipt of such notice. The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.

b) Exercise Price. The exercise price per share of the Common Stock under this Warrant shall be $0.47, subject to adjustment hereunder (the “Exercise Price”).

c) Cashless Exercise. If at any time after the Initial Exercise Date, there is no effective registration statement registering, or no current prospectus available for, the resale of the Warrant Shares by the Holder, then this Warrant may also be exercised, in whole or in part, at such time by means of a “cashless exercise” in which the Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:

(A) = the VWAP on the ten (10) Trading Days immediately preceding the date on which Holder elects to exercise this Warrant by means of a “cashless exercise,” as set forth in the applicable Notice of Exercise;

(B) = the Exercise Price of this Warrant, as adjusted hereunder; and

(X) = the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless exercise.

“VWAP” means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported in the “Pink Sheets” published by OTC Markets, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (c) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.

d) Mechanics of Exercise.

i. Delivery of Warrant Shares Upon Exercise. Warrant Shares purchased hereunder shall be transmitted by the Transfer Agent to the Holder by crediting the account of the Holder’s or its designee’s balance account with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (“DWAC”) if the Company is then a participant in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale limitations pursuant to Rule 144, and otherwise by physical delivery of a certificate, registered in the Company’s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is one (1) Trading Day after the delivery to the Company of the Notice of Exercise (such date, the “Warrant Share Delivery Date”). The Warrant Shares shall be deemed to have been issued, and Holder or any other person so designated to be named therein shall be deemed to have become a holder of record of such shares for all purposes, as of the date the Warrant has been exercised, with payment to the Company of the Exercise Price (or by cashless exercise, if permitted) and all taxes required to be paid by the Holder, if any, pursuant to Section 1(d)(iv) prior to the issuance of such shares, having been paid.

ii. Delivery of New Warrants Upon Exercise. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects be identical with this Warrant.

iii. No Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Exercise Price or round up to the next whole share.

iv. Charges, Taxes and Expenses. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental expense in respect of the issuance of Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; provided, however, that in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.

v. Closing of Books. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant, pursuant to the terms hereof.

Section 2. Certain Adjustments.

a) Stock Dividends and Stock Splits. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes a distribution or distributions payable in shares of Common Stock on shares of Common Stock or any Common Stock Equivalents (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of a reverse stock split) outstanding shares of Common Stock into a smaller number of shares or (iv) issues, in the event of a reclassification of shares of the Common Stock, any shares of capital stock of the Company, then the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding any treasury shares of the Company) outstanding immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant to this Section 2(a) shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or re-classification.

b) Subsequent Equity Sales. If and whenever during the period starting on the Initial Exercise and continuing until the earlier of the Term or such time as the Warrant is exercised (the “Applicable Period”), the Company issues, sells or delivers, or is deemed to have issued, sold or delivered, any Common Stock or common stock equivalent in a transaction, other than an Exempt Issuance, for consideration per share less than a price equal to the Exercise Price in effect immediately prior to such issuance, sale or delivery or deemed issuance (such Exercise Price then in effect is referred to as the “Applicable Price”) (the foregoing a “Dilutive Issuance”), then immediately after such Dilutive Issuance, the Exercise Price then in effect shall be reduced to the lowest consideration per share for shares issued or sold in such transaction, but in no event shall the adjusted Exercise Price shall be reduced to a price lower than the par value of the Company’s shares of Common Stock. Upon each adjustment in the Exercise Price pursuant to this Section 2(b), the number of Warrant Shares purchasable hereunder shall be adjusted, to the nearest whole share, to the product obtained by multiplying the number of Warrant Shares purchasable immediately prior to such adjustment by a fraction, (i) the numerator of which shall be the Exercise Price immediately prior to such adjustment, and (ii) the denominator of which shall be the Exercise Price immediately thereafter. An Exempt Issuance shall mean the issuance of (i) shares of Common Stock, options or any other equity securities to employees, officers, directors or consultants of the Company pursuant to any stock or option plan, (ii) securities upon the exercise or exchange of or conversion of any Securities issued hereunder and/or other securities exercisable or exchangeable for or convertible into shares of Common Stock issued and outstanding as of the issuance date of this Warrant, (iii) securities issued pursuant to acquisitions or strategic transactions, (iv) securities issued by the Company pursuant to any of the Company’s agreements and/or obligations existing as of the issuance date of this Warrant, and (v) securities issued by the Company to vendors and other service providers.

c) Calculations. All calculations under this Section 2 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes of this Section 2, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.

d) Notice to Holder. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 2, the Company shall promptly deliver to each Holder a notice setting forth the Exercise Price after such adjustment and setting forth a brief statement of the facts requiring such adjustment.

Section 3. Transfer of Warrant.

a) Transferability. Subject to compliance with any applicable securities laws, this Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date the Holder delivers an assignment form to the Company assigning this Warrant full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.

b) New Warrants. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the Initial Exercise Date and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.

c) Warrant Register. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the “Warrant Register”), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual notice to the contrary.

d) Transfer Restrictions. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under applicable state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public information requirements pursuant to Rule 144.

e) Representation by the Holder. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant to sales registered or exempted under the Securities Act.

Section 4. Miscellaneous.

a) No Rights as Stockholder Until Exercise. This Warrant does not entitle the Holder to any voting rights, dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 1(d)(i).

b) Loss, Theft, Destruction or Mutilation of Warrant. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.

c) Saturdays, Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Business Day, then, such action may be taken or such right may be exercised on the next succeeding Business Day.

d) Authorized Shares.

The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).

Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.

Before taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof.

e) Jurisdiction. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance with the laws of the State of New York.

f) Restrictions. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered and the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.

g) Limitation of Liability. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the Company.

h) Successors and Assigns. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable by the Holder or holder of Warrant Shares.

i) Amendment. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.

j) Severability. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.

k) Headings. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.

(Signature Page Follows)

IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.

CATASYS, INC.

By: ________________________________

Name:

Title:

NOTICE OF EXERCISE

TO: CATASYS, INC.

(1) The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.

(2) Payment shall take the form of (check applicable box):

[ ] in lawful money of the United States; or

[ ] [if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 1(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 1(c).

(3) Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:

_______________________________

The Warrant Shares shall be delivered to the following DWAC Account Number:

_______________________________

(4) Accredited Investor. The undersigned is an “accredited investor” as defined in Regulation D promulgated under the Securities Act of 1933, as amended.

[SIGNATURE OF HOLDER]

Name of Investing Entity:

Signature of Authorized Signatory of Investing Entity:

Name of Authorized Signatory:

Title of Authorized Signatory:

Date:

EXHIBIT B

ASSIGNMENT FORM

(To assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)

FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to

Name:

Address:

Dated: _______________ __, ______
Holder’s Signature:
Holder’s Address:

EX-4.4 4 ex4-4.htm EXHIBIT 4.4 cats20160401_10q.htm

Exhibit 4.4

COMMON STOCK PURCHASE WARRANT

CATASYS, INC.

Warrant Shares: 450,000

Initial Exercise Date: March 30, 2016

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Acuitas Group Holdings, LLC. or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the five year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Catasys, Inc., a Delaware corporation (the “Company”), up to 450,000 shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 1(b).

Section 1. Exercise.

b) Exercise Price. The exercise price per share of the Common Stock under this Warrant shall be $0.47, subject to adjustment hereunder (the “Exercise Price”).

(B) = the Exercise Price of this Warrant, as adjusted hereunder; and

d) Mechanics of Exercise.

v. Closing of Books. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant, pursuant to the terms hereof.

Section 2. Certain Adjustments.

Section 3. Transfer of Warrant.

Section 4. Miscellaneous.

d) Authorized Shares.

e) Jurisdiction. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance with the laws of the State of New York.

i) Amendment. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.

k) Headings. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.

(Signature Page Follows)

IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.

CATASYS, INC.

By: ________________________________

Name:

Title:

NOTICE OF EXERCISE

TO: CATASYS, INC.

(2) Payment shall take the form of (check applicable box):

[ ] in lawful money of the United States; or

(3) Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:

_______________________________

The Warrant Shares shall be delivered to the following DWAC Account Number:

_______________________________

(4) Accredited Investor. The undersigned is an “accredited investor” as defined in Regulation D promulgated under the Securities Act of 1933, as amended.

[SIGNATURE OF HOLDER]

Name of Investing Entity:

Signature of Authorized Signatory of Investing Entity:

Name of Authorized Signatory:

Title of Authorized Signatory:

Date:

EXHIBIT B

ASSIGNMENT FORM

(To assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)

FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to

Name:

Address:

Dated: _______________ __, ______
Holder’s Signature:
Holder’s Address:

EX-31.1 5 ex31-1.htm EXHIBIT 31.1 cats20160401_10q.htm

Exhibit 31.1

CERTIFICATION

I, Terren S. Peizer, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of Catasys, Inc.;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; and

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect the registrant’s internal control over financial reporting; and

5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 13, 2016	/s/ TERREN S. PEIZER
	Terren S. Peizer
	Chief Executive Officer
	(Principal Executive Officer)

EX-31.2 6 ex31-2.htm EXHIBIT 31.2 cats20160401_10q.htm

Exhibit 31.2

CERTIFICATION

I, Susan Etzel, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of Catasys, Inc.;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, and cash flows of the registrant as of, and for, the periods presented in this report;

5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 13, 2016	/s/ SUSAN ETZEL
	Susan Etzel
	Chief Financial Officer
	(Principal Financial and Accounting Officer)

EX-32.1 7 ex32-1.htm EXHIBIT 32.1 cats20160401_10q.htm

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Catasys, Inc. (the “Company) for the quarter ended March 31, 2016, as filed with the Securities and Exchange Commission on the date hereof (the “Report), I, Terren S. Peizer, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

	(1)	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and

	(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ TERREN S. PEIZER		May 13, 2016
Terren S. Peizer		Date
Chief Executive Officer
(Principal Executive Officer)

EX-32.2 8 ex32-2.htm EXHIBIT 32.2 cats20160401_10q.htm

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Catasys, Inc. (the “Company) for the quarter ended March 31, 2016, as filed with the Securities and Exchange Commission on the date hereof (the “Report), I, Susan Etzel, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

	(1)	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and

	(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ SUSAN ETZEL		May 13, 2016
Susan Etzel		Date
Chief Financial Officer
(Principal Financial and Accounting Officer)

EX-101.INS 9 cats-20160331.xml EXHIBIT 101.INS 110900 4 3 0.12 1337000 1 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Warrant Liabilities</div></div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In March 2016, we entered into a promissory note with Acuitas, pursuant to which we received aggregate gross proceeds of $900,000 for the sale of $900,000 in principal amount (the "March 2016 Promissory Note"). The March 2016 Promissory Note is due within 30 business days of demand by Acuitas (the "Maturity Date"), and carries an interest rate on any unpaid principal amount of 8% per annum until the Maturity Date, after which the interest will increase to 12% per annum. In addition, Acuitas was granted five-year warrants to purchase an aggregate 450,000 shares of our common stock, at an exercise price of $0.47 per share, which warrants include, subject to certain exceptions, a full-ratchet anti-dilution protection (the “March 2016 Warrants”).</div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The warrant liability associated with the March 2016 Warrants were calculated using the Black-Scholes model based upon the following assumptions:</div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div><div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 85%; MARGIN-RIGHT: 15%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">March</div><div style="display: inline; font-weight: bold;"> 31, 201</div><div style="display: inline; font-weight: bold;">6</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px"><div style="display: inline; font-weight: bold;"> </div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 82%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Expected volatility</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">133.19</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">%</div></div></td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Risk-free interest rate</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">1.21</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">%</div></div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Weighted average expected lives in years</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">5</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Expected dividend</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">0</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">%</div></div></td> </tr> </table> </div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">We have issued warrants to purchase common stock in December 2011, February 2012, April 2015, July 2015, and March 2016. The warrants are being accounted for as liabilities in accordance with FASB accounting rules, due to anti-dilution provisions in some warrants that protect the holders from declines in our stock price and a requirement to deliver registered shares upon exercise of the warrants, which is considered outside our control.  The warrants are marked-to-market each reporting period, using the Black-Scholes pricing model, until they are completely settled or expire.</div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">For the three months ended March 31, 2016 and 2015, we recognized a loss of $228,000 and a gain of $2.5 million, respectively, related to the revaluation of our warrant liabilities.</div></div></div></div> P5Y P5Y 12400000 false --12-31 Q1 2016 2016-03-31 10-Q 0001136174 55007761 Yes Smaller Reporting Company CATASYS, INC. No No cats

129000

772000

753000

1515000

1491000

253228000

253053000

174000

826000

2000

216000

3720716

23409694

2067000

2880000

1306000

2081000

106000

38000

66000

262000

916000

708000

84000

106000

-654000

-624000

0.47

450000

200000

0.0001

500000000

55007761

6000

0.94

0.93

3662000

966000

406000

1300000

1.30

0.08

P30D

178000

198000

2276000

1683000

32000

34000

32000

33000

-228000

2500000

3685000

2348000

<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Derivative Liability</div></div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In July 2015, we entered into the July 2015 Convertible Debenture. The derivative liability associated with the July 2015 Convertible Debenture was calculated using the Black-Scholes model based upon the following assumptions:</div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div><div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 85%; MARGIN-RIGHT: 15%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">March</div><div style="display: inline; font-weight: bold;"> 31, 201</div><div style="display: inline; font-weight: bold;">6</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;"> </div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 82%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Expected volatility</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">133.19</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">%</div></div></td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Risk-free interest rate</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">0.59</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">%</div></div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Weighted average expected lives in years</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">0.80</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Expected dividend</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">0</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">%</div></div></td> </tr> </table> </div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The expected volatility assumption for the three months ended March 31, 2016 was based on the historical volatility of our stock, measured over a period generally commensurate with the expected term. The weighted average expected lives in years for 2015 reflect the application of the simplified method set out in Security and Exchange Commission (SEC) Staff Accounting Bulletin (SAB) 107 (and as amended by SAB 110), which defines the life as the average of the contractual term of the options and the weighted average vesting period for all option tranches. We use historical data to estimate the rate of forfeitures assumption for awards granted to employees. </div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">For the three months ended March 31, 2016 and 2015, we recognized a loss of $1.3 million and $0 related to the revaluation of our derivative liability, respectively.</div></div></div></div>

4676000

-0.08

-0.01

1703000

841000

P1Y186D

228000

-2474000

P5Y

P292D

1.3319

0.0121

0.0059

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px;; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 55%; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Level III</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 25%; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Level III</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 55%; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Warrant </div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 25%; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Warrant </div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 55%; VERTICAL-ALIGN: bottom"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">(Dollars in thousands)</div></div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Liabilities</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; PADDING-LEFT: 9pt" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">(Dollars in thousands)</div></div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Liabilities</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;"> </div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 55%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Balance as of December 31, 2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff">509 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #cceeff" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Balance as of December 31, 2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 7%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff">2,348 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 55%; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Issuance of warrants</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">216 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 25%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; PADDING-LEFT: 18pt; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Issuance of warrants</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 7%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">- </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 55%; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Change in fair value </div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff">228 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 25%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; PADDING-LEFT: 18pt; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Change in fair value </div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 7%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff">1,337 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 55%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Balance as of March 31, 2016</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">953 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #ffffff" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Balance as of March 31, 2016</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 7%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">3,685 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> </tr> </table></div>

228000

1337000

216000

509000

2348000

953000

3685000

-1300000

<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Fair Value Measurements</div></div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Assets and liabilities recorded at fair value in the condensed consolidated balance sheets are categorized based upon the level of judgment associated with the inputs used to measure fair value. The fair value hierarchy distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level I) and the lowest priority to unobservable inputs (Level III). The three levels of the fair value hierarchy are described below:</div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"> </div></div></div><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 84.5%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" align="center" border="0"> <tr> <td style="WIDTH: 16.2%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-LEFT: 9pt"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Level Input:</div></div></div></td> <td style="WIDTH: 3.5%; VERTICAL-ALIGN: bottom">  </td> <td style="WIDTH: 80.5%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Input Definition:</div></div></div></td> </tr> <tr> <td style="WIDTH: 16.2%; VERTICAL-ALIGN: top; PADDING-LEFT: 9pt"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Level I</div></div></td> <td style="WIDTH: 3.5%; VERTICAL-ALIGN: top">  </td> <td style="WIDTH: 80.5%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.</div></div></td> </tr> <tr> <td style="WIDTH: 16.2%; VERTICAL-ALIGN: top; PADDING-LEFT: 9pt"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Level II</div></div></td> <td style="WIDTH: 3.5%; VERTICAL-ALIGN: top">  </td> <td style="WIDTH: 80.5%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Inputs, other than quoted prices included in Level I, that are observable for the asset or liability through corroboration with market data at the measurement date.</div></div></td> </tr> <tr> <td style="WIDTH: 16.2%; VERTICAL-ALIGN: top; PADDING-LEFT: 9pt"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Level III</div></div></td> <td style="WIDTH: 3.5%; VERTICAL-ALIGN: top">  </td> <td style="WIDTH: 80.5%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Unobservable inputs that reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date.</div></div></td> </tr> </table><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"> </div></div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The following table summarizes fair value measurements by level at March 31, 2016 for assets and liabilities measured at fair value:</div></div><div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 22pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div><div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 85%; MARGIN-LEFT: 72pt; MARGIN-RIGHT: 15%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 40%; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="14"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Balance at March 31, 2016</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;"> </div></td> </tr> <tr> <td style="WIDTH: 40%"> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr> <td style="WIDTH: 40%"> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 40%; VERTICAL-ALIGN: bottom"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">(Amounts in thousands)</div></div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Level I</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Level II</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Level III</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Total</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;"> </div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 40%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Certificates of deposit</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff">106 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff">- </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff">- </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff">106 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 40%; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Total assets</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">106 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">- </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">- </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">106 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="WIDTH: 40%; BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 40%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Warrant liabilities</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">- </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">- </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">953 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">953 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 40%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Derivative Liability</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff">3,685 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff">3,685 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 40%; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Total liabilities </div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">- </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">- </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">4,638 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">4,638 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> </tr> </table> </div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></div></div><div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> </div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Financial instruments classified as Level III in the fair value hierarchy as of March 31, 2016, represent our liabilities measured at market value on a recurring basis which include warrant liabilities and derivative liabilities resulting from recent debt and equity financings. In accordance with current accounting rules, the warrant liabilities and derivative liabilities are being marked-to-market each quarter-end until they are completely settled. The warrants are valued using the Black-Scholes option-pricing model, using both observable and unobservable inputs and assumptions consistent with those used in our estimate of fair value of employee stock options. See <div style="display: inline; font-style: italic;">Warrant Liabilities</div> below. </div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"> </div></div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The following table summarizes our fair value measurements using significant Level III inputs, and changes therein, for the three months ended March 31, 2016:</div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div><div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 55%; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Level III</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 25%; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Level III</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 55%; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Warrant </div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 25%; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Warrant </div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 55%; VERTICAL-ALIGN: bottom"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">(Dollars in thousands)</div></div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Liabilities</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; PADDING-LEFT: 9pt" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">(Dollars in thousands)</div></div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Liabilities</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;"> </div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 55%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Balance as of December 31, 2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff">509 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #cceeff" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Balance as of December 31, 2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 7%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff">2,348 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 55%; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Issuance of warrants</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">216 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 25%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; PADDING-LEFT: 18pt; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Issuance of warrants</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 7%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">- </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 55%; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Change in fair value </div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff">228 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 25%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; PADDING-LEFT: 18pt; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Change in fair value </div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 7%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff">1,337 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 55%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Balance as of March 31, 2016</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">953 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #ffffff" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Balance as of March 31, 2016</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 7%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">3,685 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> </tr> </table> </div></div></div></div></div></div>

-1337000

2187000

2734000

728000

433000

-4290000

-258000

2000

26000

2000

96000

319000

27000

-380000

593000

160000

-23000

-17000

-141000

18000

65000

11000

333000

2000

172000

14908000

11604000

2067000

2880000

13739000

4821000

4638000

858000

195000

6000

-8000

-1518000

-811000

-4292000

-260000

<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Recently Issued or Newly Adopted Accounting Standards</div></div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"> </div></div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In April 2016, the FASB issued Accounting Standards Update (“ASU”) 2016-10, <div style="display: inline; font-style: italic;">Revenue from Contracts with Customers (Topic 606)</div>, which amends certain aspects of the Board’s new revenue standard, ASU 2014-09, Revenue from Contracts with Customers. The standard should be adopted concurrently with adoption of ASU 2014-09 which is effective for annual and interim periods beginning after December 15, 2017. Early adoption is permitted. The Company has not yet selected a transition method nor has it determined the effect of the standard on its ongoing financial reporting.</div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In March 2016, the FASB issued ASU 2016-09, <div style="display: inline; font-style: italic;">Compensation — Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting</div>, which outlines new provisions intended to simplify various aspects related to accounting for share-based payments and their presentation in the financial statements. The standard is effective for the Company beginning December 15, 2016, and interim periods within those annual periods. Early adoption is permitted. The Company is evaluating the impact of the adoption of this guidance on its financial statements.</div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In February 2015, the FASB issued ASU 2015-02, <div style="display: inline; font-style: italic;">Consolidation (Topic 810): Amendments to the Consolidation Analysis</div> (“ASU 2015-02”). ASU 2015-02 modifies existing consolidation guidance for reporting organizations that are required to evaluate whether they should consolidate certain legal entities. ASU 2015-02 is effective for fiscal years and interim periods within those years beginning after December 15, 2015, and requires either a retrospective or a modified retrospective approach to adoptions. Early adoption is permitted. We are currently evaluating the potential impact of this standard on our consolidated financial statements, as well as the available transition methods. </div></div><div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> </div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In August 2014, the FASB issued FASB ASU 2014-15, <div style="display: inline; font-style: italic;">Presentation of Financial Statements—Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern, </div>(“ASU 2014-15”)<div style="display: inline; font-style: italic;">. </div>ASU 2014-15</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> changes to the disclosure of uncertainties about an entity’s ability to continue as a going concern. Under U.S. GAAP, continuation of a reporting entity as a going concern is presumed as the basis for preparing financial statements unless and until the entity’s liquidation becomes imminent. Even if an entity’s liquidation is not imminent, there may be conditions or events that raise substantial doubt about the entity’s ability to continue as a going concern. Because there is no guidance in U.S. GAAP about management’s responsibility to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern or to provide related note disclosures, there is diversity in practice whether, when, and how an entity discloses the relevant conditions and events in its financial statements. As a result, these changes require an entity’s management to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the entity’s ability to continue as a going concern within one year after the date that financial statements are issued. Substantial doubt is defined as an indication that it is probable that an entity will be unable to meet its obligations as they become due within one year after the date that financial statements are issued. If management has concluded that substantial doubt exists, then the following disclosures should be made in the financial statements: (i) principal conditions or events that raised the substantial doubt, (ii) management’s evaluation of the significance of those conditions or events in relation to the entity’s ability to meet its obligations, (iii) management’s plans that alleviated the initial substantial doubt or, if substantial doubt was not alleviated, management’s plans that are intended to at least mitigate the conditions or events that raise substantial doubt, and (iv) if the latter in (iii) is disclosed, an explicit statement that there is substantial doubt about the entity’s ability to continue as a going concern. ASU 2014-15 is effective for periods beginning after December 15, 2016. The adoption of ASU 2013-15 will not have a material effect on our consolidated financial position or results of operations.</div></div></div></div>

3185000

3174000

-2457000

-2741000

627000

682000

371000

387000

-16000

10000

8000

0.0001

50000000

434000

575000

400000

900000

400000

900000

200000

390000

412000

P2Y

P7Y

P5Y

P7Y

7000

66000

610000

590000

42000

5000

-266075000

-261783000

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 85%; MARGIN-LEFT: 72pt; MARGIN-RIGHT: 15%; TEXT-INDENT: 0px;; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 40%; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="14"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Balance at March 31, 2016</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;"> </div></td> </tr> <tr> <td style="WIDTH: 40%"> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr> <td style="WIDTH: 40%"> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 40%; VERTICAL-ALIGN: bottom"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">(Amounts in thousands)</div></div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Level I</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Level II</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Level III</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Total</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;"> </div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 40%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Certificates of deposit</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff">106 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff">- </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff">- </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff">106 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 40%; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Total assets</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">106 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">- </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">- </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">106 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="WIDTH: 40%; BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 40%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Warrant liabilities</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">- </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">- </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">953 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">953 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 40%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Derivative Liability</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff">3,685 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff">3,685 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 40%; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Total liabilities </div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">- </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">- </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">4,638 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">4,638 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> </tr> </table></div>

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 80%; MARGIN-LEFT: 10%; MARGIN-RIGHT: 10%; TEXT-INDENT: 0px;; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-ALIGN: center"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Weighted Avg.</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"> </div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Shares</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Exercise Price</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;"> </div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 62%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Balance December 31, 2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff">1,471,000 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff">6.49 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="BACKGROUND-COLOR: #ffffff"> </td> <td style="BACKGROUND-COLOR: #ffffff"> </td> <td style="BACKGROUND-COLOR: #ffffff"> </td> <td style="BACKGROUND-COLOR: #ffffff"> </td> <td style="BACKGROUND-COLOR: #ffffff"> </td> <td style="BACKGROUND-COLOR: #ffffff"> </td> <td style="BACKGROUND-COLOR: #ffffff"> </td> <td style="BACKGROUND-COLOR: #ffffff"> </td> <td style="BACKGROUND-COLOR: #ffffff"> </td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Granted</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff">- </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff">- </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Cancelled</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">(7,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">)</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">10.38 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Balance March 31, 2016</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">1,464,000 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">6.49 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> </tr> </table></div>

174000

828000

P3Y

P5Y

1825000

303609

7000

1300000

1471000

1464000

6.49

1464154

10.38

P10Y

<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Note 2. Summary of Significant Accounting Policies</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Revenue Recognition</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">        Our Catasys contracts are generally designed to provide cash fees to us on a monthly basis based on enrolled members. To the extent our contracts may include a minimum performance guarantee; we reserve a portion of the monthly fees that may be at risk until the performance measurement period is completed. To the extent we receive case rates or other fees in advance that are not subject to the performance guarantees, we recognize the case rate ratably over the twelve months of the program.</div></div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Cost of Services</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"> </div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Cost of healthcare services consists primarily of salaries related to our care coaches, healthcare provider claims payments, and fees charged by our third party administrators for processing these claims. Healthcare services cost of services is recognized in the period in which an eligible member receives services. We contract with doctors and licensed behavioral healthcare professionals, on a fee-for-services basis. We determine that a member has received services when we receive a claim or in the absence of a claim, by utilizing member data recorded in the On<div style="display: inline; font-style: italic;">Trak</div><div style="display: inline; bottom:.33em; font-size: 82%; position: relative; vertical-align: baseline; vertical-align: baseline; position: relative; bottom:.33em;">TM</div> database within the contracted timeframe, with all required billing elements correctly completed by the service provider. </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Cash Equivalents and Concentration of Credit Risk</div><div style="display: inline; font-weight: bold;"> </div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">We consider all highly liquid investments with an original maturity of three months or less to be cash equivalents. Financial instruments that potentially subject us to a concentration of credit risk consist of cash and cash equivalents. Cash is deposited with what we believe are highly credited, quality financial institutions. The deposited cash may exceed Federal Deposit Insurance Corporation (“FDIC”) insured limits. At March 31, 2016, cash and cash equivalents exceeding federally insured limits totaled $110,900.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">For the three months ended March 31, 2016, four customers accounted for approximately 94% of revenues and three customers accounted for approximately 93% of accounts receivable. </div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Basic and Diluted </div><div style="display: inline; font-weight: bold;">Income (Loss) per Share</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Basic income (loss) per share is computed by dividing the net income (loss) to common stockholders for the period by the weighted average number of common shares outstanding during the period. Diluted income (loss) per share is computed by dividing the net income (loss) for the period by the weighted average number of common and dilutive common equivalent shares outstanding during the period.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Common equivalent shares, consisting of 3,720,716 and 23,409,694 common shares for the three months ended March 31, 2016 and 2015, respectively, issuable upon the exercise of stock options and warrants have been excluded from the diluted earnings per share calculation as their effect is anti-dilutive. </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Share-Based Compensation</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Our 2010 Stock Incentive Plan, as amended (the “Plan”), provides for the issuance of up to 1,825,000 shares of our common stock. Incentive stock options (ISOs) under Section 422A of the Internal Revenue Code and non-qualified options (NSOs) are authorized under the Plan. We have granted stock options to executive officers, employees, members of our board of directors, and certain outside consultants. The terms and conditions upon which options become exercisable vary among grants, but option rights expire no later than ten years from the date of grant and employee and board of director awards generally vest over three to five years. At March 31, 2016, we had 1,464,154 vested and unvested shares outstanding and 303,609 shares available for future awards under the Plan.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Total share-based compensation expense on a consolidated basis was $174,000 and $828,000 for the three months ended March 31, 2016 and 2015, respectively.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"> </div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Stock Options – Employees and Directors</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">We measure and recognize compensation expense for all share-based payment awards made to employees and directors based on estimated fair values on the date of grant. We estimate the fair value of share-based payment awards using the Black-Scholes option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods in the condensed consolidated statements of operations.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Share-based compensation expense recognized for employees and directors for the three months ended March 31, 2016 and 2015 was $174,000 and $826,000, respectively.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">For share-based awards issued to employees and directors, share-based compensation is attributed to expense using the straight-line single option method. Share-based compensation expense recognized in our condensed consolidated statements of operations for the three months ended March 31, 2016 and 2015, is based on awards ultimately expected to vest, reduced for estimated forfeitures. Accounting rules for stock options require forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.</div></div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">There were no options granted to employees and directors during the three months ended March 31, 2016 and 1,300,000 options were granted to employees and directors during the same period in 2015 under the Plan. Employee and director stock option activity for the three months ended March 31, 2016 are as follows:</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 80%; MARGIN-LEFT: 10%; MARGIN-RIGHT: 10%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; TEXT-ALIGN: center"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Weighted Avg.</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"> </div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Shares</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Exercise Price</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;"> </div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 62%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Balance December 31, 2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff">1,471,000 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff">6.49 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="BACKGROUND-COLOR: #ffffff"> </td> <td style="BACKGROUND-COLOR: #ffffff"> </td> <td style="BACKGROUND-COLOR: #ffffff"> </td> <td style="BACKGROUND-COLOR: #ffffff"> </td> <td style="BACKGROUND-COLOR: #ffffff"> </td> <td style="BACKGROUND-COLOR: #ffffff"> </td> <td style="BACKGROUND-COLOR: #ffffff"> </td> <td style="BACKGROUND-COLOR: #ffffff"> </td> <td style="BACKGROUND-COLOR: #ffffff"> </td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Granted</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff">- </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff">- </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Cancelled</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">(7,000</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">)</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">10.38 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Balance March 31, 2016</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">1,464,000 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 16%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">6.49 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> </tr> </table> </div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The expected volatility assumptions have been based on the historical and expected volatility of our stock, measured over a period generally commensurate with the expected term. The weighted average expected option term for the three months ended March 31, 2016 and 2015, reflects the application of the simplified method prescribed in SEC Staff Accounting Bulletin (“SAB”) No. 107 (as amended by SAB 110), which defines the life as the average of the contractual term of the options and the weighted average vesting period for all option tranches.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">As of March 31, 2016, there was $841,000 of total unrecognized compensation cost related to non-vested share-based compensation arrangements granted under the Plan. That cost is expected to be recognized over a weighted-average period of approximately 1.51 years.</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">          </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Stock Options and Warrants – Non-employees</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">We account for the issuance of options and warrants for services from non-employees by estimating the fair value of warrants issued using the Black-Scholes pricing model. This model’s calculations include the option or warrant exercise price, the market price of shares on grant date, the weighted average risk-free interest rate, the expected life of the option or warrant, and the expected volatility of our stock and the expected dividends.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">For options and warrants issued as compensation to non-employees for services that are fully vested and non-forfeitable at the time of issuance, the estimated value is recorded in equity and expensed when the services are performed and benefit is received. For unvested shares, the change in fair value during the period is recognized in expense using the graded vesting method.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">There were no options issued to non-employees for the three months ended March 31, 2016 and 2015, respectively. Share-based compensation expense relating to stock options and warrants recognized for non-employees was $0 and $2,000 for the three months ended March 31, 2016 and 2015, respectively.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">There was no stock option activity for the three months ended March 31, 2016.</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Common Stock</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">There were 0 and 76,000 shares of common stock issued in exchange for investor relations services during the three months ended March 31, 2016 and 2015, respectively. Generally, the costs associated with shares issued for services are being amortized to the related expense on a straight-line basis over the related service periods. </div></div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Income Taxes</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">We have recorded a full valuation allowance against our otherwise recognizable deferred tax assets as of March 31, 2016.  As such, we have not recorded a provision for income tax for the period ended March 31, 2016.  We utilize the liability method of accounting for income taxes as set forth in ASC 740, Income Taxes. Under the liability method, deferred taxes are determined based on the temporary differences between the financial statement and tax basis of assets and liabilities using tax rates expected to be in effect during the years in which the basis differences reverse. A valuation allowance is recorded when it is more likely than not that some of the deferred tax assets will not be realized. In determining the need for valuation allowances, we consider projected future taxable income and the availability of tax planning strategies.  After evaluating all positive and negative historical and perspective evidences, management has determined it is more likely than not that our deferred tax assets will not be realized. </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">We assess our income tax positions and record tax benefits for all years subject to examination based upon our evaluation of the facts, circumstances and information available at the reporting date. For those tax positions where there is greater than 50% likelihood that a tax benefit will be sustained, we have recorded the largest amount of tax benefit that may potentially be realized upon ultimate settlement with a taxing authority that has full knowledge of all relevant information. For those income tax positions where there is less than 50% likelihood that a tax benefit will be sustained, no tax benefit has been recognized in the financial statements.  Based on management's assessment of the facts, circumstances and information available, management has determined that all of the tax benefits for the period ended March 31, 2016 should be realized.   </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Fair Value Measurements</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Assets and liabilities recorded at fair value in the condensed consolidated balance sheets are categorized based upon the level of judgment associated with the inputs used to measure fair value. The fair value hierarchy distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level I) and the lowest priority to unobservable inputs (Level III). The three levels of the fair value hierarchy are described below:</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"> </div></div></div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 84.5%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" align="center" border="0"> <tr> <td style="WIDTH: 16.2%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-LEFT: 9pt"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Level Input:</div></div></div></td> <td style="WIDTH: 3.5%; VERTICAL-ALIGN: bottom">  </td> <td style="WIDTH: 80.5%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Input Definition:</div></div></div></td> </tr> <tr> <td style="WIDTH: 16.2%; VERTICAL-ALIGN: top; PADDING-LEFT: 9pt"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Level I</div></div></td> <td style="WIDTH: 3.5%; VERTICAL-ALIGN: top">  </td> <td style="WIDTH: 80.5%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.</div></div></td> </tr> <tr> <td style="WIDTH: 16.2%; VERTICAL-ALIGN: top; PADDING-LEFT: 9pt"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Level II</div></div></td> <td style="WIDTH: 3.5%; VERTICAL-ALIGN: top">  </td> <td style="WIDTH: 80.5%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Inputs, other than quoted prices included in Level I, that are observable for the asset or liability through corroboration with market data at the measurement date.</div></div></td> </tr> <tr> <td style="WIDTH: 16.2%; VERTICAL-ALIGN: top; PADDING-LEFT: 9pt"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Level III</div></div></td> <td style="WIDTH: 3.5%; VERTICAL-ALIGN: top">  </td> <td style="WIDTH: 80.5%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Unobservable inputs that reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date.</div></div></td> </tr> </table> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"> </div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The following table summarizes fair value measurements by level at March 31, 2016 for assets and liabilities measured at fair value:</div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 22pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 85%; MARGIN-LEFT: 72pt; MARGIN-RIGHT: 15%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 40%; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="14"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Balance at March 31, 2016</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;"> </div></td> </tr> <tr> <td style="WIDTH: 40%"> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr> <td style="WIDTH: 40%"> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 40%; VERTICAL-ALIGN: bottom"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">(Amounts in thousands)</div></div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Level I</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Level II</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Level III</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Total</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;"> </div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 40%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Certificates of deposit</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff">106 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff">- </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff">- </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff">106 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 40%; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Total assets</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">106 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">- </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">- </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">106 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="WIDTH: 40%; BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> <td style="BACKGROUND-COLOR: #cceeff"> </td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 40%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Warrant liabilities</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">- </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">- </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">953 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">953 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 40%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Derivative Liability</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff">3,685 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff">3,685 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 40%; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Total liabilities </div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">- </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">- </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">4,638 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">4,638 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 3px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> </tr> </table> </div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Financial instruments classified as Level III in the fair value hierarchy as of March 31, 2016, represent our liabilities measured at market value on a recurring basis which include warrant liabilities and derivative liabilities resulting from recent debt and equity financings. In accordance with current accounting rules, the warrant liabilities and derivative liabilities are being marked-to-market each quarter-end until they are completely settled. The warrants are valued using the Black-Scholes option-pricing model, using both observable and unobservable inputs and assumptions consistent with those used in our estimate of fair value of employee stock options. See <div style="display: inline; font-style: italic;">Warrant Liabilities</div> below. </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"> </div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The following table summarizes our fair value measurements using significant Level III inputs, and changes therein, for the three months ended March 31, 2016:</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 55%; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Level III</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 25%; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Level III</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 55%; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Warrant </div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 25%; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Warrant </div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 55%; VERTICAL-ALIGN: bottom"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">(Dollars in thousands)</div></div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Liabilities</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; PADDING-LEFT: 9pt" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">(Dollars in thousands)</div></div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: center; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Liabilities</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;"> </div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 55%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Balance as of December 31, 2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff">509 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #cceeff" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Balance as of December 31, 2015</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 7%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff">2,348 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 55%; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Issuance of warrants</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">216 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 25%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; PADDING-LEFT: 18pt; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Issuance of warrants</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 7%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">- </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 55%; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Change in fair value </div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff">228 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 25%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; PADDING-LEFT: 18pt; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Change in fair value </div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 7%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff">1,337 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 55%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Balance as of March 31, 2016</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">953 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #ffffff" colspan="2"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: left; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Balance as of March 31, 2016</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 7%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff">3,685 </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 0%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> </td> </tr> </table> </div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Intangible Assets</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;">Property and Equipment</div></div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"> </div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Property and equipment are stated at cost, less accumulated depreciation. Additions and improvements to property and equipment are capitalized at cost. Expenditures for maintenance and repairs are charged to expense as incurred. Depreciation is computed using the straight-line method over the estimated useful lives of the related assets, which range from two to seven years for furniture and equipment. Leasehold improvements are amortized over the lesser of the estimated useful lives of the assets or the related lease term, which is typically five to seven years. </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"> </div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Warrant Liabilities</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In March 2016, we entered into a promissory note with Acuitas, pursuant to which we received aggregate gross proceeds of $900,000 for the sale of $900,000 in principal amount (the "March 2016 Promissory Note"). The March 2016 Promissory Note is due within 30 business days of demand by Acuitas (the "Maturity Date"), and carries an interest rate on any unpaid principal amount of 8% per annum until the Maturity Date, after which the interest will increase to 12% per annum. In addition, Acuitas was granted five-year warrants to purchase an aggregate 450,000 shares of our common stock, at an exercise price of $0.47 per share, which warrants include, subject to certain exceptions, a full-ratchet anti-dilution protection (the “March 2016 Warrants”).</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The warrant liability associated with the March 2016 Warrants were calculated using the Black-Scholes model based upon the following assumptions:</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 85%; MARGIN-RIGHT: 15%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">March</div><div style="display: inline; font-weight: bold;"> 31, 201</div><div style="display: inline; font-weight: bold;">6</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px"><div style="display: inline; font-weight: bold;"> </div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 82%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Expected volatility</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">133.19</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">%</div></div></td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Risk-free interest rate</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">1.21</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">%</div></div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Weighted average expected lives in years</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">5</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Expected dividend</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">0</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">%</div></div></td> </tr> </table> </div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">We have issued warrants to purchase common stock in December 2011, February 2012, April 2015, July 2015, and March 2016. The warrants are being accounted for as liabilities in accordance with FASB accounting rules, due to anti-dilution provisions in some warrants that protect the holders from declines in our stock price and a requirement to deliver registered shares upon exercise of the warrants, which is considered outside our control.  The warrants are marked-to-market each reporting period, using the Black-Scholes pricing model, until they are completely settled or expire.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">For the three months ended March 31, 2016 and 2015, we recognized a loss of $228,000 and a gain of $2.5 million, respectively, related to the revaluation of our warrant liabilities.</div></div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Derivative Liability</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In July 2015, we entered into the July 2015 Convertible Debenture. The derivative liability associated with the July 2015 Convertible Debenture was calculated using the Black-Scholes model based upon the following assumptions:</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 85%; MARGIN-RIGHT: 15%; TEXT-INDENT: 0px; width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;"> </div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">March</div><div style="display: inline; font-weight: bold;"> 31, 201</div><div style="display: inline; font-weight: bold;">6</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px"><div style="display: inline; font-weight: bold;"> </div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 82%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Expected volatility</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">133.19</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">%</div></div></td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Risk-free interest rate</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">0.59</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">%</div></div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Weighted average expected lives in years</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">0.80</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> </td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Expected dividend</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 15%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">0</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">%</div></div></td> </tr> </table> </div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The expected volatility assumption for the three months ended March 31, 2016 was based on the historical volatility of our stock, measured over a period generally commensurate with the expected term. The weighted average expected lives in years for 2015 reflect the application of the simplified method set out in Security and Exchange Commission (SEC) Staff Accounting Bulletin (SAB) 107 (and as amended by SAB 110), which defines the life as the average of the contractual term of the options and the weighted average vesting period for all option tranches. We use historical data to estimate the rate of forfeitures assumption for awards granted to employees. </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">For the three months ended March 31, 2016 and 2015, we recognized a loss of $1.3 million and $0 related to the revaluation of our derivative liability, respectively.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Recently Issued or Newly Adopted Accounting Standards</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;"> </div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In April 2016, the FASB issued Accounting Standards Update (“ASU”) 2016-10, <div style="display: inline; font-style: italic;">Revenue from Contracts with Customers (Topic 606)</div>, which amends certain aspects of the Board’s new revenue standard, ASU 2014-09, Revenue from Contracts with Customers. The standard should be adopted concurrently with adoption of ASU 2014-09 which is effective for annual and interim periods beginning after December 15, 2017. Early adoption is permitted. The Company has not yet selected a transition method nor has it determined the effect of the standard on its ongoing financial reporting.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In March 2016, the FASB issued ASU 2016-09, <div style="display: inline; font-style: italic;">Compensation — Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting</div>, which outlines new provisions intended to simplify various aspects related to accounting for share-based payments and their presentation in the financial statements. The standard is effective for the Company beginning December 15, 2016, and interim periods within those annual periods. Early adoption is permitted. The Company is evaluating the impact of the adoption of this guidance on its financial statements.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In February 2015, the FASB issued ASU 2015-02, <div style="display: inline; font-style: italic;">Consolidation (Topic 810): Amendments to the Consolidation Analysis</div> (“ASU 2015-02”). ASU 2015-02 modifies existing consolidation guidance for reporting organizations that are required to evaluate whether they should consolidate certain legal entities. ASU 2015-02 is effective for fiscal years and interim periods within those years beginning after December 15, 2015, and requires either a retrospective or a modified retrospective approach to adoptions. Early adoption is permitted. We are currently evaluating the potential impact of this standard on our consolidated financial statements, as well as the available transition methods. </div></div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 18pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In August 2014, the FASB issued FASB ASU 2014-15, <div style="display: inline; font-style: italic;">Presentation of Financial Statements—Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern, </div>(“ASU 2014-15”)<div style="display: inline; font-style: italic;">. </div>ASU 2014-15</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> changes to the disclosure of uncertainties about an entity’s ability to continue as a going concern. Under U.S. GAAP, continuation of a reporting entity as a going concern is presumed as the basis for preparing financial statements unless and until the entity’s liquidation becomes imminent. Even if an entity’s liquidation is not imminent, there may be conditions or events that raise substantial doubt about the entity’s ability to continue as a going concern. Because there is no guidance in U.S. GAAP about management’s responsibility to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern or to provide related note disclosures, there is diversity in practice whether, when, and how an entity discloses the relevant conditions and events in its financial statements. As a result, these changes require an entity’s management to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the entity’s ability to continue as a going concern within one year after the date that financial statements are issued. Substantial doubt is defined as an indication that it is probable that an entity will be unable to meet its obligations as they become due within one year after the date that financial statements are issued. If management has concluded that substantial doubt exists, then the following disclosures should be made in the financial statements: (i) principal conditions or events that raised the substantial doubt, (ii) management’s evaluation of the significance of those conditions or events in relation to the entity’s ability to meet its obligations, (iii) management’s plans that alleviated the initial substantial doubt or, if substantial doubt was not alleviated, management’s plans that are intended to at least mitigate the conditions or events that raise substantial doubt, and (iv) if the latter in (iii) is disclosed, an explicit statement that there is substantial doubt about the entity’s ability to continue as a going concern. ASU 2014-15 is effective for periods beginning after December 15, 2016. The adoption of ASU 2013-15 will not have a material effect on our consolidated financial position or results of operations.</div></div></div>

76000

-12841000

-8724000

953000

509000

953000

55008000

25286000

iso4217:USD xbrli:pure xbrli:shares iso4217:USD xbrli:shares 0001136174 2015-01-01 2015-03-31 0001136174 cats:StockOptionsAndWarrantsNonemployeesMember 2015-01-01 2015-03-31 0001136174 cats:CommonStockIssuedForConsultingServicesMember 2015-01-01 2015-03-31 0001136174 cats:CommonStockIssuedForInvestorRelationServicesMember 2015-01-01 2015-03-31 0001136174 cats:TwentyTenStockIncentivePlanMember cats:EmployeesAndDirectorsMember 2015-01-01 2015-03-31 0001136174 us-gaap:CommonStockMember 2015-01-01 2015-03-31 0001136174 2016-01-01 2016-03-31 0001136174 cats:StockOptionsAndWarrantsNonemployeesMember 2016-01-01 2016-03-31 0001136174 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2016-01-01 2016-03-31 0001136174 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember cats:ThreeCustomersMember 2016-01-01 2016-03-31 0001136174 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2016-01-01 2016-03-31 0001136174 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember cats:FourCustomersMember 2016-01-01 2016-03-31 0001136174 us-gaap:FairValueInputsLevel3Member us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2016-01-01 2016-03-31 0001136174 us-gaap:FairValueInputsLevel3Member cats:WarrantsMember 2016-01-01 2016-03-31 0001136174 cats:DerivativeLiabilityMember 2016-01-01 2016-03-31 0001136174 cats:WarrantLiabilityMember 2016-01-01 2016-03-31 0001136174 cats:CommonStockIssuedForConsultingServicesMember 2016-01-01 2016-03-31 0001136174 cats:CommonStockIssuedForInvestorRelationServicesMember 2016-01-01 2016-03-31 0001136174 cats:TwentyTenStockIncentivePlanMember 2016-01-01 2016-03-31 0001136174 cats:TwentyTenStockIncentivePlanMember us-gaap:MaximumMember 2016-01-01 2016-03-31 0001136174 cats:TwentyTenStockIncentivePlanMember us-gaap:MinimumMember 2016-01-01 2016-03-31 0001136174 cats:TwentyTenStockIncentivePlanMember cats:EmployeesAndDirectorsMember 2016-01-01 2016-03-31 0001136174 cats:FurnitureAndEquipmentMember us-gaap:MaximumMember 2016-01-01 2016-03-31 0001136174 cats:FurnitureAndEquipmentMember us-gaap:MinimumMember 2016-01-01 2016-03-31 0001136174 us-gaap:LeaseholdImprovementsMember us-gaap:MaximumMember 2016-01-01 2016-03-31 0001136174 us-gaap:LeaseholdImprovementsMember us-gaap:MinimumMember 2016-01-01 2016-03-31 0001136174 us-gaap:CommonStockMember 2016-01-01 2016-03-31 0001136174 cats:EmployeesAndDirectorsMember 2016-01-01 2016-03-31 0001136174 cats:AcuitasMember 2016-03-01 2016-03-31 0001136174 cats:AcuitasMember cats:March2016PromissoryNoteMember 2016-03-01 2016-03-31 0001136174 cats:AcuitasMember cats:March2016PromissoryNoteMember us-gaap:SubsequentEventMember 2016-04-01 2016-04-30 0001136174 cats:AcuitasMember us-gaap:SubsequentEventMember 2016-04-01 2016-04-30 0001136174 cats:AcuitasMember cats:March2016PromissoryNoteMember us-gaap:SubsequentEventMember 2016-04-01 2016-04-30 0001136174 2014-12-31 0001136174 2015-03-31 0001136174 2015-12-31 0001136174 us-gaap:FairValueInputsLevel3Member us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2015-12-31 0001136174 us-gaap:FairValueInputsLevel3Member cats:WarrantsMember 2015-12-31 0001136174 cats:EmployeesAndDirectorsMember 2015-12-31 0001136174 2016-03-31 0001136174 cats:AcuitasMember 2016-03-31 0001136174 us-gaap:FairValueInputsLevel1Member 2016-03-31 0001136174 us-gaap:FairValueInputsLevel2Member 2016-03-31 0001136174 us-gaap:FairValueInputsLevel3Member 2016-03-31 0001136174 us-gaap:FairValueInputsLevel3Member us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2016-03-31 0001136174 us-gaap:FairValueInputsLevel3Member cats:WarrantsMember 2016-03-31 0001136174 cats:AcuitasMember cats:ChairmanAndChiefExecutiveOfficerMember 2016-03-31 0001136174 cats:AcuitasMember cats:March2016PromissoryNoteMember 2016-03-31 0001136174 cats:TwentyTenStockIncentivePlanMember 2016-03-31 0001136174 cats:TwentyTenStockIncentivePlanMember cats:EmployeesAndDirectorsMember 2016-03-31 0001136174 cats:ChairmanAndChiefExecutiveOfficerMember 2016-03-31 0001136174 cats:EmployeesAndDirectorsMember 2016-03-31 0001136174 cats:AcuitasMember cats:March2016PromissoryNoteMember us-gaap:SubsequentEventMember 2016-04-30 0001136174 cats:AcuitasMember us-gaap:SubsequentEventMember 2016-04-30 0001136174 cats:AcuitasMember cats:March2016PromissoryNoteMember us-gaap:SubsequentEventMember 2016-04-30 0001136174 2016-05-12

EX-101.SCH 10 cats-20160331.xsd EXHIBIT 101.SCH 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink 001 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) link:calculationLink link:definitionLink link:presentationLink 002 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) link:calculationLink link:definitionLink link:presentationLink 003 - Statement - Condensed Consolidated Statements of Operations (Unaudited) link:calculationLink link:definitionLink link:presentationLink 004 - Statement - Condensed Consolidated Statement of Cash Flows (Unaudited) link:calculationLink link:definitionLink link:presentationLink 005 - Disclosure - Note 1 - Basis of Consolidation, Presentation and Going Concern link:calculationLink link:definitionLink link:presentationLink 006 - Disclosure - Note 2 - Summary of Significant Accounting Policies link:calculationLink link:definitionLink link:presentationLink 008 - Disclosure - Note 4 - Short-term Debt link:calculationLink link:definitionLink link:presentationLink 009 - Disclosure - Note 5 - Subsequent Events link:calculationLink link:definitionLink link:presentationLink 010 - Disclosure - Significant Accounting Policies (Policies) link:calculationLink link:definitionLink link:presentationLink 011 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Tables) link:calculationLink link:definitionLink link:presentationLink 012 - Disclosure - Note 1 - Basis of Consolidation, Presentation and Going Concern (Details Textual) link:calculationLink link:definitionLink link:presentationLink 013 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Details Textual) link:calculationLink link:definitionLink link:presentationLink 014 - Disclosure - Note 2 - Employee and Director Stock Option Activity (Details) link:calculationLink link:definitionLink link:presentationLink 015 - Disclosure - Note 2 - Fair Value, Assets and Liabilities Measured on Recurring Basis (Details) link:calculationLink link:definitionLink link:presentationLink 016 - Disclosure - Note 2 - Fair Value Measurements Using Significant Level III Inputs (Details) link:calculationLink link:definitionLink link:presentationLink 017 - Disclosure - Note 2 - Fair Value Assumptions (Details) link:calculationLink link:definitionLink link:presentationLink 019 - Disclosure - Note 4 - Short-term Debt (Details Textual) link:calculationLink link:definitionLink link:presentationLink 020 - Disclosure - Note 5 - Subsequent Events (Details Textual) link:calculationLink link:definitionLink link:presentationLink EX-101.CAL 11 cats-20160331_cal.xml EXHIBIT 101.CAL EX-101.DEF 12 cats-20160331_def.xml EXHIBIT 101.DEF EX-101.LAB 13 cats-20160331_lab.xml EXHIBIT 101.LAB Supplemental disclosure of cash paid Document And Entity Information Goodwill and Intangible Assets, Policy [Policy Text Block] Note To Financial Statement Details Textual us-gaap_AssetsFairValueDisclosure Total assets statementsignificantaccountingpoliciespolicies statementnote2summaryofsignificantaccountingpoliciestables Operating expenses statementnote2employeeanddirectorstockoptionactivitydetails statementnote2fairvalueassetsandliabilitiesmeasuredonrecurringbasisdetails statementnote2fairvaluemeasurementsusingsignificantleveliiiinputsdetails statementnote2fairvalueassumptionsdetails Notes To Financial Statements Amendment Flag us-gaap_DisclosureTextBlockAbstract Notes to Financial Statements Notes To Financial Statements [Abstract] us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Earnings Document Fiscal Year Focus Document Fiscal Period Focus us-gaap_ProceedsFromIssuanceOfDebt Proceeds from Issuance of Debt us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue Balance Balance Document Period End Date Provision for doubtful accounts Current Fiscal Year End Date us-gaap_CashAndCashEquivalentsFairValueDisclosure Certificates of deposit us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues Issuance of warrants Changes in current assets and liabilities: us-gaap_PropertyPlantAndEquipmentUsefulLife Property, Plant and Equipment, Useful Life Entity Current Reporting Status Entity Voluntary Filers Entity Filer Category Document Type us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings Change in fair value Common stock, shares outstanding (in shares) us-gaap_InterestExpense Interest expense Financing activities: us-gaap_NetCashProvidedByUsedInInvestingActivities Net cash provided by/(used in) investing activities us-gaap_StockholdersEquity Total Stockholders' Deficit Entity Well-known Seasoned Issuer us-gaap_FairValueAssumptionsRiskFreeInterestRate Risk-free interest rate Statement of Financial Position [Abstract] us-gaap_FairValueAssumptionsExpectedDividendRate Expected dividend Preferred stock, shares outstanding (in shares) us-gaap_FairValueAssumptionsExpectedTerm Weighted average expected lives in years Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Table Text Block] Related Party Transactions Disclosure [Text Block] Related Party [Axis] us-gaap_DepreciationAndAmortization Depreciation and amortization Prepaids and other current assets Furniture and Equipment [Member] Represents furniture and equipment. Related Party [Domain] us-gaap_TableTextBlock Notes Tables Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Statement [Table] Short term debt, net of discount Long term debt, net of discount Income Statement [Abstract] Revenue Recognition, Policy [Policy Text Block] Stock Options and Warrants Nonemployees [Member] Represents stock options and warrants nonemployees. Employees and Directors [Member] Information pertaining to employees and directors. us-gaap_IncreaseDecreaseInAccountsReceivable Receivables cats_WorkingCapitalDeficit Working Capital Deficit Represents working capital deficit. Statement of Cash Flows [Abstract] Warrants [Member] Represents warrants. Stockholders' Equity, Policy [Policy Text Block] Deferred rent and other long-term liabilities us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Prepaids and other current assets Basic and diluted weighted number of shares outstanding (in shares) us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Long term derivative liability Maximum [Member] Minimum [Member] Range [Axis] Range [Domain] Customer [Axis] Customer [Domain] us-gaap_HealthCareOrganizationRevenue Healthcare services revenues Basic net loss from operations per share: (in dollars per share) General and administrative us-gaap_OperatingExpenses Total operating expenses us-gaap_RepaymentsOfLongTermCapitalLeaseObligations Capital lease obligations Fair Value, Inputs, Level 3 [Member] Fair Value, Inputs, Level 2 [Member] Acuitas [Member] Represents Acuitas Group Holdings, LLC (“Acuitas”), which is a 100% owned company of Terren S. Peizer, the Chairman and Chief Executive Officer of Catasys, Inc. cats_ConcentrationRiskNumberOfCustomers Concentration Risk, Number of Customers Represents the number of customers as it pertains to the concentration of credit risk. Deferred rent Capitol leases Accumulated deficit us-gaap_LiabilitiesAndStockholdersEquity Total Liabilities and Stockholders' Deficit Fair Value, Hierarchy [Axis] Fair Value Hierarchy [Domain] Fair Value, Inputs, Level 1 [Member] Legal Entity [Axis] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Entity Registrant Name Leasehold Improvements [Member] Entity Central Index Key us-gaap_StockIssuedDuringPeriodSharesIssuedForServices Stock Issued During Period, Shares, Issued for Services us-gaap_LiabilitiesFairValueDisclosure Total liabilities Entity [Domain] Property, Plant and Equipment, Type [Domain] Property, Plant and Equipment, Type [Axis] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Cancelled (in shares) Common Stock Issued for Consulting Services [Member] Represents the issuance of common stock for consulting services. Entity Common Stock, Shares Outstanding (in shares) Fair Value by Liability Class [Domain] Liability Class [Axis] Other income cats_FairValueAdjustmentOfDerivatives Fair value adjustment on derivative liability Amount of expense (income) related to adjustment to fair value of derivative liability. us-gaap_FairValueAssumptionsExpectedVolatilityRate Expected volatility Cash and cash equivalents Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Cash and Cash Equivalents, at Carrying Value Trading Symbol us-gaap_IncreaseDecreaseInDeferredRevenue Deferred revenue Derivatives, Policy [Policy Text Block] Accounts payable and other accrued liabilities us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Loss from operations before provision for income taxes Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Change in fair value of derivative liability Proceeds from bridge loan cats_WarrantTerm Warrant Term Period of time between issuance and maturity of warrants. March 2016 Promissory Note [Member] Represents the March 2016 promissory note. Common Stock [Member] Current assets cats_DebtInstrumentInterestRateAfterMaturityDate Debt Instrument, Interest Rate, Stated Percentage After Maturity Date Contractual interest rate for funds borrowed, under the debt agreement, after the maturity date. Equity Component [Domain] Equity Components [Axis] us-gaap_DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease Net decrease in cash and cash equivalents Common Stock Issued for Investor Relation Services [Member] Represents stock issued in lieu of cash for investor relation services. us-gaap_DebtInstrumentFaceAmount Debt Instrument, Face Amount Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Provision for income taxes Class of Stock [Axis] Receivables, allowance for doubtful accounts Accrued compensation and benefits Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Domain] Accounts Receivable [Member] Accounts payable Accounts Payable, Current Common stock, par value (in dollars per share) Receivables, net of allowance for doubtful accounts of $0 and $0, respectively Other accrued liabilities New Accounting Pronouncements, Policy [Policy Text Block] Preferred stock, shares issued (in shares) Twenty Ten Stock Incentive Plan [Member] Represents twenty ten stock incentive plan. Three Customers [Member] Concentration risk information related to three customers. Preferred stock, $0.0001 par value; 50,000,000 shares authorized; no shares issued and outstanding cats_CashAndCashEquivalentsUninsuredAmount Cash and Cash Equivalents Uninsured Amount Amount of cash and cash equivalent uninsured by FDIC us-gaap_PaymentsForProceedsFromOtherDeposits Deposits and other assets Preferred stock, par value (in dollars per share) Preferred stock, shares authorized (in shares) us-gaap_AllocatedShareBasedCompensationExpense Allocated Share-based Compensation Expense Long term debt, related party, net of discount $0 and $0, respectively us-gaap_OperatingIncomeLoss Loss from operations us-gaap_LiabilitiesCurrent Total current liabilities Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] Long-term liabilities Warrant Liability [Member] Information pertaining to warrant liabilities. Common stock, $0.0001 par value; 500,000,000 shares authorized; 55,007,761 and 55,007,761 shares issued and outstanding at March 31, 2016 and December 31, 2015, respectively Short term debt, related party, net of discount $0 and $0, respectively us-gaap_DebtInstrumentTerm Debt Instrument, Term Significant Accounting Policies [Text Block] Common stock, shares issued (in shares) Derivative Financial Instruments, Liabilities [Member] Common stock, shares authorized (in shares) Accounting Policies [Abstract] Derivative Liability [Member] Information pertaining to derivative liabilities. Subsequent Event Type [Domain] Cash and Cash Equivalents, Policy [Policy Text Block] Subsequent Event Type [Axis] Statement [Line Items] Deferred revenue Sales Revenue, Net [Member] Subsequent Event [Member] Short term derivative liability us-gaap_PolicyTextBlockAbstract Accounting Policies Subsequent Events [Text Block] Revenues: Investing activities: us-gaap_NetCashProvidedByUsedInOperatingActivities Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Operating activities: us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized Four Customers [Member] Concentration risk information related to four customers. Scenario, Unspecified [Domain] Title of Individual [Axis] Relationship to Entity [Domain] Scenario [Axis] us-gaap_ConcentrationRiskPercentage1 Concentration Risk, Percentage us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights EX-101.PRE 14 cats-20160331_pre.xml EXHIBIT 101.PRE XML 15 R1.htm IDEA: XBRL DOCUMENT

Document And Entity Information - shares	3 Months Ended
Document And Entity Information - shares	Mar. 31, 2016	May. 12, 2016
Entity Registrant Name	CATASYS, INC.
Entity Central Index Key	0001136174
Trading Symbol	cats
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Entity Common Stock, Shares Outstanding (in shares)		55,007,761
Document Type	10-Q
Document Period End Date	Mar. 31, 2016
Document Fiscal Year Focus	2016
Document Fiscal Period Focus	Q1
Amendment Flag	false

XML 16 R2.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)	Mar. 31, 2016	Dec. 31, 2015
Current assets
Cash and cash equivalents	$ 262,000	$ 916,000
Receivables, net of allowance for doubtful accounts of $0 and $0, respectively	610,000	590,000
Prepaids and other current assets	434,000	575,000
Total current assets	1,306,000	2,081,000
Long-term assets
Property and equipment, net of accumulated depreciation of $1,515 and $1,491, respectively	390,000	412,000
Deposits and other assets	371,000	387,000
Total Assets	2,067,000	2,880,000
Current liabilities
Accounts payable	772,000	753,000
Accrued compensation and benefits	1,703,000	1,703,000
Deferred revenue	2,276,000	1,683,000
Other accrued liabilities	627,000	$ 682,000
Short term debt, related party, net of discount $0 and $0, respectively	4,676,000
Short term derivative liability	3,685,000
Total current liabilities	13,739,000	$ 4,821,000
Long-term liabilities
Deferred rent and other long-term liabilities	178,000	198,000
Capitol leases	$ 38,000	66,000
Long term debt, related party, net of discount $0 and $0, respectively		3,662,000
Long term derivative liability		2,348,000
Warrant liabilities	$ 953,000	509,000
Total Liabilities	14,908,000	11,604,000
Stockholders' deficit
Preferred stock, $0.0001 par value; 50,000,000 shares authorized; no shares issued and outstanding	0	0
Common stock, $0.0001 par value; 500,000,000 shares authorized; 55,007,761 and 55,007,761 shares issued and outstanding at March 31, 2016 and December 31, 2015, respectively	6,000	6,000
Additional paid-in-capital	253,228,000	253,053,000
Accumulated deficit	(266,075,000)	(261,783,000)
Total Stockholders' Deficit	(12,841,000)	(8,724,000)
Total Liabilities and Stockholders' Deficit	$ 2,067,000	$ 2,880,000

XML 17 R3.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - USD ($)	Mar. 31, 2016	Dec. 31, 2015
Receivables, allowance for doubtful accounts	$ 0	$ 0
Property and equipment, accumulated dereciation	1,515,000	1,491,000
Short term debt, net of discount	0	0
Long term debt, net of discount	$ 0	$ 0
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	50,000,000	50,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	500,000,000	500,000,000
Common stock, shares issued (in shares)	55,007,761	55,007,761
Common stock, shares outstanding (in shares)	55,007,761	55,007,761

XML 18 R4.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Revenues:
Healthcare services revenues	$ 728	$ 433
Operating expenses
Cost of healthcare services	966	406
General and administrative	2,187	2,734
Depreciation and amortization	32	34
Total operating expenses	3,185	3,174
Loss from operations	(2,457)	(2,741)
Other income	65	11
Interest expense	(333)	(2)
Change in fair value of warrant liability	(228)	$ 2,474
Change in fair value of derivative liability	(1,337)
Loss from operations before provision for income taxes	(4,290)	$ (258)
Provision for income taxes	2	2
Net Loss	$ (4,292)	$ (260)
Basic net loss from operations per share: (in dollars per share)	$ (0.08)	$ (0.01)
Basic and diluted weighted number of shares outstanding (in shares)	55,008	25,286

XML 19 R5.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statement of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Common Stock Issued for Consulting Services [Member]
Adjustments to reconcile net loss to net cash used in operating activities:
Issuance of stock and warrants for services		$ 172,000
Supplemental disclosure of non-cash activity
Issuance of stock and warrants for services		172,000
Common Stock Issued for Investor Relation Services [Member]
Adjustments to reconcile net loss to net cash used in operating activities:
Issuance of stock and warrants for services		172,000
Supplemental disclosure of non-cash activity
Issuance of stock and warrants for services		172,000
Net loss	$ (4,292,000)	(260,000)
Depreciation and amortization	32,000	$ 33,000
Issuance costs included in interest expense	216,000
Provision for doubtful accounts	7,000	$ 66,000
Deferred rent	(23,000)	(17,000)
Share-based compensation expense	174,000	$ 828,000
Fair value adjustment on derivative liability	(1,337,000)
Fair value adjustment on warrant liability	228,000	$ (2,474,000)
Receivables	(27,000)	380,000
Prepaids and other current assets	141,000	(18,000)
Deferred revenue	593,000	160,000
Accounts payable and other accrued liabilities	96,000	319,000
Net cash used in operating activities	(1,518,000)	(811,000)
Purchases of property and equipment	(10,000)	$ (8,000)
Deposits and other assets	16,000
Net cash provided by/(used in) investing activities	6,000	$ (8,000)
Proceeds from bridge loan	900,000	200,000
Capital lease obligations	(42,000)	(5,000)
Net cash provided by financing activities	858,000	195,000
Net decrease in cash and cash equivalents	(654,000)	(624,000)
Cash and cash equivalents at beginning of period	916,000	708,000
Cash and cash equivalents at end of period	262,000	84,000
Income taxes	$ 26,000	$ 2,000

XML 20 R6.htm IDEA: XBRL DOCUMENT

Note 1 - Basis of Consolidation, Presentation and Going Concern	3 Months Ended
	Mar. 31, 2016
Notes to Financial Statements
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	Note 1. Basis of Consolidation, Presentation and Going Concern The accompanying unaudited condensed consolidated financial statements for Catasys, Inc. and its subsidiaries have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) and instructions to Form 10-Q and, therefore, do not include all disclosures necessary for a complete presentation of financial position, results of operations, and cash flows in conformity with U.S. GAAP. In our opinion, all adjustments, consisting of normal recurring adjustments, considered necessary for a fair presentation have been included. Interim results are not necessarily indicative of the results that may be expected for the entire fiscal year. The accompanying financial information should be read in conjunction with the financial statements and the notes thereto included in our most recent Annual Report on Form 10-K for the year-ended December 31, 2015, from which the balance sheets, as of December 31, 2015, have been derived. Our financial statements have been prepared on the basis that we will continue as a going concern. At March 31, 2016, cash and cash equivalents was $262,000 and we had a working capital deficit of approximately $12.4 million. In April 2016, we amended the March 2016 promissory note with Acuitas Group Holdings, LLC (“Acuitas”), a limited liability company 100% owned by our Chief Executive Officer and Chairman, to increase the amount of the promissory note by $400,000, for a total of $1.3 million in principal amount. We have incurred significant operating losses and negative cash flows from operations since our inception. During the three months ended March 31, 2016, our cash used in operating activities was $1.5 million. We anticipate that we could continue to incur negative cash flows and net losses for the next twelve months. The financial statements do not include any adjustments relating to the recoverability of the carrying amount of the recorded assets or the amount of liabilities that might result from the outcome of this uncertainty. As of March 31, 2016, these conditions raised substantial doubt as to our ability to continue as a going concern. We expect our current cash resources to cover expenses through the end of May 2016; however delays in cash collections, revenue, or unforeseen expenditures could negatively impact our estimate. We are in need of additional capital, however, there is no assurance that additional capital can be timely raised in an amount which is sufficient for us or on terms favorable to us and our stockholders, if at all. If we do not obtain additional capital, there is a significant doubt as to whether we can continue to operate as a going concern and we will need to curtail or cease operations or seek bankruptcy relief. If we discontinue operations, we may not have sufficient funds to pay any amounts to stockholders. Our ability to fund our ongoing operations and continue as a going concern is dependent on increasing the number of members that are eligible for our programs by signing new contracts and generating fees from existing and new contracts for our managed care programs and the success of management’s plans to increase revenue and continue to control expenses. We currently operate our On Trak programs in Florida, Illinois, Kansas, Kentucky, Louisiana, Massachusetts, Missouri, New Jersey, Oklahoma, Pennsylvania, Texas, West Virginia and Wisconsin, and our On Trak for anxiety program in Kansas. We provide services to commercial (employer funded), managed Medicare Advantage and managed Medicaid populations. We have generated fees from our launched programs and expect to increase enrollment and fees throughout 2016. However, there can be no assurance that we will generate such fees or that new programs will launch as we expect.

XML 21 R7.htm IDEA: XBRL DOCUMENT

Note 2 - Summary of Significant Accounting Policies

3 Months Ended

Mar. 31, 2016

Notes to Financial Statements

Significant Accounting Policies [Text Block]

Note 2. Summary of Significant Accounting Policies

Revenue Recognition

Cost of Services

Trak

database within the contracted timeframe, with all required billing elements correctly completed by the service provider.

Cash Equivalents and Concentration of Credit Risk

For the three months ended March 31, 2016, four customers accounted for approximately 94% of revenues and three customers accounted for approximately 93% of accounts receivable.

Basic and Diluted

Income (Loss) per Share

Share-Based Compensation

Total share-based compensation expense on a consolidated basis was $174,000 and $828,000 for the three months ended March 31, 2016 and 2015, respectively.

Stock Options – Employees and Directors

Share-based compensation expense recognized for employees and directors for the three months ended March 31, 2016 and 2015 was $174,000 and $826,000, respectively.

				Weighted Avg.
	Shares			Exercise Price
Balance December 31, 2015		1,471,000		$	6.49

Granted		-		$	-
Cancelled		(7,000	)	$	10.38

Balance March 31, 2016		1,464,000		$	6.49

Stock Options and Warrants – Non-employees

There was no stock option activity for the three months ended March 31, 2016.

Common Stock

Income Taxes

Fair Value Measurements

Level Input:		Input Definition:
Level I		Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.
Level II		Inputs, other than quoted prices included in Level I, that are observable for the asset or liability through corroboration with market data at the measurement date.
Level III		Unobservable inputs that reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date.

The following table summarizes fair value measurements by level at March 31, 2016 for assets and liabilities measured at fair value:

	Balance at March 31, 2016


(Amounts in thousands)	Level I		Level II		Level III		Total
Certificates of deposit		106		-		-		106
Total assets		106		-		-		106

Warrant liabilities		-		-		953		953
Derivative Liability						3,685		3,685
Total liabilities		-		-		4,638		4,638

Warrant Liabilities

below.

The following table summarizes our fair value measurements using significant Level III inputs, and changes therein, for the three months ended March 31, 2016:

	Level III				Level III
	Warrant				Warrant
(Dollars in thousands)	Liabilities		(Dollars in thousands)		Liabilities
Balance as of December 31, 2015	$	509	Balance as of December 31, 2015		$	2,348
Issuance of warrants		216		Issuance of warrants		-
Change in fair value		228		Change in fair value		1,337
Balance as of March 31, 2016	$	953	Balance as of March 31, 2016		$	3,685

Intangible Assets

Property and Equipment

Warrant Liabilities

The warrant liability associated with the March 2016 Warrants were calculated using the Black-Scholes model based upon the following assumptions:

	March 31, 201 6
Expected volatility		133.19	%
Risk-free interest rate		1.21	%
Weighted average expected lives in years		5
Expected dividend		0	%

For the three months ended March 31, 2016 and 2015, we recognized a loss of $228,000 and a gain of $2.5 million, respectively, related to the revaluation of our warrant liabilities.

Derivative Liability

	March 31, 201 6
Expected volatility		133.19	%
Risk-free interest rate		0.59	%
Weighted average expected lives in years		0.80
Expected dividend		0	%

For the three months ended March 31, 2016 and 2015, we recognized a loss of $1.3 million and $0 related to the revaluation of our derivative liability, respectively.

Recently Issued or Newly Adopted Accounting Standards

In April 2016, the FASB issued Accounting Standards Update (“ASU”) 2016-10,

Revenue from Contracts with Customers (Topic 606)

, which amends certain aspects of the Board’s new revenue standard, ASU 2014-09, Revenue from Contracts with Customers. The standard should be adopted concurrently with adoption of ASU 2014-09 which is effective for annual and interim periods beginning after December 15, 2017. Early adoption is permitted. The Company has not yet selected a transition method nor has it determined the effect of the standard on its ongoing financial reporting.

In March 2016, the FASB issued ASU 2016-09,

Compensation — Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting

, which outlines new provisions intended to simplify various aspects related to accounting for share-based payments and their presentation in the financial statements. The standard is effective for the Company beginning December 15, 2016, and interim periods within those annual periods. Early adoption is permitted. The Company is evaluating the impact of the adoption of this guidance on its financial statements.

In February 2015, the FASB issued ASU 2015-02,

Consolidation (Topic 810): Amendments to the Consolidation Analysis

(“ASU 2015-02”). ASU 2015-02 modifies existing consolidation guidance for reporting organizations that are required to evaluate whether they should consolidate certain legal entities. ASU 2015-02 is effective for fiscal years and interim periods within those years beginning after December 15, 2015, and requires either a retrospective or a modified retrospective approach to adoptions. Early adoption is permitted. We are currently evaluating the potential impact of this standard on our consolidated financial statements, as well as the available transition methods.

In August 2014, the FASB issued FASB ASU 2014-15,

Presentation of Financial Statements—Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern,

(“ASU 2014-15”)

ASU 2014-15

changes to the disclosure of uncertainties about an entity’s ability to continue as a going concern. Under U.S. GAAP, continuation of a reporting entity as a going concern is presumed as the basis for preparing financial statements unless and until the entity’s liquidation becomes imminent. Even if an entity’s liquidation is not imminent, there may be conditions or events that raise substantial doubt about the entity’s ability to continue as a going concern. Because there is no guidance in U.S. GAAP about management’s responsibility to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern or to provide related note disclosures, there is diversity in practice whether, when, and how an entity discloses the relevant conditions and events in its financial statements. As a result, these changes require an entity’s management to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the entity’s ability to continue as a going concern within one year after the date that financial statements are issued. Substantial doubt is defined as an indication that it is probable that an entity will be unable to meet its obligations as they become due within one year after the date that financial statements are issued. If management has concluded that substantial doubt exists, then the following disclosures should be made in the financial statements: (i) principal conditions or events that raised the substantial doubt, (ii) management’s evaluation of the significance of those conditions or events in relation to the entity’s ability to meet its obligations, (iii) management’s plans that alleviated the initial substantial doubt or, if substantial doubt was not alleviated, management’s plans that are intended to at least mitigate the conditions or events that raise substantial doubt, and (iv) if the latter in (iii) is disclosed, an explicit statement that there is substantial doubt about the entity’s ability to continue as a going concern. ASU 2014-15 is effective for periods beginning after December 15, 2016. The adoption of ASU 2013-15 will not have a material effect on our consolidated financial position or results of operations.

XML 22 R8.htm IDEA: XBRL DOCUMENT

Note 3 - Related Party Disclosure	3 Months Ended
Note 3 - Related Party Disclosure	Mar. 31, 2016
Notes to Financial Statements
Related Party Transactions Disclosure [Text Block]	Note 3 . Related Party Disclosure In March 2016 we entered into the March 2016 Promissory Note and March 2016 Warrants with Acuitas. In addition, we have accounts payable outstanding with Mr. Peizer for travel and expenses of $129,000 as of March 31, 2016.

XML 23 R9.htm IDEA: XBRL DOCUMENT

Note 4 - Short-term Debt	3 Months Ended
Note 4 - Short-term Debt	Mar. 31, 2016
Notes to Financial Statements
Debt Disclosure [Text Block]	Note 4. Short-term Debt In March 2016, we entered into the March 2016 Promissory Note with Acuitas. The March 2016 Promissory Note is due within 30 business days of the Maturity Date, and carries an interest rate on any unpaid principal amount of 8% annum until the Maturity Date, after which the interest will increase to 12% annum. In addition, Acuitas was granted the March 2016 Warrants.

XML 24 R10.htm IDEA: XBRL DOCUMENT

Note 5 - Subsequent Events	3 Months Ended
Note 5 - Subsequent Events	Mar. 31, 2016
Notes to Financial Statements
Subsequent Events [Text Block]	Note 5. Subsequent Event In April 2016, we amended the March 2016 Promissory Note with Acuitas to increase the amount of the March 2016 Promissory Note by $400,000, for a total of $1.3 million in principle amount. In connection with the amendment, Acuitas was granted five-year warrants to purchase an additional 200,000 shares of our common stock, at an exercise price of $0.47 which warrants include, subject to certain exceptions, a full-ratchet anti-dilution protection.

XML 25 R11.htm IDEA: XBRL DOCUMENT

Significant Accounting Policies (Policies)

3 Months Ended

Mar. 31, 2016

Accounting Policies [Abstract]

Revenue Recognition, Policy [Policy Text Block]

Revenue Recognition

Cost of Sales, Policy [Policy Text Block]

Cost of Services

Trak

database within the contracted timeframe, with all required billing elements correctly completed by the service provider.

Cash and Cash Equivalents, Policy [Policy Text Block]

Cash Equivalents and Concentration of Credit Risk

For the three months ended March 31, 2016, four customers accounted for approximately 94% of revenues and three customers accounted for approximately 93% of accounts receivable.

Earnings Per Share, Policy [Policy Text Block]

Basic and Diluted

Income (Loss) per Share

Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]

Share-Based Compensation

Total share-based compensation expense on a consolidated basis was $174,000 and $828,000 for the three months ended March 31, 2016 and 2015, respectively.

Stock Options – Employees and Directors

Share-based compensation expense recognized for employees and directors for the three months ended March 31, 2016 and 2015 was $174,000 and $826,000, respectively.

				Weighted Avg.
	Shares			Exercise Price
Balance December 31, 2015		1,471,000		$	6.49

Granted		-		$	-
Cancelled		(7,000	)	$	10.38

Balance March 31, 2016		1,464,000		$	6.49

Stock Options and Warrants – Non-employees

There was no stock option activity for the three months ended March 31, 2016.

Stockholders' Equity, Policy [Policy Text Block]

Common Stock

Income Tax, Policy [Policy Text Block]

Income Taxes

Fair Value of Financial Instruments, Policy [Policy Text Block]

Fair Value Measurements

Level Input:		Input Definition:
Level I		Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.
Level II		Inputs, other than quoted prices included in Level I, that are observable for the asset or liability through corroboration with market data at the measurement date.
Level III		Unobservable inputs that reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date.

The following table summarizes fair value measurements by level at March 31, 2016 for assets and liabilities measured at fair value:

	Balance at March 31, 2016


(Amounts in thousands)	Level I		Level II		Level III		Total
Certificates of deposit		106		-		-		106
Total assets		106		-		-		106

Warrant liabilities		-		-		953		953
Derivative Liability						3,685		3,685
Total liabilities		-		-		4,638		4,638

Warrant Liabilities

below.

The following table summarizes our fair value measurements using significant Level III inputs, and changes therein, for the three months ended March 31, 2016:

	Level III				Level III
	Warrant				Warrant
(Dollars in thousands)	Liabilities		(Dollars in thousands)		Liabilities
Balance as of December 31, 2015	$	509	Balance as of December 31, 2015		$	2,348
Issuance of warrants		216		Issuance of warrants		-
Change in fair value		228		Change in fair value		1,337
Balance as of March 31, 2016	$	953	Balance as of March 31, 2016		$	3,685

Goodwill and Intangible Assets, Policy [Policy Text Block]

Intangible Assets

Property and Equipment

Warrant Liabilities, Policy [Policy Text Block]

Warrant Liabilities

The warrant liability associated with the March 2016 Warrants were calculated using the Black-Scholes model based upon the following assumptions:

	March 31, 201 6
Expected volatility		133.19	%
Risk-free interest rate		1.21	%
Weighted average expected lives in years		5
Expected dividend		0	%

For the three months ended March 31, 2016 and 2015, we recognized a loss of $228,000 and a gain of $2.5 million, respectively, related to the revaluation of our warrant liabilities.

Derivatives, Policy [Policy Text Block]

Derivative Liability

	March 31, 201 6
Expected volatility		133.19	%
Risk-free interest rate		0.59	%
Weighted average expected lives in years		0.80
Expected dividend		0	%

For the three months ended March 31, 2016 and 2015, we recognized a loss of $1.3 million and $0 related to the revaluation of our derivative liability, respectively.

New Accounting Pronouncements, Policy [Policy Text Block]

Recently Issued or Newly Adopted Accounting Standards

In April 2016, the FASB issued Accounting Standards Update (“ASU”) 2016-10,

Revenue from Contracts with Customers (Topic 606)

In March 2016, the FASB issued ASU 2016-09,

Compensation — Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting

In February 2015, the FASB issued ASU 2015-02,

Consolidation (Topic 810): Amendments to the Consolidation Analysis

In August 2014, the FASB issued FASB ASU 2014-15,

Presentation of Financial Statements—Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern,

(“ASU 2014-15”)

ASU 2014-15

XML 26 R12.htm IDEA: XBRL DOCUMENT

Note 2 - Summary of Significant Accounting Policies (Tables)

3 Months Ended

Mar. 31, 2016

Notes Tables

Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]

				Weighted Avg.
	Shares			Exercise Price
Balance December 31, 2015		1,471,000		$	6.49

Granted		-		$	-
Cancelled		(7,000	)	$	10.38

Balance March 31, 2016		1,464,000		$	6.49

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]

	Balance at March 31, 2016


(Amounts in thousands)	Level I		Level II		Level III		Total
Certificates of deposit		106		-		-		106
Total assets		106		-		-		106

Warrant liabilities		-		-		953		953
Derivative Liability						3,685		3,685
Total liabilities		-		-		4,638		4,638

Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]

	Level III				Level III
	Warrant				Warrant
(Dollars in thousands)	Liabilities		(Dollars in thousands)		Liabilities
Balance as of December 31, 2015	$	509	Balance as of December 31, 2015		$	2,348
Issuance of warrants		216		Issuance of warrants		-
Change in fair value		228		Change in fair value		1,337
Balance as of March 31, 2016	$	953	Balance as of March 31, 2016		$	3,685

Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Table Text Block]

	March 31, 201 6
Expected volatility		133.19	%
Risk-free interest rate		1.21	%
Weighted average expected lives in years		5
Expected dividend		0	%

	March 31, 201 6
Expected volatility		133.19	%
Risk-free interest rate		0.59	%
Weighted average expected lives in years		0.80
Expected dividend		0	%

XML 27 R13.htm IDEA: XBRL DOCUMENT

Note 1 - Basis of Consolidation, Presentation and Going Concern (Details Textual) - USD ($)	1 Months Ended		3 Months Ended
	Apr. 30, 2016	Mar. 31, 2016	Mar. 31, 2016	Mar. 31, 2015	Dec. 31, 2015	Dec. 31, 2014
Chairman and Chief Executive Officer [Member] \| Acuitas [Member]
Ownership Percentage by Related Party		100.00%	100.00%
Acuitas [Member] \| March 2016 Promissory Note [Member] \| Subsequent Event [Member]
Proceeds from Issuance of Debt	$ 400,000
Debt Instrument, Face Amount	$ 1,300,000
Acuitas [Member] \| March 2016 Promissory Note [Member]
Proceeds from Issuance of Debt		$ 900,000
Cash and Cash Equivalents, at Carrying Value		262,000	$ 262,000	$ 84,000	$ 916,000	$ 708,000
Working Capital Deficit		$ 12,400,000	12,400,000
Net Cash Provided by (Used in) Operating Activities			$ (1,518,000)	$ (811,000)

XML 28 R14.htm IDEA: XBRL DOCUMENT

Note 2 - Summary of Significant Accounting Policies (Details Textual)	1 Months Ended	3 Months Ended
	Mar. 31, 2016 USD ($) $ / shares shares	Mar. 31, 2016 USD ($) $ / shares shares	Mar. 31, 2015 USD ($) shares
Sales Revenue, Net [Member] \| Customer Concentration Risk [Member] \| Four Customers [Member]
Concentration Risk, Percentage		94.00%
Sales Revenue, Net [Member] \| Customer Concentration Risk [Member]
Concentration Risk, Number of Customers		4
Accounts Receivable [Member] \| Customer Concentration Risk [Member] \| Three Customers [Member]
Concentration Risk, Percentage		93.00%
Accounts Receivable [Member] \| Customer Concentration Risk [Member]
Concentration Risk, Number of Customers		3
Twenty Ten Stock Incentive Plan [Member] \| Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period		3 years
Twenty Ten Stock Incentive Plan [Member] \| Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period		5 years
Twenty Ten Stock Incentive Plan [Member] \| Employees and Directors [Member]
Allocated Share-based Compensation Expense \| $		$ 174,000	$ 826,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross		0	1,300,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized \| $	$ 841,000	$ 841,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition		1 year 186 days
Twenty Ten Stock Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized	1,825,000	1,825,000
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period		10 years
Minimum [Member] \| Furniture and Equipment [Member]
Property, Plant and Equipment, Useful Life		2 years
Minimum [Member] \| Leasehold Improvements [Member]
Property, Plant and Equipment, Useful Life		5 years
Maximum [Member] \| Furniture and Equipment [Member]
Property, Plant and Equipment, Useful Life		7 years
Maximum [Member] \| Leasehold Improvements [Member]
Property, Plant and Equipment, Useful Life		7 years
Employees and Directors [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Stock Options and Warrants Nonemployees [Member]
Allocated Share-based Compensation Expense \| $		$ 0	$ 2,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross		0	0
Common Stock [Member]
Stock Issued During Period, Shares, Issued for Services		0	76,000
Acuitas [Member] \| March 2016 Promissory Note [Member]
Proceeds from Issuance of Debt \| $	$ 900,000
Debt Instrument, Term	30 days
Debt Instrument, Interest Rate, Stated Percentage	8.00%	8.00%
Debt Instrument, Interest Rate, Stated Percentage After Maturity Date	12.00%
Acuitas [Member]
Warrant Term	5 years
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	450,000	450,000
Class of Warrant or Right, Exercise Price of Warrants or Rights \| $ / shares	$ 0.47	$ 0.47
Cash and Cash Equivalents Uninsured Amount \| $	$ 110,900	$ 110,900
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount		3,720,716	23,409,694
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number	1,464,154	1,464,154
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant	303,609	303,609
Share-based Compensation \| $		$ 174,000	$ 828,000
Derivative, Gain (Loss) on Derivative, Net \| $		(228,000)	2,500,000
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Earnings \| $		$ (1,300,000)	$ 0

XML 29 R15.htm IDEA: XBRL DOCUMENT

Note 2 - Employee and Director Stock Option Activity (Details) - Employees and Directors [Member]	3 Months Ended
	Mar. 31, 2016 $ / shares shares
Balance (in shares) \| shares	1,471,000
Balance (in dollars per share) \| $ / shares	$ 6.49
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross \| shares
Granted (in dollars per share) \| $ / shares
Cancelled (in shares) \| shares	(7,000)
Cancelled (in dollars per share) \| $ / shares	$ 10.38
Balance (in shares) \| shares	1,464,000
Balance (in dollars per share) \| $ / shares	$ 6.49

XML 30 R16.htm IDEA: XBRL DOCUMENT

Note 2 - Fair Value, Assets and Liabilities Measured on Recurring Basis (Details) - USD ($)	Mar. 31, 2016	Dec. 31, 2015
Fair Value, Inputs, Level 1 [Member]
Certificates of deposit	$ 106,000
Total assets	$ 106,000
Warrant liabilities
Derivative Liability
Total liabilities
Fair Value, Inputs, Level 2 [Member]
Certificates of deposit
Total assets
Warrant liabilities
Derivative Liability
Total liabilities
Fair Value, Inputs, Level 3 [Member]
Certificates of deposit
Total assets
Warrant liabilities	$ 953,000
Derivative Liability	3,685,000
Total liabilities	4,638,000
Certificates of deposit	106,000
Total assets	106,000
Warrant liabilities	953,000	$ 509,000
Derivative Liability	3,685,000
Total liabilities	$ 4,638,000

XML 31 R17.htm IDEA: XBRL DOCUMENT

Note 2 - Fair Value Measurements Using Significant Level III Inputs (Details) - Fair Value, Inputs, Level 3 [Member] $ in Thousands	3 Months Ended
	Mar. 31, 2016 USD ($)
Warrants [Member]
Balance	$ 509
Issuance of warrants	216
Change in fair value	228
Balance	953
Derivative Financial Instruments, Liabilities [Member]
Balance	$ 2,348
Issuance of warrants
Change in fair value	$ 1,337
Balance	$ 3,685

XML 32 R18.htm IDEA: XBRL DOCUMENT

Note 2 - Fair Value Assumptions (Details)	3 Months Ended
Note 2 - Fair Value Assumptions (Details)	Mar. 31, 2016
Warrant Liability [Member]
Expected volatility	133.19%
Risk-free interest rate	1.21%
Weighted average expected lives in years	5 years
Expected dividend	0.00%
Derivative Liability [Member]
Expected volatility	133.19%
Risk-free interest rate	0.59%
Weighted average expected lives in years	292 days
Expected dividend	0.00%

XML 33 R19.htm IDEA: XBRL DOCUMENT

Note 3 - Related Party Disclosure (Details Textual) - USD ($)	Mar. 31, 2016	Dec. 31, 2015
Chairman and Chief Executive Officer [Member]
Accounts Payable, Current	$ 129,000
Accounts Payable, Current	$ 772,000	$ 753,000

XML 34 R20.htm IDEA: XBRL DOCUMENT

Note 4 - Short-term Debt (Details Textual) - Acuitas [Member] - March 2016 Promissory Note [Member]	1 Months Ended
	Mar. 31, 2016
Debt Instrument, Term	30 days
Debt Instrument, Interest Rate, Stated Percentage	8.00%
Debt Instrument, Interest Rate, Stated Percentage After Maturity Date	12.00%

XML 35 R21.htm IDEA: XBRL DOCUMENT

Note 5 - Subsequent Events (Details Textual) - Acuitas [Member] - USD ($)	1 Months Ended
	Apr. 30, 2016	Mar. 31, 2016
March 2016 Promissory Note [Member] \| Subsequent Event [Member]
Proceeds from Issuance of Debt	$ 400,000
Debt Instrument, Face Amount	$ 1.30
Subsequent Event [Member]
Warrant Term	5 years
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	200,000
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.47
Warrant Term		5 years
Class of Warrant or Right, Number of Securities Called by Warrants or Rights		450,000
Class of Warrant or Right, Exercise Price of Warrants or Rights		$ 0.47

EXCEL 36 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( -R$K4C_-Y-0B $ )8/ 3 6T-O;G1E;G1?5'EP97-= M+GAM;,U774_",!3]*V2OAI5.Q8\ +^*KDN@?J-L=:^A7VC+@W]L.-+I, \J2 M^[*N._?><]K;GF23UYT!-]A*H=PTJ;PW]X2XO +)7*H-J("4VDKFP]0NB6'Y MBBV!9*/1F.1:>5!^Z&.-9#9YKL%:7L#@80_$VM.$&2-XSCS7BM2J:%4=ZK+D M.10Z7\N0DOI #1I19$$^,J;@Y4C]M0Q85OTR2@[BB&=N)ORKB,33-J M^2TCSO^XEM8FUE+,+=OP%D'=6YOBF$K&55>K-MJNWK1>G?.80%Q5 <70V!!H M/>\X)2%X$5!'0NE_<7^A/1^QK\_Y3 MTQO0D6;HT21.TI$AT7&)1,<5$AW72'2,D>BX0:+C%HF..R0ZZ B+$"R.2K%8 M*L7BJ12+J5(LKDJQV"K%XJL4B[%2+,Z:87'6[--92?,[/GL'4$L#!!0 ( M -R$K4A(=07NQ0 "L" + 7W)E;',O+G)E;'.MDLMNPD ,17\EFGUQ M2B46$6'%AAU"_( [XSR4S'CD,2+]^X[8@,)#K<32KWN/KKP.J:P.-*+V'%+7 MQU1,?@RIROW:=*JQ DBV(X]IP9%"GC8L'C67TD)$.V!+L"S+%4EK0VTPAGEN&;>5ADZ3SXB?078VZ:WM*6[13@2=&AXD7U(V8#$NTIO8+Z>@"%,;X[)9J4@B,WHX*[ MO]C\ E!+ P04 " #?LY%85PMTJ$,F+ M=@V&0KQ9=_M&,)VL>#]BQ!63PH8PDZQ(,.+$''>-"1)>@4#SJQ!$%*R)CR M)%%8\V@-!-? XS408 ./V$"0#3QF X$V\*@-!-O XS80< ./W$#0#3QV X$W M\.BM"+T5C]Z*T%LQ?6LO]/:M=E@]!]>9QJ]=\VTX6;3 VX='C^NGS%/)AH76 M8=J$/W^4#4$L#!!0 ( -R$K4BB"!PS50( )8' 0 M 9&]C4')O<',O87!P+GAM;+U538_:,!#]*U9./90-8=E*16PD"E2MU&U1 MH?1LG E8Z]BIQT'07]]QLJ2!A:AP* <8C]^;;P]#C=W!S)HA25,I8&)$D8%V8:_;?1?"SH%.(.GD MM=$@'GHOHSQ74G GC8Z?I+ &3>K8="= #<-30,D@RW,0A95N'W0D-,CZ[6R MQ'S:4Y[*<\<;KM>0-+&O+P^U6()%GVG4N^O2IR[!05_9!IY(O9YQ:3$>;MU@ M"\(9^]*FK;NU2XD1ONFX7%!\&+ 51_#B8[#E5G+M H;R-QU[0>6VTI:RRM'9 M^*>QS[@!<#@,:V4I-K%-6?;C7E0B2#I&AG5F\4O9CO+VFH5T"O!;.N/6_:=2 ME#G5A8B"1O8'$VRD$S;5CL:1?=:5*VI>LR2U-#;T+C1"PDA"HV1"8Y:P#UQQ M+8#=P+F_AC-W]$,QW\!Y.,OY:ARPB'4H&I3(3-K@7JI!R>D19UYD&;=[SYK+ MM9;4%YJ$RYQ[XGP'54;E1V#/)A*%,EA_K=$O?>!;>B)>-A# %M5^OV8PR%[3MKL\[ZEU?W^A\[]O]]-LYTRQ79@_ M. WU1-KJ?;5S/M(+94NN"GC+1HBT#CS[7SGL"3@6UH]E2VM...2FR'(_8BVU MOC0OT?NKYH6]F8#C\LJQ*5FOUF)SOYULL_#X7SC^ U!+ P04 " #&ULS9--3\,P#(;_"NJ] M2[O"-$5=#X X,0F)(1"WD'A;6/.AQ%/7?T^6=2T#+KUQJVN_CU_'2+MW=80)3J &!1H]R2^?'F*&)%WEPCU_/TYVX6\PK+HA_JWCL\&X7918P\C=1HV(RXV?$23 -EVT#;&"5_%^S5$QY<35K8QKCVE?D07KZKZ E!+ P04 M" #621A'^_1S80RY8- M[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X8-DOV]:[MR_>X%#BVR]*+41B1%G\@MNN01.+5)#3(3/PB=AIAJ4!P" MI DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7H5A)VH3X$$8:XIQSYG/1;/L' MI4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V@S&L%&KQMUAVC2/'K^!?F<-0H< MD1L= F<;LT8AA&F[\!ZO)(Z:K<(1*T(^8ADV&G*U%H&V<:F$8%H2QM%X3M*T M$?Q9K#63/F#([,V1=<[6D0X1DEXW0CYBSHN0$;\>ACA*FNVB<5@$_9Y>PTG! MZ(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0'HYI9";V$5FJ?JH,@H% M\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y?RY]SZ7ON?0]H=*W-R-]9\'3 MBUO>1FY;Q/NN,=K7-"XH8U=RSTS0LS0[=R2^JVE+ZU)CA*]+',<$X>RPP[9SR2';9WH!TU M^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D*TU*0;\/YZ<5X&N(YV02Y?9A7 M;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-#AWE[7YAGE<90-!1M;*PD+$:W M8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B?$R,1>APYY=<7^/1DN/;IF6U M;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*POFH]M!5.S_Y9KF4Q M9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=WP6#R_7#)1P_E.^=?]%U#KG[V MW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2D 83 >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F$RQ#I'[!?8J*@!&K8KZZKT_Y M)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+!WP?D@9CC%OT-%^/%&*MIK&M MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'50.4_V]0-:/8--!R1!5XQF;8V MH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0 ( -R$K4AM.MDY1@( .() - M >&PO2 (DSB-92L6PC0H M5ZTT";X8(.3C;U1!$_QP]O%7J\SU!^3'R:?))'PXOS[$S]S".4:>XUN1X&A^ MB8.7DTY#>(XRN]4#^ODKZ9\B/Z"^LM1!?T1I7"HYGM0,>R"-FT>T)AS\(^N> M*ZXT,G 5H,$AD@CJ/6X(9YEF%BR)8'SCX9D%W.WU?H))I5UNG^$PSS0<,^DJ M2W#8/R]/EXWL;K#;8YSO;P^ -*Z),53+!4Q0;R\W-6Q.*DF]2.?WC'>ER2:: M7>X$N 'R9DH75 ^9([R%TIC3TD" 9M7*CD;55KHR1@DP"D8J)0FWE-N(W@#: MG')^9]^5^W*/NRN1][%W'&)D56Q-.(C>',O '6JPR^:Y=VG#-_&BKAP20#2I M:[[YREDE!?5B/;10_>PY^N@(?1J3+2M:*P=\60@X U1BMJ38LWT5^:U(O M:6?Z"@ZZ\IC"MV[YU#6-^:'H_N>!N-K'!WJ>EN"@VU9D5"]<0WR]L(NK?Z?L M7>OYS??T#H=D/VTG>G_VLWBRTOZVMH*^_>[T^+T./Z H:QDW3&XU$/M-OK6Z M^5[S';L[8G6ROC%A,\VM^M_&@^>"T'B@2/ M]@]:L%9\=@K&O[KT#U!+ P04 " #P[?\X=^<'2NONIM??BL=#&#]PP6810#EHM MGRV@4/Z'+<'0LYEUA0K4=?.6G9"('&:JTN&6-KM>=YC( MM)NF_14C3KM#6'H.C -"90$?X%9-ATD[$:H*]AQU #=2 7XZ6Y5HYL1*Q R= M#Y,8;CVS0(,%/L=]4\\O[/*7=?AL35!ZDCFK=?U6?%"_1"OXUQ':8\!L8V)0 MTYMX$L.DWR;@ WJM=*'7ZWUK"U,E9'[$X,;D8FT 4<6%6 MAT>IB7N@R1=YO; ;(#7<12Y7J>*@,VMR,!YR02UO->:4E5R<*JU,!H*!4@9* MOPKJ,%"'@3J?!DT"_5'(#-1EH.Y703T&ZC%0[R/HR@804NQ1,!Z]L#,&W$QV MGX'Z#:"40).J*)1[BJ@)S@W2K54F,- ^ ^TW@#H$NHF7FX*Z5HX,&*'/M/45 M QTPT$$#J!MWM+ N[-&M*,0(IGPKAXQPV$#HU3%-/?RKHI3C!_KU7,(VM[#] MD<*R($ZRS%:DM)F+:TIRAK"!VA!ZB]$[DRQ3CN)*RRU.[SQXR9V67&JYQ>K= MN^IR%-=:;O'Z%34N2FV? (2BC\ ('63!.GYE)1=;-ID=4><*G;A3NH+OXL1[ M^N)$*$=QM>4NM]]0XA*4KUR\M5PHR>6637:_0]&FJJ*LZQA'<;UED]]-%T4> MVQ"$ MSXZWYEISV1%5933YSDV'>]:0/J#XL@UW8', N90HQ>\&/YCQ',C!'PEYEXV? MYVT8RS'@%I^X#('$[8X/N&UE)$'^.P;]9$JC^?R,_EU-5PS_B!@^D/9/<^:U M&&T6OY''#SS.(9,!3Z1EZAJ<;HR3[FD)@PY]Z'O3J_M#O\G@:/,; MX&B DP'F7QJ2T9!,!I"JF>J1J7E]0QQ5)26/@ U([C;8"#F5043D@*EH5"^7 MF!D3O?KU$(,E!D3&9C".P]3L9H'Y X@-^QK M+\!4@'B>4#B$PO0#+\*2P'G$RD&L3'_B15B2!1NQ=A!KTY]Y$98DGT> V&'( M#\QG!/]VVYHE%.!2K-Q=^<[N8=3HPYME<5P4^8(T!]!EF6D,_.?+TL %!PRX MR0[,7(;^(V9K%IPQX&8\,%,>)MZ0_,M(:Y?\TL3>%0(J.F=)A>5:UEP8G<>JY+RM0[U?.=JGK1I[PJ!W3%OQ"] M-CT+CH2+RJ;*T(40CL4@XA&PO=V]R:W-H965T&ULE9A-+>]^_+Y_ND2(UZB8VY#WB$9(>9+97TW[OSEKWR<^Z:KK[S;GO+W=IVCV>=5UT M[\U%-\-_3J:MBWXX;)_2[M+JXC@5U54*62;2NBB;S6X[G?O:[K;FN:_*1G]M MD^ZYKHOV_[VNS/5^0S;KB6_ET[D?3Z2[;7JK.Y:U;KK2-$FK3_>;#^3N0&&, M3(E_2WWMT/=DA'\PYOMX\,_Q?I.-#+K2C_W81#%\O.B#KJJQI>'*/Y9&?U]S M+,3?U]8_3=T=\!^*3A],]5]Y[,\#;;9)COI4/%?]-W/]K)<^\+'!1U-UT]_D M\;GK3;V6;)*Z^#E_ELWT>9W_H[*ES%\ 2P'<"@C[8P%="JA3D,YD4[\^%GVQ MV[;FFG278AQM6DFUIKY]LU]*P;SK[L0&W3E[&=)0)39&]%?(F# ME"-,RA89C&N6%\IF'H,H)DKVCFV ''>)Y%T7"'AF,:ZJ7AZ#*,LA -CG') MHVB$0R,P#?/2"'090C,1PL$YR!2)XI'.S).8A[]=KYS^*%POO/U1B)/FP;'& M,48@JC>Y0Y-C&NFER3&-)"$:*Z9D% W)')S1HK]YE)=GR:S#*&2(R XJ%;<: M"'$&G&!7T0A7$7![A6W%O+#[)3/#2OE:-VNGK!RG<7UR]4>P_QCQ$V&S$9G1 M(-*?@F$F5X($6Y#Y+4BPWP!D<*E;02)4)).K0H)=R/PN)-AR EY/Q^5!8>=4 MW'HEK@X)]B'S^Y!@T3'AN4MT0;(:BY 9D2X.UB'SZVS)+&H0B@=QY-_BN'(E MV*[,[S.BK,>%G SK'S'+L KB'A@D=P6")RO$LCR-RQ0I8K-RO M,<#")"S/PE/(2@Z; ?1CHD#\2YG!%"%B$ MW"]"P'H+/DG#J3"-N\L$;$#NW]8!WD "IP#AX7:B6>0VB+I>I=BKW.]5BGWY M#@9!R=C2D+< J&N9BE6J C\ M;L8*]>[/UU_.5M"[/T_1JXE+\:2_%.U3V73)@^E[4T^O)$[&]'IH+GL_]/6L MB^/MH-*G?OPJQYLPOX^9#WIS65\OW=YQ[7X!4$L#!!0 ( -R$K4B:2M1@ M:P( '\) 8 >&PO=V]R:W-H965T&ULC9;=CJ,@%(!? MQ?@ %?Q#&VLR=;/9O=AD,A>[U[2EU8R*"[3.OOV"V@X:L'-3A7[GG(^?(%E/ MV3LO"1'.1U.W?.>60G1;S^/'DC28;VA'6OG/F;(&"]ED%X]WC.#3$-34G@] M[#6X:MT\&_I>69[1JZBKEKPRAU^;!K-_>U+3?N="]][Q5EU*H3J\//,><:>J M(2VO:.LPA4F#YN)&" MU+7*)"O_G9)^UE2!^OL]^_=AN%+_@#DI:/VG.HE2V@+7.9$SOM;BC?8_R#2& M2"4\TIH/O\[QR@5M[B&NT^"/\5FUP[,?_TG %&8.\*< _Q$ P]6 8 H(%@'> M:#:,ZQL6.,\8[1W>8;7:<"MQII+(S X?LK%QNN3(N.R]Y;&?>3>59T+\ =GK MB)$H9D3Z0#Q9WRCAWR7&YHNO2P3S$FB4&)%V0(")*,R$U2%8. 2Z0SBO$(T. M@58!1C " )BX8L:%*=0YJT^X\ EUG\CH$]KG9#(Q$U:':.$0Z0ZQ<5VBI^MB M)JP.\<(AUAW0O$(R.L1ZA8V<;6C"BA7,:H,6-DBW28RK@K0R:HL VS99!:U& MR<(HT8U2HU'R=)^8":M#NG!(-0=DK+!/GSJ8":L#! L)=69_6ABWP'YBGFZ5 M-MU _;U%@]M*/TTA60RB&9JU5TFZU M/("A?@(C\PD,@R];K9*CE:=]*CM\(;\PNU0M=PY4R*_N\(D\4RJ(S =QY\K_ U!+ P04 " #JNI ^']E/WKT*["?ZT$*WGSN][+DZ(-?6_/#M6ED3_Y M]1L;>XAUPAUOQ/#I[2Y"\G8*\;VV^C#7NANN5_,-#< _ <,-=Q!Y Q M@-P"HJ%30S;T]:6259'W_.J) M=9Y1@@?)%DK0K A4F MA)HH7/$\4HLCA1S(R9&"&AC1U FR$*4DND]"+1(*2;"3A((BQ"DI%Y(5%)E% MD4$*XJ3(8 E$8R?'4I2N($&AA:*-[<82.5E&C:GS@*/8_70L61JM\ :$;!YH M+NZVMZ/&%$K<1[/0H#4DV":!+D2=;\9VU(PM$^)\EN52A5>P$)L%.IK[Y=B. MFJG*)YZT4.%HU6_&MD<$_9%2-PTTOP=$B 5-1AR8*HI7P,0V##1)FKEA8@@3 MX2QTG\U"AF.Z L>V7 0]UZXSX4!#=3O,)Y+/.6S+1=!S,^3J=XM2ZUBP^U@6 M,IR$*W!LWT70>.TZV8@#;?4A? RI2U;^)UOSXSBT>:9' M!64XQM3^ QF :QE_7$83(6WXY=.FNEHWIV'WV>L!SAK?ZN'XF&PNZ4I\G-U M9#^J_EAWPGOE4HV'PRQWX%PRQ1<^*LZ3&MOG1<,.4M^FN@$SR)J%Y.=I+I__ M.2C^ 5!+ P04 " #"BSVT)X5F[:% ME417DN/MOZ\^'0Y%KIE<8DM^AWQFR'FE<',3S8_VS'GG_*S*NGUVSUUW>?*\ M=G_F5=Y^%1=>][\<15/E77_9G+SVTO#\, 95I8>^'WE57M3N=C/>^]9L-^+: ME47-OS5.>ZVJO/DOXZ6X/;O@+C>^%Z=S-]SPMAOO'G+/P[/K#PR\Y/MN&"+O/][XCI?E,%(_\[_S MH.]S#H'R]V7TW\=T>_S7O.4[4?Y3'+IS3^N[SH$?\VO9?1>W/_B>GDS#-*/[+3C:,U4KCZSMK_[MDV#C? :VS#!=OC YA_!Q?+#$1U-\(,=;S!\J M\X=R?$Q3G"29+ E"*HFG*DR2>BISW'>;_Y@D4C*)9)+D<7RL9!(_SB3^12;A ME$G\B4P2A2212=+'\:E2B?2#:PJ^ C!8P*-:$(VA&+/F8]4 4-(!^.#* JKY MH$4^:)$/?B8?M65![EF0AI Z(IM%TU1? DS)9 2**#'R[:@"E4IV@@1U4V6S M9IJ*K8GF;J8R9L>C&@N$I$J@!Y*- R%:$;&9R.!!9IQ(Q8D(CJ$^D803&\LC MJZ+(KCRJ6T%,>)B>)R9;@QFW$-%!;(>DVA8D!"G0(R6DA0)CD61=@HD=4JHB MI01)V]79+%JR9VR]8NUXCHOF! JVF& A6* MO.7XL1X*R&3K&LU[B>A88N=&J#HVRF[,]+L;B1L'8"1"LKYV6PE5UT;9M0-] M_Z-LQ6%J[#>B TO'1M6Q,2#+ENB19"].UP:Y$!'+AM2.2/5LI)Z=ZHE"LAPA MK/?W D64"8 =E6K=2*P;M'-E&!$JW]AS1&>YEU3S1MF\F:'?8G6/:"T)#>^D M9AC5MI'8-N@?M"C;\1IF*4[RB>*HGHW$L\'0:;)G#[O5M(5D'?IVG<94UV;$ MM4%O1XRX<6!\7Z.ZT(Y(M6Q&+!OTSUHF6W$2&ON,Z""U1%(MFR%!TC]K&?'B M*%P__Q3+(NL2R2:MN,V#8DNM[.&'G5-EH E:UY/.F(IN+-:3RZ:IV]N-;=='YR MOWL_'GO!X8A'N9_!TVXZY'H?9KNYY"?^5]ZS__: MXYUY?KA?E/S8#5_CH:#34==TT8G+*%GFH/>DBQ\&*3L&3)F:0DNNW$P@\1 ?"W@]&L8N*]GQ%??/*G.M+$6P !I?4*W"T7N MX5O\5IG7NS]S /8I_765;9S:AI(*:#$^X_@;IA&NO6")PH0O*0=C M49%K'(GIN3^[].#@VHLX M96*"FH[3.Z/&52]%FO[,V<4+39A(.6TP"X(Y]2];9'1+SU;T['OZ;J;?1(>[ M=?S) )JZ\-;%^MXI6)BL9\? MR/)*BW=02P,$% @ W(2M2,?XHBZD 0 L0, !@ !X;"]W;W)K&<,V=\*48TK[8#<.1-26V/M'.N/S!FJPX4MS?8 M@_9_&C2*.Y^:EMG> *\C24F69]DM4UQH6A:Q]FS* @9([S>'TRX@(N"/@-%>Q21X/R.^AN17 M?:19L 2*A<4N%\N\ !2!B'?^-^D^=$R$*_C6?TQ3NO=G[F%!Y1_1>TZ;S:C MI(:&#]*]X/@$TPC[(%BAM/%+JL$Z5#.%$L7?TBIT7,?T9Y]/M*$^43(%\)= M%HVG1M'F3^YX61@UY.+O-P<--$/'*Q$8UDZ;W1JVO7LI-OBW8)0A-F$0Y MK3 +@GGU+UOD=$W/K^CY]_3M3+]-#KV=*DNM_,^'B+[@)=%SUOXS4TKM"5G=/YDXS$TB Z\ MB>QF3TGGW\^22&A<"'_XV*0KE1*'_?Q EE=:O@-02P,$% @ W(2M2/)& MXAZC 0 L0, !@ !X;"]W;W)K2G3G2UMK^P)@I6U#!5(2K(L2?9, M<='1(@^U)UWD.%@I.GC2Q Q* MQ"D3$]1TG-X9-:YZ*=)LG[.+%YHPD7):818$<^K?MLCHFIY=T;.?Z9N9OH\. M-RN'R<\"VUE@$P6V*X';]8@1H84N+0V;BE2W6YG?=9 M.)-/>)'WO(&_7#>B,^2,UIUL.(8:T8(SD=SL*&G=^UD2";7UX:V+=;Q2,;'8 MSP]D>:7%?U!+ P04 " #:@]Z2+'P8I.P9,F9I"2Z_<3 M"!R/=$?GPG/7M-876)&SA5=U$I3I4!$-]9'>[@ZGO4<$P-\.1K.*B?=^1GSQ MR6-UI(FW )*ZQ6X6RYP!T)X(=?X==+\;.F)ZWA6OP_3.O=G;N .Q;^NLJTS MFU!20N[/;G=P<.U%G#(Q04W'Z9U1XZJ78I?^RMG%"TV8 M2#EM, N".?4O6Z1T2T]7]/1[>C;3;Z+#;.,P^5Y@/PMD46"_%LB2[8@1<]IB M_A^2K?94@F["U3&DQ$'9N*5+=;F=MVDXDT]XD?>\@3]<-YTRY(S6G6PXAAK1 M@C.17%U3TKKWLR0":NO#'R[6\4K%Q&(_/Y#EE18?4$L#!!0 ( -R$K4AV MQNELI $ +$# 9 >&PO=V]R:W-H965TVF'>N>%(B*U[D,S>Z &4_]-J(YGSJ>F('0RP)I*D(#3+ M[HAD7.&JC+4G4Y5Z=((K>#+(CE(R\^\,0D\GG..E\,R[WH4"J4JR\AHN05FN M%3+0GO!]?CP? B("_G"8["9&P?M%ZY>0_&I.. L60$#M@@+SRQ4>0(@@Y!N_ MSIKO+0-Q&R_J/^*TWOV%67C0XB]O7._-9A@UT+)1N&<]_81YA-L@6&MAXQ?5 MHW5:+A2,)'M+*U=QG=*?(I]IGQ/H3* KX7L6C:=&T>8C&5DHYI)TWNCUE>O55[0DER#T(Q)E/,.LR*(5_^T!<5[.MW0Z=?T8J'? M)8?%MCO-OA8X+ )%$CCL1BSV(R;,>8\Y?&A"-GLJP73QZEA4ZU&YM*5K=;V= M]S2>R3N\*@?6P6]F.JXLNFCG3S8>0ZNU V\BN[G%J/?O9TT$M"Z$WWQLTI5* MB=/#\D#65UK]!U!+ P04 " #'>SH" ;" &0 'AL+W=O M6--8)>/\]R;ZZ6F)]^-1_;O; MK@E_3Q5[$K.(;+4Q(;H3$(^#!R(7YC6I:%E+T2'74)H]L#%Q:$:.,E%.3P^Y- MH,JL7DN29@6^6J$;9J#L &9"8*,>M$@B2$_NZ,EC>CK2\R'"%$28/Q98C +I M(+ DNXQ0&S@YC58Y/,,\F P#IH C"+^+%)[IGD0( $32!FQO^]]$R60" - MFD#,XK')RC-9 8$L: (Q,Q*_]DS60""<>(B9D7@2>R[VZ-])A%,/0=F,W!/B M^X!CF(6S[X%FI)\DOD\"),(%X(%F5 !)?1]PL+-P#7B@&45 _.-/P-G.PF7@ M@>;4@7\#$'"\LR_J (!ROP[PW>7-F3R['J7005Q:/=S=T^K4!Y\3=_E_PLNB MHV?VB\ISW2JT%]JT$'??GX30S$01/YDH*M.IITG#3MH.EV8LA]XU3+3HQE8\ M?0^4_P%02P,$% @ W(2M2" 2!)#* 0 X 0 !D !X;"]W;W)K&ULC53;;ILP&'X5BP>H@230102IZ51M%Y.J7FS7#OP< M5!M3VX3N[><#T!@A93?8_\]W,MC.1B[>90.@T">CG3P%C5+]$6-9-,"(?. ] M=/I-Q04C2I>BQK(70$I+8A3'89A@1MHNR#/;>Q5YQ@=%VPY>!9(#8T3\/0/E MXRF(@KGQUM:-,@V<9WCAE2V#3K:\0P*J4_ 4'<^I05C [Q9&>3-')ON%\W=3 M_"Q/06@B (5"&06BARL\ Z5&2!M_3)I?EH9X.Y_57^QJ=?H+D?#,Z9^V5(T. M&P:HA(H,5+WQ\0=,2S@8P8)3:9^H&*3B;*8$B)%/-[:='4?WYC&<:-N$>"+$ M*P)V1C;F=Z)(G@D^(MD3\^^BHX8+(Z*5D;1JPJU>!Y6Z>\VC),KPU0A-&$Y@%@;7ZID4<^/3XAA[?I^]F>N(2[KR$_R&PGP5V3F#O">S\)3K,V)CDOLFR M-(D*/G3*[<"ENQSFI]ANX2]XGO6DAE]$U&TGT84K?1#LKJTX5Z!#A _Z>S;Z MNED*"I4RTU3/A3N!KE"\G^^3Y5++_P%02P,$% @ W(2M2&$QU\J8 @ MP0D !D !X;"]W;W)K&ULC5;;[%SG1ZL7N=:E2F0-PDUN[;;T[2)!LK7@@)WRD_$/[ZC,D;/2#$ M@H^^&^@B/#!VG$<1W1Q0#^D=/J*!7]EATD/&AV0?T2-!<"M)?1).GQ>A""\3+RT^P,3$U%31R-OV_9HH"T> M H)VB_ >S)] (B 2\:M%9VJ4 MN/,?+?KI*8CF^47]42Z7QW^%%*UP][O=L@-/&X?!%NW@J6,O^/P=Z37D0G"# M.RK_@\V),MQ?*&'0PP]U; =Y/*LK5:QI?D*B"H7ABP9S#B1#AR@&5:D3= M6 MM=%4F;_PB6'V#>2@NEIZ"UD!\'^JR/AZ](CL96= @PT^#4QM8^/LV'W/+XCA?VP/NI M<="A'1.GI:BXZC#4@.'CI6$:N[;F'U!+ P04 " #'$R1U2_EV9S:_^S*JLB:]K#:A_6Y,MFV M'U3D(0@1A45V/,T6\_[WL=MCX4YUL-JLR_^>X M;0ZM6C$+MF:77?+F6WG]P]AKT!WAILSK_F^PN=1-6=R&S((B^S%\'D_]YW7X M3R+L,/< L /@/@#CAP/0#D#? AY^=$06 SUF23 QN# K@KDCPE:!4P;, MZ!1 9$3.*3PP:XJ)GPO!FQ 3:#:))@0> M]8X8040(V"W5@\H!<^HQZOD4,9LB)E/@E228U$-ERB9)"8%^3B % M8^C"Y6DM+6@HIDE!P$TGE M(W4,:IA/Y;-W_2%P6A2/$@ BRIW- M%"1]YN%1 D@H?!H+'B5 4D*"6RH%>00T\"@!$B728RD"'B40^4B-?C7U@.<# MD'R0'HL><$]#XB.5@GP,Q(T*Q(/2IZ'C'D3A(96!/*0B-RH2HTJ/E1.YK1 > M!?=-ZABD/&X>?NIQJ:L\%FCDKD*Z]KI7/0MR+C%VP2,0\ HCY,Y#_:AJ-O@L MZ-%R-P&9%L+]B\2:X$/!K8G$FB#=U_)\Z2:0V*^/0&YRI!VX1_HB]R\2_X+S M.5E:T" V]6PS%/>Y(A8&IWF6#.21THK[7!&?@[-W6#)0Y'3R)&A:#$\,11(# MG(WRDH%\7FIY9"@2&> 1&>K3BS&)#!1NJ;_!XK$ 3HMM%1CKRLMIOJE M1[AI23P8% D&9"Y(K:1Q[R]>5.Q"K:91TW)XR"@2,HA.4RK2_$N13C3DCW#3 MDGC4*-(JH'+?C''OCW';3\O(F7X$V+*)-/+9&U \O11)+]3N1VF<7E)%2NH) M^8^ TUL_/.FVO<;ZG6P*2^G9MA_O9^];]I_@6X?F9U?R=?UL/7^DV8Q/V=[ M\U=6[8^G.G@OFZ8L^BWE75DVIM4F7MK*'4RVO1_D9M=T7^.NI,,&_'#0E.?; M[PGW'S46_P-02P,$% @ W(2M2#I,\K<0 @ 108 !D !X;"]W;W)K M&ULE97+CML@%(9?!7G?@.])Y%B:3%6UBTJC6;1K MDI#8&C ND'CZ]N7B>(SED=--@./__-_!X).BX^)-5H0H\,YH(W=!I52[A5 > M*\*P7/&6-/K)F0N&E5Z*"Y2M(/ADDQB%$4(99+AN@K*PL1=1%ORJ:-V0%P'D ME3$L_NX)Y=TN"(-[X+6^5,H$8%G (>]4,]+(FC= D/,N> JW^Q 9B57\JDDG M1W-@BC]P_F86/TZ[ )D:""5'92RP'F[DF5!JG#3Y3V_ZP32)X_G=_9O=KB[_ M@"5YYO1W?5*5KA8%X$3.^$K5*^^^DWX/J3$\I>+LGA( AM_=6#=V M[-R3->K3YA.B/B$:$F*; !W(EOD5*UP6@G= MM@<7KC5M" MI8[>RBA!!;P9HU[C4O9C33@HH':?142!GQYYB <,XKM![&J,/8/(KS%U$*=I M7(U)'B*$ED')!)1XH-@';1PH&8&R5;)9IJ032NI1$I_B-/NQ)DF7&=F$D7F, M=):1_2EM?\H<.93W!K#U,/GLHZ_'IHU6\7L9L)IC- Y=L MXUVR+'EH/R&:D$RO6+QFO>C3>P9'GSDCXF*[F01'?FV4^\J'Z- QGR+;)C[D M9='B"_F)Q:5N)#API9N-[0QGSA719:"5WGFE>_JPH.2LS#0WK\1U.;=0O+TW M[>&?H_P'4$L#!!0 ( -R$K4AZI>2SI ( /4+ 9 >&PO=V]R:W-H M965T22V^.="FPEPLFZ/'S@W!^RZH*CT$0.15N*C=/.N>O39Y1B^\+&KR MVCCL4E6X^;,F)6U7+G2'!V_%\<3E R_/O%O=;0UF%G+/]M M^"SDC4PB,CNLR];T/Y?HC(FGUQP%2>9=92*E09UFK6FF%!M-D=XDGBA@L@HT M5-$O7Y!6A44"WTC@CQ.$0"\R[MOH-76G@2 " -SG! 8GT#APDA,\P D-3CCB MA+Z.Z27KL20([R,B Q%IK:!)1K20$1N,6&-,]Q$O9"0&(]$8P?T$J9$@G?.. M*C)=6"0$!D3N*)\[1U$TD14&FAAXWSB:QHIBCBM$%M[11%88 @NG5AHCBR,;$RT=&BA.;4PGC&1VN24IM_ETM"WVN6@ M.;LPF3-2J%#)".5'26C',L<B9LZ6G DVCA),[@MT5)#ES> MQK*W_E3:+S@]#X?LVTD__PM02P,$% @ W(2M2 J=!28C @ PP8 !D M !X;"]W;W)K&ULC97=;J,P$(5?Q>(!:FP"A(@@ M-5U5W8N5JE[L7CN)$U!MS-I.Z+[]^H=00&GA!K Y<[X9&P]Y*^2[*BG5X(.S M6FV#4NMF Z$ZE)03]2 :6ILW)R$YT68HSU UDI*C"^(,XC!,("=5'12YFWN5 M12XNFE4U?95 73@G\M^.,M%N Q3<)MZJ"QPG.;Q:HT[C0W9##>H5T+C?1>!@'(Y'B'3>(+H91#[' M:&2PGC=830Q6(X-L7&3JL_2:VFGB,)N'Q!-(/(0DX1@2>T@\@&"4S$.2"209 M0=!=2#*$X 7+E4X@Z7?+U4'2 22+HWG(>@)9CRK!\P;9Q"!;L*G9<"FBU8*U M0.$$8T_VU_L:=2=D*%K%"S!HBD'?[6Q73B?R]: H6G"6$)Z"\()UZT0>%"7K M:45PT&0XE6?72Q4XB$NM?8_I9_M^_>C:-?R4%WE#SO07D>>J5F OM&EUKB^= MA-#4I!$^F(^M-'^4?L#H2=O'U'Z%OL?Z@1;-[9?1_[>*_U!+ P04 " #< MA*U(;+#M?P4" "_!@ &0 'AL+W=O:J!$?G$.VCU3LD%(THO185E)X"< M+8E1G,;Q&C/2M%&1V]BK*')^4;1IX54@>6&,B'\'H+S?1TET#[PU5:U, !4^>DYVAR0U$(OXW4 O1W-DDC]R_FX6/\_[*#8Y (63,A)$ M#U=X 4J-DG;^>Q/]]#3$\?RN_MT>5Z=_)!)>./W3G%6MLXTC=(:27*AZX_T/ MN)UA901/G$K[1:>+5)S=*1%BY,.-36O'WNTLTQOM,2&]$=*!X'RP,[)I?B.* M%+G@/9(=,<5+=AHNC(A61M*J"7=ZG:C4T6N1KA-ED%)BM/('MHXF,V MTR;KP&3M"6P?FGB8.)XVR0*3;"R0Q0]-?,R,?V(3F&P\@1E_Q380V,XHZO:K M14WBP,5C(E6YSMB>5G"O06<1/^K;4^C49 M%A1*9::9G@O77]U"\>[^7 QO5O$?4$L#!!0 ( -R$K4B?H[Y$K0$ !T$ M 9 >&PO=V]R:W-H965T"95W<N1OHX9UW,Z62\S1LQIB=G<-]E@7H.G2Q087JI(VW.U6GA_)$0GO\ MP/.LI37\H[IFTJ"SLJ[)0D=42EEP(=('EZ)Q3WE:<*BLG^[<7,?NC@NKVO&M M3C^,_!M02P,$% @ W(2M2'MYFDXW @ .0< !D !X;"]W;W)K&ULC55=KZ(P$/TKA!\@M(BH01)EL]E]V.3F/NP^5ZU" M;DO9MLK=?[_]0"P--^B#M,.9R-%SF[25(W^(T'XD8I MXO\.F+!N%X+P$7BOKY74@:C(HR'O7%/77;@'VQ) #3&(WS7NA',. M=/%'QC[TY>=Y%\:Z!DSP26H*I!YW7&)"-)-2_MN3/C5UHGM^L'\W[:KRCTC@ MDI$_]5E6JMHX#,[X@FY$OK/N!^Y[2#7AB1%AOH/334A&'REA0-&G?=:->7;V M39;U:=,)L$^ 0\*@,YV0] G),V%I.K65F;Z^(8F*G+,N$"W2OS;8*CC7)(HY M$(:-6[M49T)%[P7,-GETUT0]!AK,P<6 # Z82/%/BL!P3 !'!,F42.EB7I!( M'A+VND_<]'4\3[#T"):C&CTC,MN'Q30&LXSU9UXG]7125\2*KD1M@GB#S"#*7(/&JM)C#"/.*%6M/9#T2 6.1U(JL'2O@BY9O/)W- MR TX:?G&T8D7RVQ>!<2>C!X:U/]7T]>, ]"7@O/6 ME3WH2^\B9R)1S*]F4HO@Q&Z-M+-BB [;8&^6@1<_Z"UA)MV3ILA;=,6_$+_6 MC0B.3*IY:8;;A3&)57GQ0CE2J3TV7 B^2'W,M%5VLMN+9.UC40W;LO@/4$L# M!!0 ( -R$K4A,>)D$/RD ._H 4 >&POP8@V OV&1U-V,V MV>%!L@9[D7?X_YL%=E\N3[+?J8I%LM@'R3(OR^7+9\^*<*X603'(EBJ%;Z99O@A* M^#6?/2N6N0JB8JY4N4B>C8?#DV>+($Z??/-U$7_S=?G-1196"Y66WED:>9=I M&9?WWE7**\19ZAUXQ3S(5?'UL_*;KY_A._S>H?]$*FI_^R;(!][A MR/?&P]%)]\O[@3<:N[\4$+Y7L[@H\P >QLL5/NI\[/W9S=_N_&]J[?G@YXE MSN%4>9# :2+UV?L7==]^[GT>1'$Z\V[N%Y,L:7\; @8[VU9YCKAZ'11X?N\B*#L@'AR,Q@>'HQ[@7L>)RKUS>&^6Y1W(;A9!@M]_KY997B*,Y]EB M&:2=!_51!:[Z^9LR**L._'_KTE%6^"%+@+F"7"#K//8VZWGQHTJ2@T]I=I=Z M-RHHLE1%WE515"KO@S5;+("O;LHL_.1[-\1#7BUY-@UOYV&B1%5Q(R8.^T *S#3T66Q!$<+_)>!4F0A@KP"X)?>'N: M0P2>#VE013$\N \"_N'FPMM[VD6V"HT,'_=)0E 4RB$G03'W@)Q>B#^HGZOX M-DC@\31!6^EZK2RZ8>L'YV1\"#%O*BK)J4TRKQ@C!$_5?@(T^' MM/K3H>\!FRQ56,:W*NE(QW6NED$<%?1P5LY!HL*5<+_/2J#9ZF>^R]+90:GR M1<_WUSEHX1P8'3?%HR^1H/7I0F"0*B$B10J40?G8Y6 M'^\"I+V(2_MXJXYUYB:5'#:)@TF@H8$4^ M#L(T4:F:QMT]+]14P:X1G.Y6I55GP7=\%EEV!60W9; ?L6?8-=I',:E0T4((@LV2$^'@^%P.,+3>J"T*O5G[WCHPT?X?[%+ M7E"50/SX[RKZLY=F^M,8S5[$Q*CM65=AD_U;M=W*_8Z/X9OG_O.3$>UD_;H2 M#"\H/;!RX=RX9?0$*'FUF #C:$6_FHIG$5@-$&_ /&K6@S@]")&9@H[[=-;0 MY??UO2VL_H W ML\T505L"[+PM/'[JF"QXVA^SRY"\;+]Q5]5D)3S$';ST$+'(>PJ_D1G!X$: MSJ\^HXOB,(E900(P[Z[:?O1;\&HPKD1!#:)%G%*@BOK2X:#5_AT]OL#P[.]. M"685EZV%]+NL*+QIGBWTLT +MP,5I^"1=8"Z2D'L%9Q6-NA@8AZD,X4$FP:Q MYG? S%W+)'=L0]^+F]A[UZ' ?03-J;QEGMW&!:(0%2D?RBN#SUW47&_\Y%M0 M=[AG^_-701&'I P3%T1&U%]NJ %X/21]%"<5BM.=BF=S_"&MR.X"@KZLF.** M%'^]!OO3(Z4]:H/L*4?O$:$0=Z@23BAH&?OQ#3D,_]9U#7ZJBI(519F!*(99 M&L:)JK$)G^+/%!-6> X9,WO ;H<9-L[HHX0D25%9!&,B%%AR((@[1/6FVJY M3 @O(%QHW0"2*J>5T@R=%PQ4>>&+)[\/PFLM[[ M\EH-8_E7ZV)4.R9>'T>^W80M.P2HP)O& J9:>ETWWKW(9V&A)[=DDB6=N8^$"RIO&*?#E:E#P MQ4B%.6T 2 LWS?KTIHA!!'"9@UZ-P0R06PHZ :*[V-A, M0L'9 M@E#+R]7W_YSP^#FX'W[=G9]:^__-<^0Y6"AU>%[ ,@13.(FS#=C-_Z MN&).KHH/:AC,2JGU.,: EM$IP/R!D2@PRX['#TC7)JI$'Z=)WQIEE.(CNL C M8(L)W-HE\6LYF)*]1SG,J'Z#R7;"CCG0 ! -;@8X'4OP6G%-!+!6PK :$BYF M'40F,E\ #&#+(3HF9=!Y%F/2J',P\@ ;AZH)J8T<0@,F+EZ8DZ'7C>C3J\5 MT!@M?S%D0^@.%9397NH;LP-T\#AFLB>0UJ.*'[$$,XWBO)@@9 M;:3'.X#->2R'%&:I;(=*A$AQA\((_ 38 OY!ZP[X\&:D/$)6'@/OK)V%\OO- M!C@$A?=T?#*F5!BY? I =GV[K+\$ZTK1DXR3)1@7X(=^QP#,16PS]/1>'#D M+0 N(![Q_QFH@T2VAO6"!6,6#\.046X,UEA N)T!1R,MF>QG806[%=ZW>58M MO;]F"?KJ@./OOCLGS2'?H]X Q(/#L2 U8_P93W@/R#O\RLON4K:UR!+G\UA- MO)8Q##NX#L.'+/69M7RF:&O+.Y7<:LA9USA%J6TA M@!LLI,) 0ND0/&728$T&P(=S1!F7@3R!KW[(_/L3N'3$>#[OC#>:P@1O0K%LDHVR4<\5F@@X(A*8B(X)EET9A_- M+&BO0,(%4O3E40TQZ^7D(Z=*$21!G4@7'>9KF,2A\ #Q:8:DK'+2Z$2P[GOP M;XK&"O;"_07OZ"2EFO)L'6)TK5"MQ(@^9-Z*6 0UNQQ?9&TOY5!:@9 [[ M90)Q&2ED0PF=Q2IH+5KGEA9D]D7:D0?AN+,8:8P,@+N#U9CE 9 ?S 51!]9( MU1UMGP,K,S#L89-FFBHE>EU]%E>1%:/]CEX=S%8PPX @X$P>;Z7=I*(*T=,C M0.E!5(*__O(?$,:#%U,T[)U(8Q,UHCKR+#%R3](F2@+D07,/ O,.HI<\^$3_ M<49%8XC^;JK% AU9@.G&8M:S.IZXAL@F=!4<5S^^/B@;#[;8W9/,./P;9O D M>:?(8A)5V00$W-0N,'=LJ.!VQ(RIILS>*C3%V'F;+%]4"HW-RN%&OS:H TSY*_1G%3.KM\"RU M,G$XA*MK:!A*R_>'G_*X^.0A?A)VA*S5%\ \H*DIQ\0Y 10>'7A%;> ) LPR M$4[@%XX0<\DET>:DY6XMG2QA"]BZG]!*B>EVGI%U2"%AYXK@)/* :SJE8/C H1NTQTVHB%V8E5AO"MNSN1UE( M4.+!0.8XLS%18 #B# M 3:Q,\1!H]P 5)#Z BP,XX(&!E>2(]HD46MPXU0RD MH9H'A88LJL\(MC&U&3-@%'E4XV /;P*!-N?'Y4L?L0^A1!+_'3$KZT? 7[67 M*"\;K?B&ZP:7=CXMC3CQDY:Y24Z<0S0 L=;W*'2,-$H#4#)A#@XE<%82PR*1 M)#39LR64 B6R'"B![@&X1N#W:Z?6L%$=:+"@97\XL2,U!P0D\L, MI3@F/:?%L:*5 K:=]CE"/@(X#U4Y'L_0YB/IYTVH KX@D-5N MX7F6@Z;D0V$0^OKBZIPR5S$^0N$GA*'%EJ$W;\OF/A+#T5R08TF%K6JCH7\Z M' XP=;%I$#=E5QXL5^6 MFRH"YT"Y/G.WUYZ#\?#_WGTNHT/O2/AJ?^R>E1"W'33=F6E^DT M2?G4F$&!4[64O)CZK/(P+JR29;:L77M3NJP3:R!PG",T4;BN&*L@1Z?<*C.# MN"9A);7'@/*,,82;TRFJ.PRS0 4>:"P/F($/7@5<,[:J>^@MPG&&NL1)^A$) MPYOV! MM6L33WM7-^^ T2!(0AGDH-P[&H_/M!M$V>.4,_+6H!12<2ID<7<8Y.F [!=YD=D_>G0ZXY*R3 M+,@C[JP"O8/NA&3L.:%"G$X..%?: S(S: HX))=@1R=5B+W8I]$0312)I? ; M,>$M!A 0A8(0T"E@RTE5RAM@[D!$4<$O8_);/?3[$ ,!Y@%2RC87%A=2\#3E ME;BZ*8?E%M_V^;P F!L"XCK>0!= >[0H8!CZ(OIH(Z=9DC3OR#\Z.?)'QT>T MA+0T5JG\XE 5^/WA\- _&9Z:;JO;($X"'>].*\S::!#;I.<.G&)-+9R=NT:! MBP,DSC@^/S+9ZJ/)4'XZ> F!.N)VQ!J#B"VH:+U E1!PH)D5B4+THPI:5'V'#'-F93: M9S#U)#@X\6\SS@B*FAMTJ):C.4+G33ON8JY,T;&G.EHT^NOJ')#6VRLXT8(( M"=E'H>W9S\G+)UQ(:#(FNGPVN81,TJG8SS9^OYRA 2O+/)Y40@!]W)KV&$"B M&CM(,(;"CQ.E]=M"@6Z/ML.>U.6VI-"#Y-K.I&B>[N<[1'=4A9K M81E^51Q M"GI@)X?R*A&3W+1;Q)RYLM^3\*I>$X2 #A,O6@H?/&_,*5/JUQ1Z?40:9O=A MY3JW4E!Z."RQI&GO%<7@G.3:JF1%O2^;NQQ]1S9'&F1M@%>HGFB+NA&].O(/ MI;%>[T*[;K=5 4Z1E6(@>6F;DDO;1AK3:-/$=)UMPT4Y)8.G&;:6%R]!BXJ[ M?78[&^BK=)?:\[S.40GI/O=.!1C-Z_,1(>.I=S(X.O6^%30
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
XML 37 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 38 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 40 FilingSummary.xml IDEA: XBRL DOCUMENT 3.4.0.3 html 56 151 1 false 28 0 false 4 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.catasyshealth.com/20160331/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) Sheet http://www.catasyshealth.com/20160331/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited Condensed Consolidated Balance Sheets (Current Period Unaudited) Statements 2 false false R3.htm 002 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) Sheet http://www.catasyshealth.com/20160331/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited-parentheticals Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://www.catasyshealth.com/20160331/role/statement-condensed-consolidated-statements-of-operations-unaudited Condensed Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 004 - Statement - Condensed Consolidated Statement of Cash Flows (Unaudited) Sheet http://www.catasyshealth.com/20160331/role/statement-condensed-consolidated-statement-of-cash-flows-unaudited Condensed Consolidated Statement of Cash Flows (Unaudited) Statements 5 false false R6.htm 005 - Disclosure - Note 1 - Basis of Consolidation, Presentation and Going Concern Sheet http://www.catasyshealth.com/20160331/role/statement-note-1-basis-of-consolidation-presentation-and-going-concern Note 1 - Basis of Consolidation, Presentation and Going Concern Notes 6 false false R7.htm 006 - Disclosure - Note 2 - Summary of Significant Accounting Policies Sheet http://www.catasyshealth.com/20160331/role/statement-note-2-summary-of-significant-accounting-policies Note 2 - Summary of Significant Accounting Policies Notes 7 false false R8.htm 007 - Disclosure - Note 3 - Related Party Disclosure Sheet http://www.catasyshealth.com/20160331/role/statement-note-3-related-party-disclosure Note 3 - Related Party Disclosure Notes 8 false false R9.htm 008 - Disclosure - Note 4 - Short-term Debt Sheet http://www.catasyshealth.com/20160331/role/statement-note-4-shortterm-debt Note 4 - Short-term Debt Notes 9 false false R10.htm 009 - Disclosure - Note 5 - Subsequent Events Sheet http://www.catasyshealth.com/20160331/role/statement-note-5-subsequent-events Note 5 - Subsequent Events Notes 10 false false R11.htm 010 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.catasyshealth.com/20160331/role/statement-significant-accounting-policies-policies Significant Accounting Policies (Policies) Policies http://www.catasyshealth.com/20160331/role/statement-note-2-summary-of-significant-accounting-policies 11 false false R12.htm 011 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Tables) Sheet http://www.catasyshealth.com/20160331/role/statement-note-2-summary-of-significant-accounting-policies-tables Note 2 - Summary of Significant Accounting Policies (Tables) Tables http://www.catasyshealth.com/20160331/role/statement-note-2-summary-of-significant-accounting-policies 12 false false R13.htm 012 - Disclosure - Note 1 - Basis of Consolidation, Presentation and Going Concern (Details Textual) Sheet http://www.catasyshealth.com/20160331/role/statement-note-1-basis-of-consolidation-presentation-and-going-concern-details-textual Note 1 - Basis of Consolidation, Presentation and Going Concern (Details Textual) Details http://www.catasyshealth.com/20160331/role/statement-note-1-basis-of-consolidation-presentation-and-going-concern 13 false false R14.htm 013 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Details Textual) Sheet http://www.catasyshealth.com/20160331/role/statement-note-2-summary-of-significant-accounting-policies-details-textual Note 2 - Summary of Significant Accounting Policies (Details Textual) Details http://www.catasyshealth.com/20160331/role/statement-note-2-summary-of-significant-accounting-policies-tables 14 false false R15.htm 014 - Disclosure - Note 2 - Employee and Director Stock Option Activity (Details) Sheet http://www.catasyshealth.com/20160331/role/statement-note-2-employee-and-director-stock-option-activity-details Note 2 - Employee and Director Stock Option Activity (Details) Details 15 false false R16.htm 015 - Disclosure - Note 2 - Fair Value, Assets and Liabilities Measured on Recurring Basis (Details) Sheet http://www.catasyshealth.com/20160331/role/statement-note-2-fair-value-assets-and-liabilities-measured-on-recurring-basis-details Note 2 - Fair Value, Assets and Liabilities Measured on Recurring Basis (Details) Details 16 false false R17.htm 016 - Disclosure - Note 2 - Fair Value Measurements Using Significant Level III Inputs (Details) Sheet http://www.catasyshealth.com/20160331/role/statement-note-2-fair-value-measurements-using-significant-level-iii-inputs-details Note 2 - Fair Value Measurements Using Significant Level III Inputs (Details) Details 17 false false R18.htm 017 - Disclosure - Note 2 - Fair Value Assumptions (Details) Sheet http://www.catasyshealth.com/20160331/role/statement-note-2-fair-value-assumptions-details Note 2 - Fair Value Assumptions (Details) Details 18 false false R19.htm 018 - Disclosure - Note 3 - Related Party Disclosure (Details Textual) Sheet http://www.catasyshealth.com/20160331/role/statement-note-3-related-party-disclosure-details-textual Note 3 - Related Party Disclosure (Details Textual) Details http://www.catasyshealth.com/20160331/role/statement-note-3-related-party-disclosure 19 false false R20.htm 019 - Disclosure - Note 4 - Short-term Debt (Details Textual) Sheet http://www.catasyshealth.com/20160331/role/statement-note-4-shortterm-debt-details-textual Note 4 - Short-term Debt (Details Textual) Details http://www.catasyshealth.com/20160331/role/statement-note-4-shortterm-debt 20 false false R21.htm 020 - Disclosure - Note 5 - Subsequent Events (Details Textual) Sheet http://www.catasyshealth.com/20160331/role/statement-note-5-subsequent-events-details-textual Note 5 - Subsequent Events (Details Textual) Details http://www.catasyshealth.com/20160331/role/statement-note-5-subsequent-events 21 false false All Reports Book All Reports cats-20160331.xml cats-20160331.xsd cats-20160331_cal.xml cats-20160331_def.xml cats-20160331_lab.xml cats-20160331_pre.xml true true ZIP 42 0001437749-16-031856-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001437749-16-031856-xbrl.zip M4$L#!!0 ( -R$K4@MRF,\0($ +Y2!@ 1 8V%TX9W$B !.\@A5//$U,D,-/=T]W3/=.7?_[?EY'-GK@G+-?Y M^40[;9PP[ABN:3F#GT]^>ZA?/ES=W9W\WP___%_U^B_Z[UL77S^RWQRO6;&C=>J-3UUKU^H=_OO0\VWJ'_V4P MGR-^/AGZ_OC=V[?/S\^G^/6IZPW>-AN-UEO+$;[N&/Q$/OG.T/WTX_"%+B9B MR'7;'YX:[N@MSM5HM;3H%3=P?&\2O443"&Z<#MRGM^I'?*E5;VCUQ&N!YP'N M>>^I7_'%=OI%DUO9[\ /&8_S%V.8_3S^DO&"Y3QQX6>_(G_+P,82;KNIG[J(UL71+4-DPT0_(4A:&B3'=9Q@E#V'Z7MO_SG/PR\9+_B2E4U@Y11PWZY_N;4 [X% -@N? M#D1]H.OCZ,F^+GJ$@OKAK63]Y 2![^52]N(M_!H^B#^84\RDGNN^E3\F'[66 MD*.7F?5];M'3VL7%Q5OZ-7I49#T'HVIO__OSIP=CR$=Z?69\82WSUH?_^3\8 M^R?.^D[03]]XGQ$4[X8>[_]\@G)?#R7[]$68)^IGY)*?3X0U&MO\Y*T_.3!GX''SNU1Z LO1$",/.,?'<>J X4N#=H5@$@&AW7KV7R[1+K((5)K%2)=\YY_!V+E@=)TX)// M/=@1OL$^?=F'SY]U/_ L?W(-7V12JS5%K4^6PV$FX%C+O]4-4(#^1%$IL&#K M5:1Y&+J>_\B]$6S[AE#'.RKYXXL(5QO\L7U^2*2-+N=')(T3K6FHLH2 MB";(1Y#:6I%%N*8H,?ON@? ^I\LO8?B8''Q MU;4M8R+_^PB$^&B[QO=BK*1@[+:ZC>[)A_]M^^]-ZXD)?V+#MF9:8FSKDW?, M:_'^N7G^Y^^?*.V;SOOV>?+[_]<@=_P1OOV:>[+S?U7V_N?OGU$08Y;78* M@75[_^6Q_G#W_]W(B=47MY>?[S[]YQU[)#B_ )S?$,Z:_*+&!,A%OSC:S]P: M#/UWK.?:YGMZ32TM2ZPMCO06A@I'S?N\#DG>RS?NOES??,&OS@LNWMI4TD?C M]TY/C(\.LSN'T>9#GF>-/7/P8W&',&$&WV4Z&T<[$G-@2V+/EC]D2CW5&"@' M$2 CP+//0PO&@1$\L@=@"'TP\$"QP5L#SQ4"QS(X-P5S^^P'L !KH.F!PSSF M#SD38&^E?K <>,%R#&NLVTR79N@;?))6XZ_ ]=_'H+-XYV2X=<;/_'0*3C=G M^8\R2S SD)C!G*T&ZP4"B L F_J$@#7!TG;(?U>8SP(B=U&&VVAB[AK#]PR0 M%I 0^(Q4I?V7X8D L3KL/H4N0%C@++;@QQ1, H7N1V1RZ<&.HP.4+O!AYH]]$(\ 0+S/@.D/KX M#G^!W<."]P%E0ZYZX[1]1I#1V[60F\)) 0<[,.%[$?3^Y 8Q'&QGOF[A: 8? MTX8(X[-^8-MUH"ZX1SB7;]5-RP[P9^0_G]/6&0MTO)#_> 'N,)(\I;2[8")S/ M.MNV6?8UU]2\^)'A9Q_=WQ"*-29]SWZ_NW[\]1T[[_P8KGK]FUII_"JUT(WQ MRWM@8M,?OF/@-L%?)Z 5;5N,P0/%H^B&_'N,2E[]W7,]DWOX,0;>BS^:&T'B MWS??'N^N+C^%3-QS??# U[$XYV@IWZS +P#^>_;Q_MOUS;?ZQ_O'Q_O/[]@_ M&O0_IHU?F "?S'R?JWCJGVYNB=]\8"@7^\C+(FCQD3X=VAF4T M3LXXK*75<(/9P%#=HJ[6_EAKQ$T+#%;'132^7EY?WWWY)?H1]-3V1>EM4JEY MX1P?+Z_^]O[C_=?P,A,, EZ?=/-DVH4(TW?YQ#M,70) 5+B6), MQE@\'^^_[E6X;E[&8%B# ?3D@K%$=M:.&5/16UN9W%-L]9HA[,P!,:G=/13- MV2UB$1Y:JW6J7>R/RLO "RKLV<-K2_GOXAVO-"=[/Q85P,*:LD__V[BF7$(8 MIB$X$.V(=U'UOL=Y^OCG(#1D@N0EU9#[@' ;&C*!!W"F5G+]J*"M]./6+N*S I.R77EG.LR?PE MJ RSG;FM,(EE>TOW+O&?1WN?5F%65LQ^YVP( M=BNSA CP2CD9,T ()^,EDL$0\1-@WUYS@R+S\(I J[%;WO,"W9O@G\T:NQQ[ MEHV?.S7V_P)[HCYB;$E\Q@G0C11 2&(F,X\_E=@>1Q#.7%BDZ,WX,'7 TO( M&"45:4*W[E%,B=NGR4(PPE 2BT) !6SS^*8;^/A11:@XON?:IPD>C3[-D!2C MG[E9]]TZ??(9UV%PCX]=CX@U!L9PS5INM BB+]0U$ M#NF9T.C 'V.;^QR6 M6'#?MQ%2#]TAH,/6 D\J!; 69K7V1@>AV%0S>8YQ5!)"1A@>!-]?=IA(\NV*4X+6![-5A &>X)_ MR? 4D!"$PN-/NAU0"'P8@34= @-B/Y>7LCZK\-^"(;VS0< 8\EXHCOZ*5)4W MQECB+_J(SX9#IP+@NR:A2 X(^'H"= .8%BNGF" M_T1Q_%/?S\#;:ET4@-?UOH.&N-+',*-]S?N@,%9*P#EOY4;9-]MT]1_"D36C MA,CDUKM+T, F:N%;6Q\L$:U=U]HG'_H &?_GVYEQXN&O*$70O[6$H=O_X;IW MXYBY:1NP8E1,A'OI+6OH7O"F8V* 1;)Q_^2TV9 M.V#>G C6\C,V3S[@MUES1@/.SBC!68&PFB;GD]^F9TT-.CLG2L524S6 ,1OU M_TI/@J/$8\L4B2O*\K'O0,>^_(M/EID$R =\KVFMKG;6EC-ECCDS)1EN#VBC M/)#1<0\&A ]:&O?R+-GLX%)ERF9]-H])VC$G'SJ=1N/LK*NE )LS\PR4DNV_ MA=;(@Z_[R_$7Z-/_<)&:/W/,Z9EO+9M[5\ ' PRK7F+"SLF'!Z 0O,VB*1C@ M/-:=21*,U 33LW\CDQ!U*2KLI9CNY,/5Y>/EPW\>:NSNR]5I_ZA-TXA6?Y>=(;34+ M*KUUMIKM_*WS@C;.^5BLA6E>=E:CTH)OZF[[]Z+GA<_N2K#6(*OV$*\7BT"G5; M[?PU[VB=:40V N2N4%^PA*UV)Q?U]H6V"]15$@H83KIEWCG*%%U>1%JYB]CL MM,"Y2N.2/>N*H"V2DU8ND0&TQK2H% +-!F<+5X(,@X^8@8 [)P?5B._B[88C M"FV'?^#Z1,[.XS,L$'ASTNJXHZQJ4)[XC'* 'BW?!F4*UA)>G 2Z3>_=C,:V M.^%3AC"UB?Y2J+C2SW,Q[W MWKK>M1OT_'Y@S]9R6-5*:;5SK90IN O#L%'P%^Z%N>;,AL!/[([W_5O+@6'P M\,45OM0)0@ZS7H6%\UR%T=2F%$9!>#:%Q?RR"^=+E5V(H '=*Z\DGO@#F/H> M'4W>O%#.J'GKN2,4BL!7X-[HGH/UB;YRC\0FH\9- 8)/26Q#RW7K6V"=G^&9 MS4;AW0D)LE8KGP3-7!(T6^W&1?>BO5T:",&G6*Z QFI=7)SG*]ON65I::(IB MT\[7-#!MKN'3/#]O%)QV134-L^=)V@>MU>AFS)ZMS>8#L9 $N7M%$U3!5P;!GL.*^370%N-%90?^ GK M.=SW;&M ZA%M2V/54Z5\_ZN5=I<7SKTVJ(M84Q 5 V C4&41.,VTS=V>XT*;)O"N@VPN!SC\;;4RS\>XH MO4 ]Y!\SG[>W W-I-LE6_JE/HPB3%="4^\0_:Q/-4UYS=Z/]HI&UJ:[DH:V/ MQIQ--E?TM\I*\OK[3A57NN:JR-(Z;KN6OQ?7NYTB*B$;J$VB,]\CG-)ON?MU MO=O<,CIK%!G4NBVM%RMO 7R,4LP,H4"IDK;8ER?+#3+,+-X M Q5%B@5G5O&FI8@W_9U'@P;"-6MA\1YU TMP[\XED# MR]%M-@K+!E*,="),K4 :^.Q03#4L)A@+?KX]47 M0#*)BO,%-)*.<*;9UI!LZP';2B0$53FD"66EQ.F921RP0B,?N\**BK8]X]3/ M&.%N6V"H4/"T(H2<@YLU]E>@4\6W?@IZRZ?0=2'CY>-Q:>Z1/J%Z@O#W+0<* MPSO7\@EVAP7)*4K^RO7&KD+J3;)VX.WUW56J6"!35\@9"K[?HO?5(T(5<\7;K-.9%*M-?%YH M 69%ED>OV+H0]WUUPWKO?<.-[48E@GS%5)+H1Z%^%5J^HU0D]CR_%GO.)4)] MS+UZ^C($:YTF\%X%B6W184L1\+F!=GG>Y-ZH%O8,B*^DKC ZU?PXF1YM6WPT MVPLBI$"[D[X56A.![5-CY]S4R+^ ;&R3=G&,]E?=N_N<'K< MZBRC4C"L/8'>8H@V@$+&4?(T"CD'&EM&04;*7P;^$&Q?3+%:@?K=?&;J--3_ M,J&=GGP-*!<3N)L?=K!1*.]D>NLJ=,R/"HCS'1;,NR)P!+>C#)NP9P:*)O%G=^.I_AK;#-43*B:!YM=DW% M;?3&RB+D([IVA2D)1E ^)5LK4O*)>[X%"&*CJ4)Q"(G[_-7NDHK/N3"@(%\@G#EL>P#]Y[ D=Y):ZBI? GL6QBV;HU@-'U"-PFRE$V?XTQ@#PYDKV05]/ I^S73"0D@M$7EDA6X;!DYQ99P 7_DG5CL%V1 M;0U0[[.1K-&C&ER):*13)B]E #3#EQ<4IDN9/808; .8A0%(\:'^9+EXJY"F M2A^1P&PO( 4VA4):U '!>@1K3X<%H'E,[G,/*,'E_8L>0C741=QZ*WKO>G;9:?)12R51BGZYH@(+O)"\"IN\9;=>&;M=A MT@'\@BUZY%CYOV2-DYI9POXY"3E1!H<(6X@A84)N0*D 2>M[^@B[6M&-G&V' MM8V );"J"Q"9VUQ>J@%],2L,+[)4,2 2!FJ1)A MN)(?,7LQ'>.9FG4YB)8(8FFTYR XTDLWHW MKMT@9R\ MPC.[QGD>%>;A-X\NA>OT;9,4"=Q;)Q^^MAK7>6C&I?.R?__-T66B,H]2DE?/ M:R]2B*#H])L">F$V>ZZ6V3[0:R2EM=JYLK\,W'F'M&N!OI#DN3'\FP&]S^%K M\QO$J5OK=R__$WH['QJ#\J?=QT(%YW0:_F;P,7Z$-(MU^KUN'(U0K-YULT! M+CGE:F M+,B5OZC=\]8*8,5EGJ:J.ZWGZG=RLT-:S2DHYDC.'O'F@; +X90A^EI^4/,W!RP/O64]TM/>+;CF?7"'N MG?B[+WS=0B!GN1?]]>D"9 M!61ORI>IWG,TIGC;CDJP(>:)T]'833V-/*U=X MY]XR[P[DC%S13MZ]=$E ;BU*[^WD"D&K>][)8:4$U.L@-@>J7 ;?&%0K&Q/: MG%"$(K#E[-W+@!@9%@FH\M9Q>49<-C9D-S,OC!#)UXG@I"Q>EGP;-'QXK3B1 M;JL+YMXAQHD+.R[IQDAYVLVX+H9Y8("<-+)7@R M\'B85A@Q1-AV8$T(5PT5<,DQ@*CT9F[H=N&++F;VU:&VLG0/;8IV^'@(WT7 MRQ12"R A@I&L2/GNV%:L,"]&;<*H:=@FN[>=8_,YU:;MFZ((?I4B2&/\\A[6 MW?2'[]A9 _\Z80:W;3'6L70B[3OX]Q@O7M3?/0RV\/!C#'RB*>0V^SQNZ6YQ M\QWTCA+\]^SC_;?KFV]1V\Q_R%0.IHU?F "#P7R?*Z!QIT!@*!?YR_GYI+FX M%:!!JNZ0MV&Z5]A /80P]78#0W4+A]_LCK6^7EY?WWWY)>(MX*GMB\N^VVB' MJKJY[0LG6.K[ME[Z)ZMM5JGVL7^J+QN"^W#B--:J<%M MU?=[&TN!*4WU/A;%2(5;'82&K+I_[Z/[]VFG[/KQ=38 WX?S6X^]DXV-G MVB?N840<#\U)F_)>+(=-N.[-3PPKBSJJ3,H]F)2-T_-&R17F'(,R?Q4JVVQG MGJN);;.X8QZ$DJFLLGU89277,*_3)'M+UROQGP>5('ZT]YIX*L = M5=K4<$A,%O3-,:/]54AI;) M^Y@R1F !2!P?)Z@5J@KB,+TX (I34J/ZWI67O*KL9P:IL#HP0J>H3P5 ;5N] MQ[#;-6;M4Z)Y(%(+2_G?OLMP "P62N/+++4^CM/G%MY8BVF6TK$Y8B)Q#$8( MVR#.SQ8[1#$[7@52N%PM\5X4/I$HL* SVQ64!OF#=MIB(\Q\IP1'D_W02-:0 M(,;B3[H=1%**>B0KIJ(&#PH4?OC6GLRM?KPH$3$O'FLJ;BO@CVZBX?A:(7^Y M ?#M[G3^0.ZTJX.7%>ZW4JCL=&^^C[JP#.H":0?^5%V^I>.I&V.T1R2&66E([6E)2HUB*P:#VL=+* MIK.D,'+2X?[4>V!S&%1V4_HJ0^ 8KMR'1$DH684GINB,;>U0^6AJ:*%&(Y6. MCD146M4$7T+!(8<]C3A\15QB@-(#9$(_ZQ#, (U"%S;F#;^+NU(4P^G8F.UX MQ>@J9X%K8PE)"[X&W"X" MBL^-PIBYJNI/M=M0/E->[K.J/,*&P-&LQ[F#?5.HB33KP^Y)0YA*Q+BRCQ+2 M%097DRM"OK;E,=[OXW&!A5/X5CT4AVT7W%I@ODW9>LJ+5M;^)G*0&KG)+MI9 M(YUWN7#VM8%=F.:7P&D⚽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�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end